Systemic Inflammation Uncovered With Chiropractic Rehabilitation

Explore chiropractic rehabilitation for systemic inflammation and its impact on chronic disease and immune health in this comprehensive guide.

Abstract: Unraveling the Single Root of Chronic Illness

In this comprehensive educational post, I will guide you through the intricate world of systemic inflammation, a persistent, low-grade immune response that modern science now identifies as the single unifying mechanism behind many of our most devastating chronic diseases. We will explore how this state of constant immune activation, driven by a specific type of immune cell called the M1 macrophage, fuels conditions ranging from type 2 diabetes and cardiovascular disease to neurodegenerative disorders like Alzheimer’s and Parkinson’s. I will break down the complex immunology, explaining the crucial difference between the “burn it all down” M1 macrophages and their “clean it all up” counterparts, the M2 macrophages. Drawing on groundbreaking research from leading journals like The Lancet and Nature Medicine, we will see how elevated inflammatory markers are as predictive of mortality as well-known risk factors like smoking. We will also delve into the critical role of the thymus gland in immune regulation and how its dysfunction can lead to what is commonly mislabeled as “autoimmune” disease. Finally, I will connect these cutting-edge concepts to our clinical approach at Injury Medical Clinic. I will explain how our unique, multidisciplinary model—integrating my expertise in chiropractic care, functional medicine, and as a Family Nurse Practitioner with the invaluable medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD—allows us to address the upstream root cause of inflammation, rather than just managing its downstream symptoms. This post will illuminate how integrative strategies, from precise chiropractic adjustments to targeted functional medicine protocols, work synergistically to restore balance to the body and pave the way for true, lasting health.

Introducing Our Collaborative Care Model at Injury Medical Clinic

Before we embark on this deep dive into the science of inflammation, I believe it’s essential to provide some context about our unique clinical environment and the philosophy that guides our patient care. I am Dr. Alex Jimenez, and my journey in healthcare has led me to acquire a diverse set of credentials: DC (Doctor of Chiropractic), APRN (Advanced Practice Registered Nurse), FNP-BC (Family Nurse Practitioner-Board Certified), CFMP (Certified Functional Medicine Practitioner), IFMCP (Institute for Functional Medicine Certified Practitioner), ATN (Advanced Therapeutix Network), and CCST (Chiropractic Certification in Spinal Trauma). This extensive training reflects my core belief that true healing requires a multifaceted approach that honors the body’s intricate, interconnected systems.

Here at Injury Medical Clinic PA in El Paso, Texas, we have built a practice on this very principle. Our strength lies in our multidisciplinary, integrative framework. I am honored to work alongside Dr. Maria Guadalupe Cardenas, MD, a distinguished physician with over 40 years of experience as a board-certified internist. Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing essential medical oversight and a depth of clinical wisdom that is simply irreplaceable. Her Texas MD License is #J2933, and her NPI is #1164426749.

This collaborative setup, where an MD provides medical direction alongside a chiropractor and functional medicine practitioner, is a cornerstone of modern integrative care. It allows us to offer a comprehensive spectrum of services under one roof, including:

Medical Oversight (Dr. Cardenas): Ensuring all treatment plans are medically sound, safe, and appropriate, especially for patients with complex comorbidities or those requiring medical interventions.
Chiropractic Care (Dr. Jimenez): Focusing on the biomechanical and neurological integrity of the body, particularly the spine, to optimize nervous system function and reduce physical stressors that can drive inflammation.
Functional Medicine (Dr. Jimenez): Investigating the root causes of disease by looking at genetics, lifestyle, and environmental factors to create personalized treatment plans.
Personal Injury and Rehabilitation: Providing specialized care for individuals who have sustained injuries, guiding them from acute pain to full functional recovery.
Advanced Diagnostics and Therapeutics: Utilizing cutting-edge tools to understand and treat complex health issues.

Together, Dr. Cardenas and I, along with our dedicated team, bridge the gap between conventional medicine and holistic care. We don’t see the body as a collection of separate parts but as a single, dynamic organism. This integrated perspective is precisely what is needed to tackle a pervasive issue like systemic inflammation, the central topic of our discussion today.

The Unseen Fire: Understanding Systemic Inflammation

In my years of clinical practice, I have seen countless patients come to me with a constellation of seemingly unrelated symptoms: joint pain, brain fog, fatigue, digestive issues, high blood pressure, and stubborn weight gain. They have often been to multiple specialists, each providing a different diagnosis and a different prescription. Yet, they remain unwell. Conventional medicine has traditionally focused on treating the downstream effects—the smoke—while ignoring the upstream fire. That fire, more often than not, is systemic inflammation.

So, what exactly is systemic inflammation? It’s what happens when your body’s immune system, your internal defense force, gets stuck in the “on” position and never turns off. Imagine a fire alarm that blares constantly, day and night. Initially, the alarm serves a vital purpose—to alert you to danger. But when it rings incessantly, it becomes a problem in itself, creating noise, stress, and chaos. This is precisely what occurs in the body. Acute inflammation is a life-saving response to injury or infection. It’s the redness, swelling, and heat you feel when you sprain an ankle. It’s a targeted, short-lived process designed to eliminate a threat and initiate healing. Systemic inflammation, however, is different. It is chronic, low-grade, and body-wide. It’s a smoldering fire that silently damages tissues and organs over months, years, and even decades.

The Cellular Architects of Inflammation: Meet the Macrophages

To truly grasp this concept, we need to zoom in to the cellular level and meet the primary orchestrators of this process: the macrophages. These are biology’s main innate immune cells, the frontline soldiers of your immune system. They are versatile, dynamic cells that can change their function based on the signals they receive from their environment. Think of them as cellular chameleons.

From my perspective as a functional medicine practitioner, understanding this cellular behavior is paramount. The key insight is that macrophages exist on a functional spectrum.

M1 Macrophages: The “Burn It All Down“ Brigade: At one end of this spectrum, we have the M1 phenotype. When a macrophage adopts this M1 state, it becomes fiercely pro-inflammatory. Its mission is to destroy invaders—be they bacteria, viruses, or damaged cells. To do this, it unleashes a powerful arsenal of chemical weapons, including inflammatory cytokines like Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-6 (IL-6), and Interleukin-1beta (IL-1β). It also produces reactive oxygen species (ROS), highly reactive molecules that cause oxidative stress and cellular damage. Think of the M1 macrophage as being in a “burn it all down” mode. In an acute infection, this response is essential for survival.
M2 Macrophages: The “Clean It All Up“ Crew: At the other end of the spectrum lies the M2 phenotype. These macrophages are anti-inflammatory and are focused on resolution and repair. Their job is to complete the inflammatory cycle. They produce calming, healing molecules like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β). They also secrete an enzyme called arginase-1, which helps promote tissue growth. M2 macrophages are the cleanup crew; they clear away cellular debris left over from the battle, coordinate tissue repair, and effectively tell the immune system to stand down. Think of the M2 macrophage as being in a “clean it all up and rebuild” mode.

A healthy immune response involves a seamless and timely transition from an M1-dominant phase to an M2-dominant phase. The problem in systemic inflammation is that this transition never happens. The macrophages get stuck in the pro-inflammatory M1 mode. They continuously pump out TNF-alpha and IL-6, not just in one isolated tissue, but throughout your entire bloodstream, bathing every organ in a toxic, inflammatory soup.

The Stark Reality: Inflammation as a Predictor of Mortality

Just how serious is this? The gravity of this situation cannot be overstated. For a long time, we understood inflammation was bad, but we may have underestimated its direct impact on overall mortality. That changed with compelling, large-scale human studies. For instance, a landmark 2022 study published in The Lancet provided chilling evidence. Researchers demonstrated that elevated blood levels of IL-6 and TNF-alpha are independent predictors of all-cause mortality. The hazard ratios—a statistical measure of how much an event is more likely to happen in one group versus another—were comparable to those associated with smoking (Myrberg et al., 2022).

Let that sink in for a moment. Having chronically elevated inflammatory markers in your blood is as dangerous to your long-term survival as being a regular smoker. This finding fundamentally reframes how we must view and treat chronic disease. It elevates systemic inflammation from a contributing factor to a primary therapeutic target. In our clinic, when we run blood panels and see high-sensitivity C-reactive protein (hs-CRP), IL-6, or TNF-alpha creeping up, we don’t see it as a footnote. We see it as a five-alarm fire that requires immediate and decisive action.

The Unifying Mechanism: How One Problem Creates Every Problem

One of the most profound paradigm shifts in modern medicine is the recognition that many distinct chronic diseases are not, in fact, distinct at all. They are different manifestations of the same underlying pathological process. The common denominator, the single unifying mechanism, is chronic low-grade systemic inflammation, a concept often referred to as “inflammaging” (a portmanteau of inflammation and aging).

A pivotal 2023 paper in Nature Medicine articulated this concept beautifully. It showed how inflammaging is the fundamental process driving the development and progression of what we once considered separate conditions: type 2 diabetes, cardiovascular disease, atherosclerosis, dementia, and even many forms of cancer (Pawelec, 2023).

This is a game-changer. It means we can stop playing a frustrating game of whack-a-mole, chasing individual symptoms and diseases, and instead focus on extinguishing the central fire. The CliffsNotes version is this: If you can successfully fix systemic inflammation, you are simultaneously addressing the root cause of essentially every major chronic disease that threatens your health and longevity.

Let’s explore how this destructive program plays out in different organ systems. The insidious nature of systemic inflammation is that it doesn’t give you one problem; it gives you every problem at once, because the same pathological M1 macrophage phenotype runs the same destructive program in every tissue simultaneously.

The Brain on Fire: Neuroinflammation and Cognitive Decline

Nowhere is the devastation of systemic inflammation more apparent or more tragic than in the brain. Your brain has its own resident population of macrophages, specialized immune cells called microglia. In a healthy brain, microglia are caretakers. They prune unused synapses, clear away metabolic waste, and support neuronal health. They are primarily in a quiescent or M2-like state.

However, when the body is steeped in systemic inflammation, or when the brain itself suffers an insult (like a traumatic injury or infection), these microglia can shift into a chronic M1-activated state. Once they flip this switch, they become arguably the most destructive force inside your skull.

Cytokine-Mediated Damage: Chronically activated M1 microglia start spewing out the same inflammatory cytokines we discussed earlier—TNF-alpha, IL-6, and IL-1β. These molecules are directly toxic to neurons. They disrupt synaptic transmission, the very basis of communication between brain cells. This is like having constant static on the line, making it difficult for thoughts to form and memories to be retrieved. This cytokine storm wreaks havoc on the delicate architecture of your neural networks.
Oxidative Stress: M1 microglia are also potent producers of reactive oxygen species (ROS). This creates intense oxidative stress, damaging cellular components like lipids, proteins, and even DNA. The brain is particularly vulnerable to oxidative stress because of its high metabolic rate and its high concentration of fatty acids, which are easily oxidized.
Suppression of Neurogenesis: One of the most critical functions of these inflammatory cytokines is shutting down the production of Brain-Derived Neurotrophic Factor (BDNF). You can think of BDNF as the “growth hormone” for your neurons. It is essential for neuroplasticity—the brain’s ability to learn, adapt, and form new connections. When BDNF levels plummet, the brain’s capacity for repair and growth grinds to a halt. Neurons become more vulnerable to dying off, and the formation of new memories is severely impaired.

From my clinical observations, this process of neuroinflammation is the common soil from which a host of neurological and psychiatric conditions grow. We tend to categorize them as separate diseases with separate causes:

Alzheimer’s Disease
Parkinson’s Disease
Dementia
Chronic Brain Fog
Depression and Anxiety

But the latest research compels us to see them through a new lens. These aren’t fundamentally different brain diseases. At their core, they’re the same neuroinflammatory issue manifesting in different architectural locations within the brain. In Alzheimer’s, the inflammation may be concentrated in the hippocampus and cortex, affecting memory. In Parkinson’s, it targets the dopamine-producing neurons of the substantia nigra, affecting movement. In depression, it disrupts the circuits of the prefrontal cortex and limbic system, affecting mood regulation. The location changes, but the underlying pathological process—chronic microglial M1 activation—is the same.

The Body Under Siege: Inflammation in Other Tissues

This same destructive pattern repeats itself throughout the body.

Adipose (Fat) Tissue: In obesity, adipose tissue becomes a major source of systemic inflammation. Fat cells (adipocytes) enlarge and become stressed, attracting M1 macrophages. This turns your body fat into a veritable factory for inflammatory cytokines, creating a vicious cycle where inflammation promotes fat storage, and that fat, in turn, produces more inflammation. This is a key driver of insulin resistance and type 2 diabetes.
Liver: In the liver, chronic inflammation driven by M1 macrophages (known as Kupffer cells in the liver) leads to non-alcoholic fatty liver disease (NAFLD), which can progress to more serious conditions like steatohepatitis (NASH), cirrhosis, and liver cancer.
Endothelium: The endothelium is the thin layer of cells lining your blood vessels. When it’s chronically inflamed, it becomes “sticky,” promoting atherosclerotic plaque formation. This is the root cause of atherosclerosis, which leads to heart attacks and strokes. The M1 macrophages in the vessel wall engulf oxidized cholesterol, becoming foam cells—the primary component of these dangerous plaques.
Muscles and Joints: In my work as a chiropractor, I see the musculoskeletal effects of inflammation daily. Systemic inflammation can sensitize pain receptors, leading to widespread muscle aches (myalgia) and joint pain (arthralgia). It contributes to cartilage breakdown in conditions like osteoarthritis and is the central driver of inflammatory arthritis like rheumatoid arthritis.

The takeaway is clear and powerful. The patient with diabetes, the patient with heart disease, the patient with dementia, and the patient with chronic pain are not suffering from unrelated problems. They are all suffering from the consequences of a single, dysregulated biological process: a macrophage population stuck in overdrive.

The Immune System’s Misdirection: The Role of the Thymus Gland

So, why does the immune system lose its way? Why does it start attacking the body it’s meant to protect? This brings us to a small but mighty organ that is often overlooked in adult medicine: the thymus gland. Located behind your sternum, between your lungs, the thymus is the master training ground for a critical type of immune cell called the T cell.

Think of the thymus as the elite special forces training academy for your immune system. Its job is to perform rigorous quality control on developing T cells. This process, known as thymic selection, is a marvel of biological engineering.

Positive Selection: First, developing T cells (called thymocytes) are tested to see if they can recognize the body’s own “self” markers (MHC molecules). If they can’t, they are useless, as they won’t be able to recognize infected cells. These cells are eliminated through apoptosis (programmed cell death). This ensures the T cells that “graduate” are functional.
Negative Selection: Next comes the crucial step. The T cells that passed the first test are now screened for their reactivity to the body’s own proteins. T cells that bind too strongly to “self-antigens” are identified as potentially dangerous—they could attack the host’s own tissues. These autoreactive T cells are also rigorously eliminated. This step is critical for establishing self-tolerance, the immune system’s ability to distinguish self from non-self.

Only the T cells that pass both tests—those that can recognize pathogens but do not attack the host tissue—are allowed to “graduate” and enter the circulation as mature, competent T cells.

When Quality Control Fails: The Myth of “Autoimmunity”

What happens when this intricate process of thymic signaling and selection fails? This often occurs as we age (a process called thymic involution) or due to chronic stress, nutritional deficiencies, or environmental toxins. When the thymus isn’t functioning properly, the quality control system breaks down. T cells that should have been eliminated during negative selection are allowed to graduate and circulate throughout the body.

These are rogue T cells, programmed to attack your own tissues. One might start attacking the synovial lining of the joints, leading to rheumatoid arthritis. Another might target the myelin sheath that insulates nerves, causing multiple sclerosis. Others might attack the thyroid gland (Hashimoto’s thyroiditis) or even components of your own DNA (lupus).

This is the basis of what we call autoimmune disease. However, I want to propose a semantic but important shift in perspective. The term “autoimmunity” suggests the immune system has gone rogue of its own accord, that it is attacking the self for no reason. I believe a more accurate term is immune misdirection. The system isn’t inherently faulty; its education was. It’s not a suicidal system; it’s a miseducated one. There is no such thing as “autoimmunity” in the sense of a system designed to attack itself. There is only a loss of self-tolerance due to a failure in the upstream regulatory and training mechanisms, primarily in the thymus and in the balance of regulatory T cells (Tregs).

The Downstream Fallacy: Why Our Current Approach Is Failing

For decades, our medical system has been built around managing the downstream consequences of this immune misdirection and systemic inflammation. We have developed a massive, multi-hundred-billion-dollar industry focused on symptom suppression.

Consider the blockbuster drugs of our time:

Statins: Prescribed to lower cholesterol, a downstream marker of the inflammation-driven process of atherosclerosis.
Metformin: Prescribed to manage blood sugar, a downstream consequence of the inflammation-driven process of insulin resistance.
SSRIs (Selective Serotonin Reuptake Inhibitors): Prescribed to manage depression, a downstream symptom of the inflammation-driven process of neuroinflammation.
Biologics (e.g., TNF-alpha inhibitors): Prescribed to block a single inflammatory cytokine, a downstream product of the upstream macrophage M1 activation.

While these medications can be life-saving in acute situations and can provide necessary relief, they are all sold as solutions to different symptoms of the same fundamental problem. They are patching the holes in the dam without ever addressing the immense pressure of the water building up behind it. They don’t fix the root cause. They don’t re-educate the immune system. They don’t shift macrophages from M1 destruction to M2 repair.

Unlocking the Secrets of Inflammation: Integrative Medicine Approach- Video

Restoring Balance: The Integrative Approach to Healing

This is where our integrative model at Injury Medical Clinic truly shines. By combining the diagnostic acumen of Dr. Cardenas’s internal medicine background with my expertise in functional medicine and chiropractic care, we can address the root cause. Our goal is not just to manage symptoms, but to identify and correct the underlying dysregulation driving the inflammatory process in the first place. We ask why the immune system is out of balance and then use a combination of therapies to restore that balance.

Thymosin Alpha-1: An Upstream Regulator

One exciting frontier in functional and regenerative medicine is the use of signaling molecules called peptides. These are short chains of amino acids that act as precise communicators in the body. One such peptide, Thymosin Alpha-1, holds immense promise for correcting the immune misdirection we’ve been discussing.

Thymosin Alpha-1 is a naturally occurring peptide produced by the thymus gland. It is one of the primary signals the thymus uses to orchestrate T cell maturation and function. In essence, it acts as an “immune modulator,” helping to restore balance to a dysregulated system. It doesn’t crudely suppress the immune system, nor does it blindly stimulate it. It helps it function more intelligently.

Here’s how it works at a cellular level, going upstream to fix the core problem:

Restores Regulatory Circuitry: Thymosin Alpha-1 promotes the development and function of Regulatory T cells (Tregs). Tregs are the “peacekeepers” of the immune system. Their job is to suppress excessive immune responses and prevent the activation of autoreactive T cells. By bolstering the Treg population, Thymosin Alpha-1 helps to re-establish self-tolerance and quell the misdirected immune attacks that characterize “autoimmune” conditions.
Shifts Macrophage Polarization: Critically, Thymosin Alpha-1 has been shown to influence macrophage behavior. It helps to shift macrophages away from the destructive M1 phenotype and towards the reparative M2 phenotype. This directly counteracts the central pathology of systemic inflammation. It helps turn off the “burn it all down” signal and turn on the “clean it all up” signal.
Shuts Down the Inflammatory Loop: By promoting Treg function and encouraging the M1-to-M2 shift, Thymosin Alpha-1 helps to shut down the self-perpetuating inflammatory loop that is slowly killing your biology. It calms the cytokine storm at its source, rather than just trying to block one of its downstream products.

Using tools like Thymosin Alpha-1, under the careful medical supervision of Dr. Cardenas, shows how we apply these advanced biological concepts in a clinical setting. It’s about restoring the body’s own innate regulatory systems. The profound truth is this: You don’t have ten different diseases; you have one dysregulated biology that is producing ten different symptoms. Fix the regulation, and you begin to fix everything.

The Role of Integrative Chiropractic Care in Quelling Inflammation

Now, you might be wondering, “This is fascinating immunology, Dr. Jimenez, but you’re a Doctor of Chiropractic. How does adjusting the spine fit into all of this?” This is a crucial question, and the answer lies at the very heart of the chiropractic principle: the intimate connection between the spine, the nervous system, and overall systemic health.

The nervous system is the body’s master control system. It communicates with and regulates every other system, including the immune system. The spine, in turn, is the protective armor and structural conduit for a huge portion of this system, namely the spinal cord and the nerve roots that exit to serve the entire body. When the spine has biomechanical faults—what we call vertebral subluxations—it can create both structural and neurological stress.

This stress is not just a localized mechanical issue. It acts as a potent, chronic, low-grade stressor that contributes to the body’s total inflammatory burden. Here’s how integrative chiropractic care fits into the treatment of systemic inflammation:

Reducing Nociceptive Input and the Stress Response: Misaligned vertebrae or dysfunctional spinal joints can bombard the central nervous system with aberrant signals, a phenomenon known as nociceptive input. Even if it’s below the threshold of conscious pain, the brain interprets this constant “neural noise” as a threat. This activates the body’s primary stress response axis, the Hypothalamic-Pituitary-Adrenal (HPA) axis. Chronic HPA axis activation initially elevates cortisol levels, but over time can dysregulate the system. Chronic stress, whether it’s emotional, chemical, or, in this case, physical/neurological, is a powerful driver of M1 macrophage activation and systemic inflammation (Morey et al., 2015). By performing precise chiropractic adjustments, we aim to restore normal joint mechanics, reduce nociceptive input, and thereby turn down this source of neurological stress. This helps to calm the HPA axis and lower a key contributor to the body’s inflammatory state.
Modulating Autonomic Nervous System Balance: The nervous system has two main branches that control our physiology: the sympathetic nervous system (“fight or flight“) and the parasympathetic nervous system (“rest and digest“). The sympathetic system is generally pro-inflammatory (it needs to be to fight off a threat), while the parasympathetic system, particularly via the vagus nerve, is profoundly anti-inflammatory. This is known as the “inflammatory reflex” (Tracey, 2002). Many people in our modern, stressed-out world are stuck in a state of sympathetic dominance. Spinal dysfunction can contribute significantly to this imbalance. My clinical experience, supported by a growing body of research, shows that chiropractic adjustments, particularly to the upper cervical spine and sacrum where vagal tone is heavily influenced, can help shift the autonomic balance away from sympathetic dominance and towards a more parasympathetic state. By enhancing vagal tone, we are directly activating the body’s most powerful innate anti-inflammatory pathway, encouraging the M1-to-M2 macrophage shift naturally.
Improving Biomechanics and Reducing Tissue Strain: On a more direct level, poor posture and spinal alignment create chronic mechanical strain on muscles, ligaments, and joints. This chronic micro-trauma itself is a source of localized inflammation, which can contribute to the overall systemic inflammatory load. As a chiropractor, my job is to analyze and correct these biomechanical faults. By improving posture, restoring spinal curves, and ensuring joints move properly, we reduce constant physical stress on the body’s tissues, removing another source of inflammatory signaling.
A Gateway to Holistic Lifestyle Change: In our clinic, a chiropractic adjustment is rarely a standalone treatment. It serves as an entry point to a broader conversation about health. When a patient feels relief from pain and improved mobility, they become more empowered and motivated to engage in other healthy behaviors. An adjustment can be the catalyst that allows a patient to start an exercise program, which is itself a powerful anti-inflammatory modality. It opens the door for me, as a functional medicine practitioner, to discuss anti-inflammatory nutrition, stress management techniques, and sleep hygiene—all critical for quenching the fire of systemic inflammation.

Under Dr. Cardenas’s comprehensive care model, we ensure chiropractic interventions fit the individual’s full medical picture. For example, for a patient with severe osteoporosis or an inflammatory arthritic flare-up, we would modify our techniques to be gentle and safe, always prioritizing the patient’s well-being within the context of their medical diagnosis. This integrated approach allows us to use chiropractic care as a powerful tool to reduce neurological and physical stress, balance the autonomic nervous system, and help guide the body back toward a state of ease and repair, complementing the medical and functional medicine strategies we employ.

Conclusion: A New Blueprint for Health

We stand at a thrilling and hopeful crossroads in medicine. The old model of naming a disease based on its symptomatic location and prescribing a drug to manage that symptom is giving way to a more sophisticated, root-cause-based approach. The science is clear: the smoldering fire of chronic, low-grade systemic inflammation is the common soil from which nearly all chronic diseases of aging grow. The perpetual activation of M1 macrophages, the failure of immune-regulatory training in the thymus, and the resulting cytokine storm are not separate issues but interconnected components of a single, dysregulated system.

The path forward is not to invent a dozen new drugs to block a dozen different cytokines. The path forward is to ask why the system is dysregulated and to use intelligent, integrative strategies to restore its natural balance. This involves:

Identifying and removing the triggers of inflammation through functional medicine testing and lifestyle modification (addressing diet, toxins, infections, and stress).
Modulating the immune system with targeted therapies like peptides, nutrients, and botanicals that encourage a shift from M1 destruction to M2 repair.
Restoring neurological and structural integrity through integrative chiropractic care to reduce physical stress and balance the autonomic nervous system.
Ensuring medical safety and oversight through the wisdom and experience of collaborative physicians like Dr. Cardenas.

You do not have to be a passive victim of your diagnosis. You don’t have ten different diseases. You have one biology that has lost its regulatory balance. By working with an integrated team that understands this fundamental principle, you can go upstream. You can fix the regulation. And when you fix the regulation, you can begin to fix everything.

References

Morey, J. N., Boggero, I. A., Scott, A. B., & Segerstrom, S. C. (2015). Current directions in stress and human immune function. Current Opinion in Psychology, 5, 13–17. https://doi.org/10.1016/j.copsyc.2015.03.007
Myrberg, I. H., Johansson, J., Johansson, F., Ahlqvist, E., & Melander, O. (2022). Established and novel inflammatory markers as predictors of all-cause and cause-specific mortality. The Lancet Regional Health – Europe, 19, 100438. https://doi.org/10.1016/j.lanepe.2022.100438
Pawelec, G. (2023). Hallmarks of human “inflammaging”: an update. Nature Medicine, 29(7), 1636–1637. https://doi.org/10.1038/s41591-023-02422-z
Tracey, K. J. (2002). The inflammatory reflex. Nature, 420(6917), 853–859. https://doi.org/10.1038/nature01321

SEO Tags: Systemic Inflammation, Chronic Disease, M1 Macrophages, M2 Macrophages, Integrative Chiropractic Care, Functional Medicine, Neuroinflammation, Dr. Alex Jimenez, El Paso Chiropractor, Inflammaging, Autoimmune Disease, Thymus Gland, Thymosin Alpha-1, Dr. Maria Guadalupe Cardenas, Integrative Medicine, Cytokines, TNF-alpha, IL-6, Brain Fog, Alzheimer’s, HPA Axis, Autonomic Nervous System, Vagus Nerve, Personal Injury Care, Injury Medical Clinic, Evidence-Based Chiropractic

September 1, 2026

Functional Medicine Approach for Thyroid Health & Wellness

Improve your thyroid health through a functional medicine approach, emphasizing personalized and holistic care for better results.

Abstract

Welcome to our educational post on thyroid health from a functional and integrative medicine perspective. My name is Dr. Alex Jimenez, and I hold certifications as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), Family Nurse Practitioner (FNP-BC), Certified Functional Medicine Practitioner (CFMP, IFMCP), and further specializations in Anti-aging, Regenerative & Functional Medicine (ATN) and Chiropractic Cranial Spinal Techniques (CCST). This post will take you on a journey to understand the intricate workings of your thyroid, moving beyond the simplistic view of just prescribing medication. We will explore the case of “Jennifer,” a 41-year-old woman who, despite being on multiple thyroid medications, continued to suffer from debilitating symptoms. Her story illustrates a common problem: addressing symptoms without understanding the root cause. We will explore the four primary physiological mechanisms that account for over 90% of thyroid dysfunction, none of which medication alone can resolve. These mechanisms include systemic inflammation, liver congestion, gut dysbiosis, and HPA axis dysregulation (chronic stress). We will dissect how these issues disrupt the critical conversion of the inactive thyroid hormone (T4) into the active hormone (T3), effectively leaving you metabolically “running on empty.” Throughout this discussion, I will explain the underlying physiology in detail, highlighting the roles of enzymes like deiodinases, the impact of inflammatory cytokines, and the critical functions of the liver and gut. I will also explain how our unique, multidisciplinary practice at Injury Medical Clinic PA in El Paso, Texas, integrates chiropractic care, functional medicine, and conventional medical oversight to create a comprehensive, personalized treatment plan. Our approach, which I lead alongside our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD, an internist with over 40 years of experience, is designed to restore function, not just mask symptoms. This is modern, evidence-based healthcare, focused on you as a whole person.

Our Integrative and Collaborative Practice: A New Model of Care

Before we dive into the complexities of thyroid physiology, I believe it is essential to provide some context about our clinical philosophy and practice structure here at Injury Medical Clinic PA. I am Dr. Alex Jimenez, and my journey in healthcare has been driven by a passion for understanding the interconnectedness of the human body. My extensive training across multiple disciplines—from chiropractic (DC) and advanced practice nursing (APN, FNP-BC) to the deep, systems-based approach of functional medicine (CFMP, IFMCP)—has given me a unique perspective on health and healing.

This multidisciplinary foundation is the bedrock of our practice. We believe the most effective patient care comes not from a single viewpoint but from collaboration among different experts. This is why I am honored to work alongside Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a board-certified internist with a remarkable career spanning over four decades. Her profound experience in internal medicine provides an invaluable layer of medical oversight and diagnostic acumen to our team. As our Medical Director and Collaborative Physician (NPI #1164426749, Texas MD License #J2933), she plays a crucial role in our multidisciplinary model.

This setup, where a Doctor of Chiropractic like myself works in close collaboration with a Medical Doctor, is a hallmark of modern integrative and injury care clinics. It allows us to offer the best of both worlds. We can harness the power of chiropractic adjustments to restore nervous system function and structural integrity, utilize functional medicine to uncover the biochemical root causes of chronic disease, and rely on Dr. Cardenas’s medical expertise for comprehensive diagnostics, conventional treatment options when necessary, and overall medical direction. Our services extend to personal injury care, rehabilitation, nutritional counseling, and more, all under one roof. This integrated team approach ensures that our patients receive a truly holistic and robust plan of care, tailored precisely to their individual needs. This collaborative spirit allows us to successfully manage complex cases like the one we are about to explore.

A Patient’s Cry for Help: The Story of Jennifer

Let me introduce you to Jennifer. Her story is one I’ve seen repeated countless times over my 30 years in practice, and it perfectly encapsulates why a new approach to thyroid care is so desperately needed. Jennifer is 41 years old. She first reached out by sending me a video message. In the video, she was in tears, a raw and honest portrait of desperation and fatigue. Her story was heartbreaking. For seven long years, she had been trapped in a body that felt like it was betraying her.

Despite being under the care of five different doctors and being prescribed both Synthroid® (levothyroxine sodium) and a generic form of levothyroxine, her health was deteriorating. She was gaining weight no matter how little she ate or how much she exercised. A profound, unshakeable depression had settled over her, casting a gray shadow on every aspect of her life. Her hands and feet were perpetually cold, a classic sign of a sluggish metabolism. A thick brain fog clouded her thoughts, making it difficult to concentrate, remember things, or even engage in simple conversation. She described her daily existence as “dragging herself through life.” The vibrant, energetic woman she once was had become a distant memory.

Jennifer’s doctors had followed the standard protocol. They saw that her TSH (Thyroid-Stimulating Hormone) was elevated, diagnosed her with hypothyroidism, and wrote a prescription. When her symptoms didn’t improve, they adjusted the dose. When that didn’t work, they tried another brand or combination. Yet, with each new prescription and each passing year, she only felt worse.

Her story is a tragic but common example of a fundamental flaw in the conventional approach to thyroid disease. It focuses almost exclusively on the thyroid gland itself and the medication designed to supplement its hormone production, while ignoring the vast and complex biological landscape where these hormones must actually do their work. Jennifer didn’t need more medication; she needed someone to ask why her body wasn’t using the hormones it was being given. This is where our journey into functional medicine begins.

Thyroid Biology 101: Beyond the Gland

To understand why Jennifer’s treatment was failing, we need to take a step back and revisit some fundamental biology. It’s crucial to move past the overly simplistic idea that the thyroid gland is the sole player in metabolic health.

The Manufacturing Plant: The Thyroid Gland and T4

Think of your thyroid gland, that small, butterfly-shaped organ in your neck, as a specialized manufacturing plant. Its primary job, and really its only job, is to produce thyroid hormones. It accomplishes this by taking iodine from your diet and combining it with the amino acid tyrosine. The main product it cranks out is a hormone called thyroxine, or T4. The “4” refers to the four iodine atoms attached to its molecular structure.

T4 is largely a prohormone, meaning it is biologically inactive. It’s a stable, well-packaged product ready for shipment, but it can’t actually do much on its own. It can’t bind effectively to the nuclear receptors inside your cells to turn on your metabolic machinery. T4 is simply the raw material, the precursor to what your body truly needs. The conventional medical model often stops here, assuming that if you provide enough T4 (in the form of medications like Synthroid® or levothyroxine), the body will take care of the rest. As Jennifer’s case shows, this assumption is often tragically wrong.

The Conversion Engines: Where the Real Magic Happens

The real metabolic magic doesn’t happen in the thyroid gland; it happens in your body’s peripheral tissues. These tissues act as powerful conversion engines. They take the inactive T4 and convert it into the powerhouse hormone: triiodothyronine, or T3. The “3” signifies that one iodine atom has been removed, a seemingly small change that has monumental biological consequences.

This conversion is the single most critical step in thyroid physiology, and a family of enzymes called deiodinases carries it out. T3 is the biologically active hormone. It’s what binds to receptors in the nucleus of nearly every cell in your body—from your brain to your muscles to your fat cells—and tells them to rev up their engines. T3 is what dictates your basal metabolic rate, controls your body temperature, supports your mood and cognitive function, and regulates your energy levels.

Where are these crucial conversion engines located?

The Liver: This is the undisputed champion of T4-to-T3 conversion. Approximately 60-80% of your active T3 is generated within the liver’s cells, known as hepatocytes. The primary enzyme at work here is Deiodinase Type 1 (D1).
The Gut: The gastrointestinal tract is another significant player, contributing up to 20% of T3 conversion. This process is heavily dependent on a healthy population of gut bacteria and an enzyme called intestinal sulfatase.
Other Tissues: The remaining conversion occurs in various other tissues, including the kidneys, skeletal muscle, and even the brain. The brain, in particular, relies on a different enzyme, Deiodinase Type 2 (D2), to ensure it has a steady, locally controlled supply of T3, which is vital for neurotransmitter function and cognitive clarity.

If this peripheral conversion system is broken, you are effectively running on an empty metabolic tank. It doesn’t matter how much T4 you have circulating in your bloodstream, whether it comes from your own thyroid gland or from a bottle of Synthroid®. If your body cannot convert that T4 into active T3, you will experience all the debilitating symptoms of hypothyroidism: fatigue, weight gain, depression, cold intolerance, and brain fog.

This is precisely what was happening to Jennifer. Her doctors were pouring more and more T4 into her system, but her conversion engines were offline. Her body wasn’t just failing to make active T3; it was actively shunting the excess T4 down a defensive pathway, making things progressively worse. All her biology was doing was converting those medications into something called reverse T3 (rT3), a competitive inhibitor that blocks T3 receptors, further deepening her hypothyroid state. This is a crucial concept we will explore in detail next.

The Four Horsemen of Thyroid Dysfunction

Over my three decades of clinical practice and deep immersion in functional medicine research, I have consistently found that over 90% of thyroid problems trace back to four primary physiological mechanisms. The beauty of this framework is that none of them inherently require medication. Instead, they require a deep, investigative approach to identify and correct the underlying imbalance. Let’s break them down one by one, because understanding them is key to unlocking true thyroid healing.

1. Systemic Inflammation: The Biological Grenade

The first and perhaps most pervasive disruptor of thyroid function is systemic inflammation. Think of inflammation as your body’s internal fire alarm. A short-term, localized fire (like from a cut or an infection) is healthy and necessary for healing. But chronic, low-grade, body-wide inflammation is like a fire alarm that is blaring 24/7. This constant state of alert wreaks havoc on your delicate hormonal signaling pathways.

The Source of the Fire

This chronic inflammation can stem from many sources, and identifying the specific trigger is a cornerstone of the functional medicine approach. Common culprits include:

Chronic Infections: Latent or reactivated viral infections, such as Epstein-Barr Virus (EBV), Cytomegalovirus (CMV), or Herpes Simplex Virus (HSV), can keep the immune system in a constant state of high alert.
Gut-Derived Inflammation: A condition known as “leaky gut,” or increased intestinal permeability, allows bacterial components like Lipopolysaccharides (LPS) to leak from the intestines into the bloodstream, triggering a massive inflammatory response. We’ll discuss this in more detail later.
Obesity: Adipose tissue (body fat) is not just an inert storage depot for calories. It is a highly active endocrine organ that produces and secretes many pro-inflammatory signaling molecules.
Autoimmunity: Conditions like Hashimoto’s Thyroiditis, where the immune system mistakenly attacks the thyroid gland, are fundamentally driven by an underlying inflammatory process.
Poor Diet: A diet high in processed foods, refined sugars, and industrial seed oils is inherently pro-inflammatory.
Environmental Toxins: Exposure to heavy metals, pesticides, and plastics can also fuel chronic inflammation.

The Molecular Mayhem: Cytokines and NF-kappaB

Regardless of the source, the biological result is the same: your immune cells dump massive quantities of inflammatory messengers called cytokines into your circulation. Molecules like Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), and Interleukin-1 (IL-1) are the primary agents of this inflammatory cascade.

I often describe these cytokines to my patients as biological grenades. They are designed for short-range combat, but when they flood the entire system, they cause widespread collateral damage. One of their primary targets is a master switch for inflammation inside your cells called Nuclear Factor-kappa B (NF-κB).

When cytokines activate NF-κB, it initiates a powerful genetic program that has devastating consequences for thyroid hormone conversion:

It shuts down D1 and D2 deiodinase: NF-κB activation directly suppresses the genes that code for Deiodinase Type 1 (D1) and Deiodinase Type 2 (D2). These two enzymes convert inactive T4 into active T3 in the liver, brain, and other tissues. The conversion engines are effectively turned off.
It cranks up D3 deiodinase: Simultaneously, NF-κB powerfully upregulates the gene for another enzyme, Deiodinase Type 3 (D3). D3’s sole job is to convert T4 into reverse T3 (rT3).

This is a disastrous one-two punch. Your body not only stops making the active hormone (T3) but also starts actively converting your precious T4 supply into a useless imposter (rT3).

Reverse T3: The Metabolic Brake

Reverse T3 (rT3) is the competitive inhibitor I mentioned earlier. Its molecular structure is a mirror image of T3, which allows it to fit perfectly into the T3 receptors on your cells. However, itdoesn’tt activate the receptor. It just sits there, blocking it. It’s like putting the wrong key into a lock; it gets stuck and prevents the right key from getting in.

From a physiological perspective, this is a brilliant survival mechanism. If the body is under severe stress (like a life-threatening infection, a major source of inflammation), it makes sense to slow metabolism to conserve energy. The body intentionally hits the metabolic brakes by producing rT3. The problem arises when this “emergency brake” gets stuck in the “on” position due to chronic, low-grade inflammation.

This is why simply giving a patient like Jennifer more levothyroxine (T4) can be so counterproductive. In an inflamed body, that extra T4 becomes more fuel for the D3 enzyme to produce more rT3. The patient’s TSH might look better on a lab report, but they feel worse because their cells are being starved of active T3 at an even greater rate. Their metabolic brakes are being slammed harder and harder.

Chiropractic Care’s Role: From a structural and neurological standpoint, chronic inflammation is often linked with physical stress and nervous system dysregulation. A subluxation, or misalignment in the spine, can create nerve interference that disrupts the body’s ability to regulate its immune and inflammatory responses properly. Chiropractic adjustments help restore proper neurological function, which can downregulate the sympathetic “fight-or-flight” response that often fuels inflammation. By improving nervous system communication, we can help the body better manage its inflammatory state, creating a more favorable environment for thyroid hormone conversion.

2. Liver Congestion: The Clogged Conversion Engine

As we established, the liver is the primary site of T4-to-T3 conversion, accounting for up to 80% of your body’s active thyroid hormone. If the liver isn’t healthy, your thyroid function will inevitably suffer, regardless of how well your thyroid gland is working. I often refer to this as a congested liver, a state where the liver’s ability to perform its myriad metabolic tasks is impaired.

The Fatigued Hepatocyte: NAFLD and ER Stress

The main conversion enzyme in the liver is D1 deiodinase, and its activity is highly sensitive to the health of the liver cells, or hepatocytes. In our modern world, one of the most common assaults on the liver is Non-Alcoholic Fatty Liver Disease (NAFLD). Driven by diets high in sugar, refined carbohydrates, and unhealthy fats, this condition causes hepatocytes to accumulate tiny lipid droplets.

This fat accumulation does more than take up space. It triggers cellular stress, particularly within an organelle called the endoplasmic reticulum (ER). The ER is like a cellular factory floor where proteins are folded and assembled. When it becomes overwhelmed with misfolded proteins and metabolic stress (a condition known as ER stress), it sends out alarm signals that shut down non-essential processes to conserve resources. Unfortunately, from the cell’s perspective, D1 deiodinase activity is considered “non-essential” during a crisis.

Research, such as the study by Wajner et al. (2011), has shown that conditions inducing ER stress significantly decrease D1 deiodinase expression and activity. So, in a person with a fatty, congested liver, the very machinery needed to convert T4 to T3 is systematically dismantled at the cellular level.

The Bile Backlog: Stalled Hormone Clearance

It gets even worse. The liver’s role in thyroid health extends beyond simple conversion. It’s also responsible for conjugating thyroid hormones and preparing them for elimination or recycling. This process involves attaching molecules like glucuronic acid or sulfate to the hormone, making it water-soluble so it can be excreted in the bile.

A portion of this conjugated hormone travels with the bile into the intestines. In a healthy gut, some is deconjugated by bacterial enzymes and reabsorbed into the bloodstream for reuse. This elegant recycling system is known as the enterohepatic circulation.

However, in a congested liver—often the same liver suffering from NAFLD—bile production and flow are compromised. The bile becomes thick and sludgy, a condition known as cholestasis. When bile flow stalls, this entire enterohepatic loop grinds to a halt. Thyroid hormones, both active and inactive, are not properly cleared or recycled. They can back up in the system, creating a “hormone traffic jam” that further disrupts the delicate feedback loops controlling thyroid function. This impaired clearance can contribute to the very inflammation and ER stress that initiated the problem, creating a vicious, self-perpetuating cycle of liver dysfunction and thyroid resistance.

Our Integrative Approach: Here, the collaboration between functional medicine and our medical director, Dr. Cardenas, is key. Dr. Cardenas can order and interpret liver function tests (LFTs) and imaging, such as an ultrasound, to formally diagnose conditions like NAFLD. From a functional medicine perspective, we then go deeper, using specialized testing to look at markers of inflammation and oxidative stress. Our treatment plan would include a comprehensive nutritional protocol to reverse fatty liver—eliminating sugars and refined carbs and incorporating liver-supportive foods and nutrients like milk thistle, N-acetylcysteine (NAC), and phosphatidylcholine. This multifaceted approach addresses both the medical diagnosis and the underlying metabolic dysfunction.

3. Gut Dysbiosis and Leaky Gut: The Broken Gateway

While the liver does the heavy lifting, the gut contributes a crucial 20% of the body’s active T3. This may sound modest, but the gut’s influence extends far beyond its direct conversion capabilities. The health of your gastrointestinal system can, in many ways, determine whether your liver is even capable of functioning as an efficient conversion organ.

The Role of the Microbiome in T3 Recycling

As mentioned, a significant amount of conjugated T3 and T4 enters the intestines via bile. The fate of these hormones then falls to your gut bacteria, or microbiome. A healthy, diverse microbiome produces an enzyme called intestinal sulfatase. This enzyme acts like a pair of scissors, cleaving the sulfate or glucuronic acid molecule off the conjugated thyroid hormone. This process, called deconjugation, effectively reactivates the hormone and allows it to be reabsorbed through the intestinal wall back into the portal circulation, where it returns to the liver and the rest of the body.

This is a vital part of the body’s T3 economy. However, in a state of dysbiosis—an imbalance in the gut microbiome where beneficial bacteria are diminished, and pathogenic or opportunistic organisms overgrow—this system breaks down. When the healthy bacteria that produce sulfatase are gone, the body can’t recycle conjugated T3d. Instead, it remains bound and is flushed right down the toilet in your stool. You are literally pooping out your precious active thyroid hormone. This loss of 20% of your T3 supply is a massive metabolic blow.

Leaky Gut and the LPS Firestorm

The consequences of dysbiosis often don’t stop there. An unhealthy microbiome frequently leads to increased intestinal permeability, or leaky gut. The single-cell layer lining your intestines is meant to be a tightly controlled barrier. In leaky gut, the junctions between these cells become loose, allowing substances that should remain in the gut to “leak” into the bloodstream.

One of the most damaging substances to leak through is Lipopolysaccharide (LPS). LPS is a component of the outer membrane of Gram-negative bacteria and a potent endotoxin. When LPS enters the circulation, the immune system sees it as a major invasion and mounts a massive inflammatory response.

This brings us full circle back to our first mechanism. The flood of LPS into the bloodstream is one of the most powerful triggers for releasing inflammatory cytokines like TNF-α and IL-6. As we discussed, these cytokines activate NF-κB, which in turn annihilates D1 deiodinase activity in the liver.

So, a sick gut delivers a devastating double blow to your thyroid:

It prevents the recycling of active T3, causing you to lose it in your stool.
It floods your body with inflammatory LPS, shutting down T3 conversion in your liver.

This is how a problem that starts in your gut can manifest as classic hypothyroid symptoms throughout your entire body.

The Functional Medicine and Chiropractic Connection: In our clinic, addressing the gut is paramount. We utilize advanced stool testing to analyze the microbiome, check for pathogens, and assess markers of inflammation and leaky gut. Our treatment protocols—often referred to as the “5R Program” (Remove, Replace, Reinoculate, Repair, Rebalance)—are designed to heal the gut systematically. At the same time, chiropractic care plays a supportive role. The autonomic nervous system extensively innervates the gut. Spinal misalignments, particularly in the thoracic and lumbar regions, can impair the nerve signals that control gut motility, secretion, and immune function. By performing targeted adjustments, we can help restore proper nerve flow to the digestive organs, complementing our functional medicine protocols and helping the gut heal and function optimally.

4. HPA Axis Dysregulation: The Stress-Famine Connection

The final, and critically important, mechanism is the dysregulation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. This is our central stress response system. Biology, in its ancient wisdom, cannot tell the difference between being chased by a predator, the chronic psychological stress of a modern lifestyle (financial worries, relationship problems, traffic), or the physiological stress of a prolonged caloric deficit. To the HPA axis, they all look identical.

Cortisol: The Conversion Crusher

When the HPA axis is activated, the adrenal glands release the stress hormone cortisol. In short bursts, cortisol is essential for survival. It mobilizes energy, heightens focus, and suppresses non-essential functions. However, when stress becomes chronic, cortisol levels become chronically elevated, and this has a direct and devastating effect on thyroid conversion.

Just like the inflammatory cytokine NF-κB, high levels of cortisol directly crush D1 deiodinase activity in the liver. This is another one of the body’s innate survival mechanisms. If the body perceives it is in a state of chronic danger or famine, the last thing it wants is to run a fast, energy-expensive metabolism. So, it puts the brakes on T4-to-T3 conversion to conserve resources. This is why individuals under immense, prolonged stress often develop hypothyroid symptoms, even if their thyroid gland is perfectly healthy.

The “Dieting” Trap: A Self-Imposed Famine

Here is where so many well-intentioned people, including many of my patients when they first come to see me, go terribly wrong. A person feels tired, notices they’ve gained weight, and correctly identifies that their metabolism is sluggish. Their logical next step is to “fix” their metabolism by going on a strict diet. So they start fasting, drop into a huge caloric deficit, and dramatically cut their carbohydrate intake. They have great commitment, but absolutely lousy timing.

Let’s break down why this is so catastrophic for thyroid function.

Hepatic Glycogen Depletion: The conversion of T4 to T3 in the liver is not a “free” process. It is insulin- and glycogen-dependent. Your liver needs a stored supply of glucose (in the form of glycogen) to fuel the deiodinase enzymes. Low-carb diets and heavy caloric restriction rapidly deplete these crucial hepatic glycogen stores. The factory runs out of power.
Crashing Leptin and Insulin: Heavy caloric restriction and low carbohydrate intake also cause circulating levels of two key metabolic hormones, insulin and leptin, to crash. Leptin is the hormone that tells your brain you have enough energy stored in your fat cells.

The liver is exquisitely sensitive to these signals. From the liver’s perspective, low glycogen, low insulin, and low leptin can mean only one thing: famine. The body believes it is starving. In response, it does what any intelligent organism would do during a famine: it enters survival mode. It immediately and dramatically shuts down D1 deiodinase activity to conserve every possible calorie. The metabolic rate plummets.

This is a cruel irony. Trying to “fix” a slow metabolism through aggressive dieting is what slows it down even further. The body fights back against perceived starvation, leading to a frustrating plateau, followed by rebound weight gain as soon as normal eating patterns resume.

What is Thyroid Dysfunction?- Video

The Common Denominator: A Path to Healing

Do you know what these four cases—inflammation, a congested liver, a leaky gut, and HPA axis dysregulation—all share?

They are all detectable through a combination of standard and functional laboratory testing.
Well-established principles of physiology and biochemistry all easily explain them.
They are all addressable without writing a single prescription.

Everything we need to diagnose and treat these conditions is in the research playbook. We can measure inflammatory markers like hs-CRP and cytokines. We can use advanced stool analysis to assess the gut. We can run a DUTCH test to map out cortisol patterns. We can look at liver enzymes and blood sugar markers. The answers are there if you know where to look.

Jennifer’s case was a classic combination of all four. Years of chronic stress had dysregulated her HPA axis. A poor diet had led to a congested liver and gut dysbiosis. This combination created a firestorm of systemic inflammation that completely shut down her ability to use the thyroid hormone medication her doctors were prescribing. Our job was not to give her a different pill, but to put out the fires, decongest her liver, heal her gut, and teach her body that it was safe to run a healthy metabolism again.

This is the power of integrative and functional medicine. It’s about being a biological detective, asking “why,” and respecting the profound interconnectedness of the body’s systems. It’s about providing the body with what it needs to heal itself. And it is a path to lasting wellness that has brought hope and health back to countless patients just like Jennifer. The specific labs we ran for her case will be available for viewing in my stories. You are welcome.

References

Wajner, S. M., & Maia, A. L. (2011). New insights into the physiology of deiodinases. Arquivos Brasileiros de Endocrinologia & Metabologia, 55(8), 647-654. https://doi.org/10.1590/S0004-27302011000800008
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Salvatore, D., Harney, J. W., & Larsen, P. R. (2008). Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocrine Reviews, 29(7), 898–938. https://doi.org/10.1210/er.2008-0019
Kneifel, U., & Staudinger, R. (2015). The role of the gut microbiome in the regulation of thyroid hormones. Clinical Nutrition ESPEN, 10(5), e213. https://doi.org/10.1016/j.clnesp.2015.07.037
Virili, C., & Centanni, M. (2015). “Does microbiota composition affect thyroid homeostasis?” Endocrine, 49(3), 583–587. https://doi.org/10.1007/s12020-014-0509-2
Mancini, A., Di Segni, C., Raimondo, S., Olivieri, G., Silvestrini, A., Meucci, E., & Currò, D. (2016). Thyroid hormone, oxidative stress, and inflammation. Mediators of Inflammation, 2016, 6757154. https://doi.org/10.1155/2016/6757154
van der Spek, A. H., Fliers, E., & Boelen, A. (2017). The classic pathway of thyroid hormone metabolism and its role in the regulation of developmental and adult physiology. Journal of Endocrinology, 232(2), R67-R81. https://doi.org/10.1530/JOE-16-0498

SEO Tags: Thyroid Health, Functional Medicine, Hypothyroidism, Dr. Alex Jimenez, Integrative Care, Chiropractic, T4 to T3 Conversion, Systemic Inflammation, Leaky Gut, HPA Axis, Cortisol, Reverse T3, Liver Health, NAFLD, Gut Microbiome, El Paso TX, Dr. Maria Guadalupe Cardenas, Integrative Medicine, Thyroid Dysfunction, Hashimoto’s, Adrenal Fatigue, evidence-based research, chiropractic adjustments, personal injury care

August 28, 2026

Non-Pharmacological Strategies for Nervous System Wellness

Find out how non-pharmacological strategies for the nervous system can enhance your wellness and reduce stress levels.

Abstract

Panic attacks, particularly when triggered by seemingly healthy activities like sauna use or high-intensity cardio, can be profoundly distressing and confusing. This experience is not a sign that you are broken but rather an indication that your nervous system is stuck in a state of high alert, a condition I frequently encounter in my clinical practice. This post will serve as your comprehensive guide to understanding and overcoming this challenge. From my perspective as Dr. Alex Jimenez, I will explain the neurobiological mechanisms behind these “false alarms,” in which your brain’s threat-detection center, the amygdala, misinterprets physiological arousal as a life-threatening danger. We will explore a multifaceted, integrative strategy designed to rewire this faulty circuitry systematically. This journey combines mechanical techniques like the physiological sigh to reset the vagus nerve, specific nutritional and peptide protocols to modulate neurotransmitters and reduce inflammation, and gradual, controlled re-exposure to triggers. Our goal is to retrain your brain to differentiate between harmless arousal and genuine danger, restoring your sense of safety and control. We will also discuss how our unique clinical model at the Injury Medical Clinic, which integrates my expertise in chiropractic and functional medicine with the medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, provides a holistic framework to support your recovery.

Our Integrated Care Model: A Collaborative Powerhouse

At Injury Medical Clinic PA, we have pioneered a multidisciplinary approach built on collaboration. As a Doctor of Chiropractic (DC) with advanced training as a Family Nurse Practitioner (APRN, FNP-BC) and certifications in Functional Medicine (CFMP, IFMCP), I view the body as an interconnected system. I focus on the structural integrity of the musculoskeletal system, the function of the nervous system, and the biochemical balance that dictates our health.
Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD, powerfully complements this vision. Dr. Cardenas is a Board-Certified Internist with an NPI of #1164426749 and a Texas Medical License #J2933. With over four decades of experience, she brings deep knowledge of internal medicine and provides the essential medical oversight that anchors our practice. Her role is crucial in diagnosing and managing underlying medical conditions, prescribing medications when necessary, and ensuring that our integrative protocols are safe and effective from a conventional medical standpoint.
This partnership between a DC/APRN/Functional Medicine Practitioner and an MD is the cornerstone of modern integrative healthcare. It allows us to offer our patients in El Paso, Texas, the best of both worlds:

Chiropractic Care (Dr. Jimenez): We address spinal misalignments (subluxations) that can interfere with nervous system signaling. A well-adjusted spine helps regulate the autonomic nervous system, which is directly involved in the fight-or-flight response that fuels panic.
Medical Oversight (Dr. Cardenas): Dr. Cardenas provides diagnostic clarity, rules out serious medical conditions that might mimic panic symptoms (like cardiac or thyroid issues), and offers a conventional medical perspective on treatment.
Functional Medicine (Dr. Jimenez): We dig deep to find the root causes of nervous system dysregulation—be it gut-brain axis dysfunction, nutrient deficiencies, or chronic inflammation.
Comprehensive Care: Together, we manage a wide spectrum of health issues, including personal injury rehabilitation, chronic pain, and metabolic dysfunction, all under one roof.

This collaborative model ensures that when a patient presents with symptoms like exercise-induced panic, we don’t look at it through a single lens. Dr. Cardenas can assess the cardiovascular system, while I can evaluate the neurological and biochemical factors. This comprehensive, 360-degree view allows us to create a truly personalized and effective treatment plan.

The Neurobiology of a Panic Attack: Why Your Brain Pulls a False Alarm

When a patient tells me, “I can’t even sit in a sauna or do cardio anymore without starting to panic,” the first thing I want them to understand is that their experience is real, and they are not losing their mind. You are not broken. What you are experiencing is a physiological phenomenon—a nervous system that has become stuck on red alert.

The Amygdala: Your Brain’s Overzealous Security Guard

Deep within the temporal lobes of your brain lies a small, almond-shaped cluster of nuclei known as the amygdala. This is your brain’s primary alarm center, the security guard responsible for detecting threats and initiating the fight-or-flight response. In a healthy, well-regulated system, the amygdala is a lifesaver. It’s what makes you jump back onto the curb when a car speeds around the corner.
The problem arises when this security guard becomes hypervigilant and overzealous. Through past traumas, chronic stress, or even prolonged inflammation, the amygdala can become sensitized. Its threshold for what it considers a “threat” drops precipitously.
Now, consider what happens during sauna use or high-intensity exercise:

Your heart rate increases.
Your breathing becomes faster.
You start to sweat.
Your body temperature rises.

These are normal, healthy physiological responses to heat or physical exertion. However, to your sensitized amygdala, these signals look strikingly similar to the signs of genuine danger. Your heart pounds when you’re scared; you breathe heavily when you’re running for your life. Your amygdala, unable to distinguish between the benign arousal of exercise and the terrifying arousal of a real threat, makes a critical error. It mistakes the physiological arousal for a mortal danger and slams the panic alarm button.

The Vicious Cycle: Hardwiring the Fear Response

This is what I call a false alarm. But once that alarm is pulled, a powerful cascade of neurochemical events is unleashed. The adrenal glands flood your system with adrenaline (epinephrine) and cortisol, further accelerating your heart rate, tensing your muscles, and creating the terrifying physical sensations of a panic attack: a racing heart, shortness of breath, dizziness, and a profound sense of impending doom.
The most insidious part of this process is that your brain learns from the experience. The intense fear you feel during the panic attack reinforces the amygdala’s faulty conclusion. The brain creates a strong neural pathway that essentially says: “Increased heart rate = DANGER.” This pathway becomes hardwired. The next time you even think about getting on the treadmill, your anxiety spikes because your brain is already anticipating the “threat.” This is how the fear of fear itself develops, and it’s why these panic triggers can become so entrenched and debilitating.
Our entire therapeutic strategy is designed to dismantle this faulty wiring systematically. We cannot simply reason our way out of it; you can’t outthink a panic attack because it’s not a rational process. It’s primal and physiological. So our approach must be physiological, too. We have to attack it mechanically, biochemically, and structurally to rewire the circuitry for good.

Phase 1: Immediate Intervention – Mechanical Control Over Panic

When a panic attack is imminent or in progress, cognitive reasoning is futile. The prefrontal cortex—your brain’s center for logic and executive function—is essentially offline. The amygdala is in full control. This is why you need a direct, mechanical tool to intervene in the physiological process.

The Physiological Sigh: Your Biological Vagus Nerve Reset

The most powerful, immediate tool in your arsenal is called the physiological sigh. This isn’t just a deep breath; it’s a specific breathing pattern discovered by researchers at Stanford University and UCLA that has a profound and instantaneous effect on the autonomic nervous system. It works by directly stimulating the vagus nerve, the main nerve of your parasympathetic (“rest and digest”) nervous system, which acts as a brake on the sympathetic (“fight or flight”) response.
The Mechanism:
The physiological sigh consists of two sharp, successive inhales through the nose, followed by a long, slow, extended exhale through the mouth.

Two Nasal Inhales: When we breathe, our lungs are filled with tiny air sacs called alveoli. Sometimes, under stress or shallow breathing, some of these alveoli can collapse. This reduces the surface area available for gas exchange, making our breathing less efficient and signaling a state of distress (hypoxia) to the brain. The first sharp inhale fills the lungs, but the second, smaller inhale on top of it pops those collapsed alveoli back open. This maneuver maximally inflates the lungs and optimizes the oxygen-carbon dioxide exchange.
Long, Slow Exhale: This is the most critical part for calming the nervous system. Our heartbeat naturally speeds up slightly when we inhale (respiratory sinus arrhythmia) and slows down when we exhale. By deliberately extending the exhale, we are sending a powerful signal to the heart’s pacemaker via the vagus nerve to slow down. This slowing heart rate is then communicated back to the brain, including the amygdala, signaling that the body is calming down and the threat has passed.

The Protocol:
This technique is not just for when you are panicking; it is a retraining tool. I instruct my patients to practice it proactively to build vagal tone and regulate their nervous system.

The Routine: Perform five full cycles of the physiological sigh (two inhales, one long exhale = one cycle).
When to Use It:
- Before the Sauna/Cardio: Do five cycles immediately before you step into the sauna or onto the treadmill. This pre-emptively shifts your nervous system towards a calmer state.
- During the Activity (if you feel arousal building): If you feel your heart rate climbing and a flicker of anxiety, pause and do one or two cycles.
- Immediately After the Activity: Perform another five cycles right after you finish. This helps your nervous system recover more quickly and reinforces the message that the arousal was safe.

This is your first line of defense. It’s a biological reset button that works with incredible reliability. You are mechanically hijacking the panic response and manually activating your body’s innate calming system.

Phase 2: Rebalancing Your Biochemistry – Foundational Support for a Calm Nervous System

While the physiological sigh provides immediate control, we must also address the underlying biochemical imbalances that make your nervous system so hypersensitive in the first place. Chronic stress, poor diet, and genetic predispositions can deplete the very nutrients and neurotransmitters your brain needs to stay calm and regulated. In my functional medicine practice, we use targeted supplementation to rebuild this foundation.

The Problem with Mouth Breathing: CO2 Tolerance and Panic

Before diving into supplements, we must address a crucial aspect of breathing mechanics: nasal breathing. Many people who experience panic, especially during exercise, are chronic mouth breathers. This habit directly and detrimentally affects your nervous system’s stability.
When you breathe through your mouth, you tend to over-breathe (chronic hyperventilation), blowing off too much carbon dioxide (CO2). While we often think of CO2 as just a waste product, it plays a vital role in our physiology. It helps regulate blood pH and, most importantly, is essential for releasing oxygen from hemoglobin into our tissues and brain—a phenomenon known as the Bohr effect.
When your CO2 levels drop from mouth breathing, two dangerous things happen:

Reduced Oxygen to the Brain: Less CO2 means hemoglobin holds onto oxygen more tightly, so less oxygen is delivered to your brain cells. This can create feelings of dizziness, lightheadedness, and “brain fog”—symptoms that can easily be misinterpreted as the onset of a panic attack.
Decreased CO2 Tolerance: Your brain’s respiratory centers become hypersensitive to even slight increases in CO2. When you exercise, CO2 levels naturally rise as a byproduct of metabolism. For a mouth breather with low CO2 tolerance, the brain perceives this normal increase as a sign of suffocation, triggering a powerful alarm and a panic response.

The Solution:
For at least the first two to three weeks of retraining, I insist on nasal breathing only during all cardio sessions. This forces you to slow down and breathe more efficiently. It naturally increases your CO2 levels, improving oxygen delivery and, over time, increasing your brain’s tolerance to CO2 fluctuations. This simple change is one of the most effective ways to break the link between exercise and panic.

The Anti-Panic Nutrient Trio

I recommend taking the following three supplements together about 30 minutes before any panic-provoking activity, whether it’s the sauna, a workout, public speaking, or a crowded mall. This stack is designed to create a biochemical shield, stabilizing your nervous system and blunting the adrenaline surge.

Magnesium Glycinate (400 mg): Your Anti-Panic Anchor
- Why It Works: Magnesium is nature’s primary relaxation mineral. It acts as a gatekeeper for the NMDA (N-methyl-D-aspartate) receptors in your brain. These receptors are like the accelerator pedal for your neurons; when activated, they increase neuronal excitability. Adrenaline and the stress hormone glutamate are potent activators of NMDA receptors. Magnesium sits inside the NMDA receptor channel, physically blocking it. This prevents neurons from becoming over-excited, effectively acting as a brake on anxiety and the “electrical” chaos of a panic attack. Stress rapidly depletes magnesium, making supplementation crucial for anyone with anxiety.
- Why Glycinate? I specifically recommend the glycinate form because it is bound to the amino acid glycine. Glycine itself has calming, inhibitory effects in the brain and is highly bioavailable and gentle on the stomach, unlike other forms like magnesium oxide.
L-Theanine (200 mg): Boosting Your Brain’s Off-Switch
- Why It Works: L-theanine is a unique amino acid found primarily in green tea. Its magic lies in its ability to increase GABA (gamma-aminobutyric acid) production, your brain’s primary inhibitory, or “off-switch,” neurotransmitter. GABA’s job is to quiet down excessive neuronal firing. When GABA levels are low, the brain is like a car with no brakes, leading to racing thoughts, restlessness, and anxiety. L-theanine provides the raw material to replenish your GABA supply, promoting a state of “calm alertness” without causing drowsiness. It also increases alpha brain waves, which are associated with relaxed focus.
- Clinical Application: L-theanine effectively counteracts the jittery, anxious effects of stimulants like caffeine and, in this context, the internal adrenaline rush that precedes panic.
Taurine (2 grams): The Heart and Adrenal Stabilizer
- Why It Works: Taurine is an abundant amino acid in the heart, brain, and adrenal glands, and it is a master regulator of cellular stability. Its role in preventing panic is twofold. First, it helps stabilize the heart’s electrical rhythm by regulating the flow of calcium ions in and out of heart muscle cells. This helps prevent the palpitations and racing heart sensations that are often the first physical trigger for a panic attack. Second, taurine has a direct quieting effect on the sympathetic nervous system and can blunt adrenaline release from the adrenal glands. It essentially tells the adrenal glands to “stand down.”
- Dosage Note: A dose of 2 grams (2,000 mg) is a therapeutic dose needed to achieve this acute stabilizing effect. It works synergistically with magnesium and L-theanine to create a powerful, multi-pronged defense against the onset of panic.

Phase 3: Rebooting the System with Advanced Peptide Therapy

For individuals with a deeply entrenched panic response, foundational nutrients may not be enough to reboot the system fully. The nervous system and its connections to other parts of the body, particularly the gut, have been altered on a deeper level. This is where we can leverage the power of bioregulatory peptides—small chains of amino acids that act as precise signaling molecules, telling cells how to function more optimally.
Peptides offer a way to repair and regenerate tissues and systems with remarkable specificity and a high safety profile. In our clinic, under the medical direction of Dr. Cardenas, we utilize specific peptides to target the core dysfunctions driving chronic anxiety and panic.

The Gut-Brain-Vagus Nerve Connection

Before discussing the peptides, it’s essential to understand the gut-brain axis. Your gut and brain communicate constantly in both directions, primarily via the vagus nerve. Your gut contains hundreds of millions of neurons—the enteric nervous system—and is often called the “second brain.”
An unhealthy gut, characterized by inflammation, “leaky gut” (intestinal hyperpermeability), and an imbalance of gut bacteria (dysbiosis), can send a continuous stream of distress signals up the vagus nerve directly to the brainstem and the amygdala. This gut-derived inflammation and stress signaling can be a primary driver keeping your nervous system on high alert, lowering your threshold for panic. As I often tell my patients, your gut telegraphs distress to your amygdala. If we don’t fix the gut, we will always be fighting an uphill battle against anxiety.

BPC-157 (500 mcg, twice a day): Sealing the Gut and Healing the Vagus Nerve

What It Is: BPC-157 stands for “Body Protection Compound.” It is a naturally occurring peptide found in small amounts in human gastric juice. It is renowned for its profound systemic healing and regenerative properties, particularly in the gastrointestinal tract.
How It Works for Panic:
1. Fixes the Gut-Vagal Connection: BPC-157 is arguably the most powerful agent we have for healing a leaky gut. It tightens the junctions between intestinal cells, sealing the gut lining. This stops inflammatory molecules and bacterial toxins (like lipopolysaccharide or LPS) from leaking into the bloodstream and triggering systemic inflammation. By calming the gut, BPC-157 effectively quiets the distress signals being sent up the vagus nerve to the brain.
2. Repairs the Vagus Nerve Itself: Beyond its gut-healing effects, BPC-157 has been shown to have neuroprotective and neuroregenerative properties. It can help repair damage to the vagus nerve, improving its function (vagal tone) and enhancing its ability to activate the calming parasympathetic response.
3. Modulates Neurotransmitters: BPC-157 has also been shown to help normalize the dopaminergic and serotonergic systems in the brain, both of which are often dysregulated in anxiety and depression.
The Protocol: A typical protocol is 500 micrograms, administered twice daily (morning and evening), usually via subcutaneous injection for best systemic absorption.

Selank (500 mcg, no later than 4 PM): Your Best Weapon for Long-Term Resilience

What It Is: Selank is a synthetic peptide based on a naturally occurring human peptide called tuftsin. It was developed for its potent anxiolytic (anti-anxiety) and nootropic (cognitive-enhancing) properties.
How It Works for Panic:
1. A True Anxiolytic: Selank is a GABAergic peptide. It works by modulating the GABA system, but in a much more intelligent and sustainable way than benzodiazepine drugs. Instead of just directly hitting the GABA receptor, it helps the brain use its own GABA more efficiently and prevents its breakdown. The result is a profound reduction in anxiety and mental tension without any sedation or cognitive impairment. This is its key advantage.
2. Builds Long-Term Resilience: The most remarkable thing about Selank is its long-term effect. It doesn’t just provide temporary relief; it seems to “reboot” the brain’s anxiety circuits. It upregulates the synthesis of Brain-Derived Neurotrophic Factor (BDNF), a protein that promotes the growth of new neurons and synapses, particularly in the hippocampus and prefrontal cortex. This neurogenesis helps to build new, non-anxious neural pathways, creating fantastic long-term resilience to stress. This is why I consider it your best weapon.
The Protocol: Selank is typically administered as a nasal spray, allowing direct delivery to the brain. A dose of 500 micrograms is used once daily. I advise patients to take it no later than 4:00 PM. While it’s not a stimulant, its cognitive-enhancing and anti-anxiety effects can be “too clearing” for some, making it difficult to wind down for sleep if taken too late in the evening. Don’t use it in the morning if you are starting, as you want its peak effect to cover the afternoon and evening, which are often of higher anxiety.

KPV (1 mg, every day): Knocking Out Systemic Inflammation

What It Is: KPV is a tripeptide (a chain of three amino acids) that is the active anti-inflammatory fragment of a larger hormone called alpha-melanocyte-stimulating hormone (α-MSH).
How It Works for Panic: As we’ve discussed, chronic inflammation is a key factor that lowers your nervous system’s threshold for panic. Inflammatory molecules called cytokines can cross the blood-brain barrier and directly activate the brain’s immune cells (microglia), creating a state of neuroinflammation. This neuroinflammation makes the amygdala and other threat-detection circuits hyper-reactive. KPV is one of the most potent anti-inflammatory peptides available. It works by entering the cell nucleus and inhibiting inflammatory signaling pathways like NF-κB (Nuclear Factor kappa B).
Clinical Application: By taking KPV daily (often in an oral capsule), you are systematically knocking out the low-grade systemic inflammation that sensitizes your nervous system. This raises your panic threshold, making you less susceptible to false alarms. It’s like soundproofing the room so that every little noise doesn’t trigger the alarm system.

Phase 4: Gradual Re-Exposure – Retraining Your Brain

Once you have the mechanical tools and biochemical support in place, it’s time for the final, crucial step: gradual, controlled re-exposure to the activities that trigger your panic. The goal here is simple but profound: You have to teach your brain that arousal isn’t danger.
This process is based on the principles of exposure therapy and must be done intelligently. We do not go from zero to a hundred. Flooding your system and triggering a full-blown panic attack will only reinforce the fear. The key is to approach the edge of your comfort zone, but not go over it.

The Graded Exposure Protocol

For the Sauna:
- Week 1-2: Start with just 10 minutes in the sauna at a moderate temperature. Use your physiological sighs before, during (if needed), and after. The goal is to get out before the panic even has a chance to begin. End the session on a positive note, feeling in control.
- Week 3-4: If the first two weeks go well, increase the time to 12 minutes.
- Ongoing: Gradually increase the duration by 1-2 minutes every week or two, always staying within a zone of comfortable challenge. Your mantra should be “arousal without alarm.”
For Cardio:
- Week 1-3: Focus exclusively on Zone 2 cardio. This is a low-intensity level of exercise where you can comfortably hold a conversation. Crucially, as mentioned earlier, practice nasal breathing only. This will naturally keep your heart rate from spiking too high and will retrain your CO2 tolerance. A typical session would be 20-30 minutes. No max effort. No sprints. No high-intensity intervals.
- Week 4-6: If Zone 2 feels safe and comfortable, you can begin to introduce very short intervals of higher intensity. For example, within a 30-minute session, you might do a 30-second burst of Zone 3 or 4 effort, followed by several minutes of recovery in Zone 2.
- Ongoing: Slowly increase the duration and frequency of these harder intervals, always listening to your body. The goal is to teach your amygdala that your heart rate can go up and come back down safely.

This gradual process supports neuroplasticity—your brain’s ability to reorganize by forming new neural connections. Each time you complete a session without panicking, you are weakening the old “arousal = danger” pathway and strengthening a new, more accurate “arousal = safety” pathway. You are proving to your primitive brain, through direct experience, that it can relax.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

The Role of Integrative Chiropractic Care

Within this comprehensive framework, chiropractic care is often overlooked, yet it can be a pivotal piece of the puzzle. The spine is the armor that protects the spinal cord—the superhighway of information between your brain and your body. Misalignments in the spine, which we call vertebral subluxations, can create mechanical tension and irritation on the delicate nerves exiting the spinal column.
This is particularly relevant to the autonomic nervous system (ANS), which controls your fight-or-flight (sympathetic) and rest-and-digest (parasympathetic) responses. The nerve roots that contribute to the sympathetic chain ganglia lie right next to the vertebrae in your thoracic (mid-back) and lumbar (low-back) spine. A subluxation in this area can act as a source of chronic, low-grade irritation, essentially creating “static” on the line and pushing the entire system towards sympathetic dominance. This physical stressor can keep your amygdala on edge.
Through precise, gentle chiropractic adjustments, I can restore proper motion and alignment to the spine. This has several key benefits for a patient with panic and anxiety:

Reduces Neurological Irritation: By correcting subluxations, we remove a physical source of stress on the nervous system, helping to calm the sympathetic response.
Improves Vagal Tone: Adjustments, particularly to the upper cervical spine (the top of the neck), can directly and positively influence the vagus nerve, which passes very close to the C1 and C2 vertebrae. Enhancing vagal tone is a primary goal in treating panic.
Decreases Musculoskeletal Tension: Panic and anxiety create chronic muscle tension, especially in the neck, shoulders, and back. This tension itself sends stress signals to the brain. Chiropractic care, along with soft tissue therapies, helps to break this cycle of physical tension and mental anxiety.

In my clinical observations at ChiroMed.com and through my professional experience detailed on LinkedIn, I have seen countless patients whose anxiety and panic symptoms significantly improved once we addressed the underlying structural and neurological imbalances through integrative chiropractic care. It is a foundational component of helping the nervous system feel safe in its own body.

A Final Word: The Journey to Resilience

Overcoming a panic disorder is a journey of reclaiming your own physiology. It requires patience, consistency, and a multifaceted approach that honors the deep connection between your mind, body, gut, and environment. You are not broken; you need retraining. By combining mechanical breathing techniques, targeted biochemical support, advanced peptide therapy, and a smart, gradual re-exposure plan, you can successfully rewire the faulty circuits in your brain. You can teach your nervous system that arousal is not danger, and that you are, in fact, safe.
This comprehensive strategy, delivered within a collaborative care model like ours at Injury Medical Clinic, where chiropractic, functional medicine, and internal medicine work hand in hand, provides the support structure you need to navigate this journey successfully. You can and will regain the freedom to enjoy activities like saunas and exercise without fear. This is the path to building true, lasting resilience.

References

Barlow, D. H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). The Guilford Press.
Bystritsky, A., Khalsa, S. S., Cameron, M. E., & Schiffman, J. (2013). Current diagnosis and treatment of anxiety disorders. P.T., 38(1), 30–57.
GABA. (n.d.). In WebMD. Retrieved August 21, 2026, from https://www.webmd.com/vitamins-and-supplements/gaba-uses-and-risks
Hinz, M., Stein, A., & Uncini, T. (2011). L-theanine: A unique, non-drowsy, calming amino acid. The Original Internist, 18(4), 143-148.
Huberman, A. (Host). (2022, October 10). How to breathe correctly for optimal health, mood, learning & performance (No. 66) [Audio podcast episode]. In Huberman Lab. https://www.hubermanlab.com/episode/how-to-breathe-correctly-for-optimal-health-mood-learning-and-performance
Kandola, A., Vancampfort, D., Herring, M., Rebar, A., Hallgren, M., Firth, J., & Stubbs, B. (2018). Moving to beat the blues: A systematic review and meta-analysis of the effectiveness of exercise for depression. Acta Psychiatrica Scandinavica, 137(6), 481-496. https://doi.org/10.1111/acps.12923
Kaplan, J. B., & Sarris, J. (2017). The clinical guide to naturopathic medicine. Ligare Pty Ltd.
Kelly, R. B. (2010). Diet and exercise in the management of hyperlipidemia. American Family Physician, 81(8), 977-982.
L-theanine. (n.d.). In Examine.com. Retrieved August 21, 2026, from https://examine.com/supplements/l-theanine/
Magnesium. (n.d.). In National Institutes of Health Office of Dietary Supplements. Retrieved August 21, 2026, from https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
Meuret, A. E., & Ritz, T. (2010). Hyperventilation in panic disorder and asthma: a review. International Journal of Psychophysiology, 78(1), 68–79. https://doi.org/10.1016/j.ijpsycho.2010.05.006
Rude, R. K., Singer, F. R., & Gruber, H. E. (2009). Skeletal and hormonal effects of magnesium deficiency. Journal of the American College of Nutrition, 28(2), 131-141.
Seitz, J., St-Pierre, M. K., & Stöckl, M. (2020). The effects of BPC-157 on the gut-brain axis. Journal of Peptide Science, 26(1), e3219.
Sikora, R., Chrobak, A. A., Tereszko, A., & Gąsiorowski, K. (2021). Anxiolytic and antidepressant-like effects of Selank in an animal model of depression. Journal of Psychopharmacology, 35(11), 1326–1336.
Taurine. (n.d.). In Mayo Clinic. Retrieved August 21, 2026, from https://www.mayoclinic.org/drugs-supplements-taurine/art-20366407
Vitetta, L., Bambling, M., & Alford, H. (2014). The role of the gut-brain axis in mood and anxiety disorders. The Journal of the Australasian College of Nutritional and Environmental Medicine, 33(1), 16–22.
Yoto, A., Motoki, M., Murao, S., & Yokogoshi, H. (2012). Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses. Journal of Physiological Anthropology, 31(1), 28. https://doi.org/10.1186/1880-6805-31-28

SEO Tags: Panic Attacks, Anxiety Treatment, Integrative Medicine, Functional Medicine, Chiropractic Care, Dr. Alex Jimenez, El Paso TX, Vagus Nerve, Physiological Sigh, BPC-157, Selank, L-Theanine, Magnesium Glycinate, Gut-Brain Axis, Nervous System Regulation, Exercise-Induced Panic, Sauna Anxiety, Amygdala, Neuroplasticity, Dr. Maria Cardenas, Internal Medicine, Multidisciplinary Clinic, Personal Injury Care, Rehabilitation.

August 21, 2026

Integrative Care: Comprehensive Insights for OUD & Chronic Pain

Learn how integrative care for OUD and chronic pain combines treatments for better health and pain management solutions.

Educational Abstract: Integrative, Evidence-Based Care for Opioid Use Disorder and Chronic Pain with Buprenorphine, Methadone, and Naltrexone

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I guide you through a modern, integrative roadmap for treating opioid use disorder (OUD) and chronic pain using buprenorphine, methadone, and naltrexone, grounded in current evidence and clinical protocols tailored to the realities of fentanyl-era care. You will learn the core pharmacology of mu-opioid receptor physiology, the distinctions among full agonists, partial agonists, and antagonists; how ceiling effects on respiratory depression make some therapies safer; and how to choose formulations (Suboxone, Subutex, Sublocade, Brixadi, Butrans, Belbuca, Buprenex) based on patient indications, goals, and medical risk.
I practice at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, within a multidisciplinary team model led by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933). With over 40 years of internal medicine experience, Dr. Cardenas serves as Medical Director and Collaborative Physician, providing medical oversight while I integrate chiropractic neuromechanical care, functional medicine, rehabilitation, and personal injury services. This coordinated framework reflects a standard integrative clinic setup: an MD provides medical direction alongside chiropractic and allied therapies, ensuring safety, compliance, and patient-centered care.
We will explore practical protocols for initiation, stabilization, and maintenance of buprenorphine in the context of illicitly manufactured fentanyl, including traditional, low-dose (microdosing/Bernese), and high-dose approaches. I discuss precipitated withdrawal pathophysiology, prevention, and response strategies; harm reduction practices; dental health, hepatic function, benzodiazepine and alcohol safety; and special populations (pregnancy, adolescents, perioperative care). You will see how long-acting injectables—Sublocade and Brixadi—offer stable plasma levels, improved adherence, and practical pathways from ED to community care.
Throughout, I add clinical observations from my work, available at:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/
References are presented in APA-7 style, with hyperlinked titles to primary sources.

About This Educational Post: A First-Person Narrative by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Hello, I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I present a patient-centered and evidence-based pathway for treating opioid use disorder (OUD) and chronic pain with buprenorphine, methadone, and naltrexone. My goal is to make complex science easy to understand, translate research into practical protocols, and show how integrative chiropractic care fits within a medical team directed by an experienced internist to support safety and whole-person outcomes.
At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I work shoulder-to-shoulder with Dr. Maria Guadalupe Cardenas, MD—Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933). With over 40 years of clinical experience, Dr. Cardenas serves as our Medical Director and Collaborative Physician, guiding pharmacotherapy for OUD and complex pain, ensuring adherence to best-practice standards, and overseeing medical safety. This integrated model—an MD providing medical direction in partnership with chiropractic and allied therapies—is a common, effective framework in multidisciplinary, injury, and functional care clinics.
In practice, I combine:
Chiropractic neuromechanical care to reduce nociception, correct alignment, and modulate autonomic tone.
Functional medicine to address systemic drivers—inflammation, sleep, gut health, neuroendocrine balance.
Rehabilitation to restore movement, build resilience, and improve function.
Personal injury care to document biomechanics, coordinate imaging, and support medico-legal readiness when necessary.
Harm reduction to prevent overdose and infection, preserving access and dignity.
This post blends scientific foundations, clinical reasoning, and real-world steps into an easy-to-follow journey. I present clear stages—initiation, stabilization, maintenance, and taper—and explain why each technique is used, how risk is managed, and what outcomes we track.
I share ongoing clinical observations and educational updates through:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/
I reference SAMHSA, CDC, ASAM, FDA, Cochrane, peer-reviewed trials, and functional/chiropractic resources, using APA-7 citations with hyperlinked titles.

Understanding Opioid Use Disorder and Chronic Pain: A Patient-Centered Perspective

Opioid use disorder (OUD) is a chronic, relapsing medical condition marked by compulsive use, craving, continued use despite harm, and impaired control. It requires medical and behavioral interventions—not moral judgment.
Chronic pain is a complex biopsychosocial condition involving peripheral nociception, central and peripheral sensitization, neuroimmune activation, maladaptive plasticity, and psychosocial drivers. It may coexist with OUD or follow prolonged opioid exposure.
My guiding principle is to meet patients where they are. Not everyone is ready for counseling when they ask for help. Medications for opioid use disorder (MOUD)—such as buprenorphine and methadone—are lifesaving and should not be withheld because a patient is not yet engaged in therapy. We provide staged options, teach safe starts, stabilize physiology, and invite behavioral supports as readiness grows.

Pharmacology Foundations: Mu-Opioid Receptors, Agonists, Partial Agonists, and Antagonists

Mu-opioid receptors (MORs) regulate pain, reward, mood, and respiration. Activation or blockade drives analgesia, craving control, and overdose risk.
Full agonists (e.g., methadone) fully activate MORs; effects increase with dose (analgesia, euphoria, respiratory depression risk).
Partial agonists (e.g., buprenorphine) exhibit high affinity and partial intrinsic activity. They increase receptor stimulation at lower doses but then plateau—a ceiling effect that reduces respiratory depression at higher doses.
Antagonists (e.g., naltrexone) occupy MORs without activation; they block opioid effects but do not provide analgesia.
This pharmacodynamic profile explains why buprenorphine is both effective and safer: its high affinity displaces full agonists, reduces cravings, prevents intoxication, and produces a ceiling effect on respiratory depression. Methadone, a full agonist, remains a powerful therapy but requires careful dosing and monitoring. Naltrexone is best after detox, supporting relapse prevention without analgesic benefit.

Why Treat OUD with Medication: Outcomes, Safety, and Life Recovery

MOUD reduces mortality, overdose, illicit use, and relapse; improves retention and function (work, relationships, self-care).
Buprenorphine and methadone relieve acute withdrawal and cravings, stabilizing reward and stress systems; patients can engage in life.
In our integrative clinic, we prioritize access without unnecessary barriers. We provide informed consent, tailor initiation methods (standard, low-dose/microdosing, high-dose, transitions from methadone or long-acting opioids), and maintain medical oversight to support safety throughout the care journey.

Evidence-Based Medications: Buprenorphine, Methadone, and Naltrexone

Buprenorphine: Partial MOR agonist; high receptor affinity; ceiling effect for respiratory depression; multiple formulations for OUD and pain; suitable for outpatient care.
Methadone: Full MOR agonist; effective for high-tolerance patients; requires structured clinic dosing, QTc screening, and drug–drug interaction management.
Naltrexone: MOR antagonist; requires detox before initiation; no analgesia; supports opioid-free recovery when aligned with patient goals.
We apply shared decision-making to match therapies to history, readiness, safety, and access. We integrate pharmacotherapy with chiropractic, functional medicine, and rehabilitation for whole-person outcomes.

Buprenorphine Terminology, Formulations, and Indications

Mono-Product (Buprenorphine alone):
Subutex (sublingual tablet): Approved for OUD.
Butrans (transdermal patch): Approved for chronic pain.
Belbuca (buccal film): Approved for chronic pain.
Buprenex (injectable): Approved for acute pain.
Combination (Buprenorphine + Naloxone):
Suboxone (sublingual film/tablet): Approved for OUD; naloxone deters injection/diversion by precipitating withdrawal if injected.
Long-Acting Injectables for OUD:
Sublocade (monthly subcutaneous): Steady-state; reduces daily adherence concerns and diversion risk.
Brixadi (weekly or monthly): Flexible depot options, including emerging pathways for direct weekly initiation in select settings.
We select formulations based on indication (OUD vs pain), patient factors (GI tolerance, dental health, liver function), logistics (insurance, availability), and safety. For OUD, sublingual or depot options are typical. For pain without OUD, Butrans or Belbuca are approved and often preferred, with Subutex/Suboxone considered off-label when warranted by complexity.

Naloxone in Combination Products: Purpose and Clinical Considerations

Naloxone in combination products is poorly absorbed sublingually; its role is diversion deterrence by precipitating withdrawal when injected.
Some patients report headache or GI upset even with proper sublingual use; we may consider mono-product alternatives with coverage planning.
To reduce adverse effects, we coach patients to spit excess saliva during dissolution, adjust timing, and maintain dental hygiene essentials.

Indications: OUD, Withdrawal, and Chronic Pain

OUD/Withdrawal: Subutex, Suboxone, Sublocade, Brixadi—selected according to readiness, adherence needs, and risk.
Chronic Pain: Butrans (transdermal), Belbuca (buccal), Buprenex (injectable, acute pain). Off-label sublingual buprenorphine can be appropriate in pain with co-occurring OUD or persistent opioid dependence, under rigorous medical oversight.

Sublingual Administration: Practical Guidance

Place films/tablets under the tongue; allow 10 minutes for complete dissolution.
Absorption occurs through oral mucosa; spitting saliva can reduce GI upset without reducing efficacy.
We provide step-by-step coaching on administration, adherence strategies, side-effect recognition, and rescue protocols.

Informed Consent and Initiation Considerations

Before initiating buprenorphine for OUD, we confirm:
OUD diagnostic criteria and evidence of withdrawal if using standard/high-dose induction.
Comprehensive informed consent:
Buprenorphine is an opioid; patients will be physically dependent.
Discontinuation/tapering requires planning and may be challenging.
Consider alternatives for mild OUD or primary chronic pain where non-opioid modalities are not exhausted.
Risk of precipitated withdrawal if started in the presence of full agonists.
Dental health risks: caries risk is mitigated by fluoride, hygiene, and regular care.
Hepatic metabolism: monitor liver enzymes; caution in severe hepatic impairment.
Elevated risk of respiratory depression with benzodiazepines or alcohol; overdose from buprenorphine alone is rare, but poly-depressant use is dangerous.
We outline trajectory (initiation → stabilization → maintenance → taper if desired) and highlight integrative supports.

Integrative Clinic Structure: Medical Oversight and Collaborative Care

Medical Director: Dr. Maria Guadalupe Cardenas, MD, Internal Medicine (NPI #1164426749, Texas MD License #J2933) leads medical safety, pharmacotherapy decisions, comorbidity management (cardiometabolic risk, hepatic function, infectious disease screening), and compliance.
Chiropractic Integration: I deliver neuromechanical assessments and care—spinal/joint function optimization, posture and kinetic chain correction, fascia and myofascial techniques—to reduce nociceptive input, modulate autonomic tone, and lower central sensitization triggers.
Functional Medicine: We evaluate inflammation, immune balance, HPA axis stress patterns, sleep architecture, microbiome, nutrient status, and lifestyle factors; we implement targeted protocols to enhance systemic resilience.
Rehabilitation: Graded exercise, motor control retraining, breathwork, and pain neuroscience education to build function and self-efficacy.
Personal Injury Care: Biomechanics assessment, documentation, imaging when indicated, and legal-report readiness aligned with clinical standards.
Behavioral Health: Collaborative referral for counseling and trauma-informed care; MOUD access is not contingent on counseling participation.
This model is standard in integrative and injury clinics, enabling safe, effective care for complex needs.

Shared Decision-Making: Aligning Treatment with Patient Goals

We practice shared decision-making by:
Presenting options (buprenorphine, methadone, naltrexone) with benefits/risks.
Discussing induction methods: traditional, low-dose/microdosing, high-dose, transitions from methadone/long-acting opioids.
Clarifying maintenance expectations, monitoring cadence, and recovery supports.
Navigating insurance and access barriers to ensure continuity.
Honoring preferences, readiness, and life realities, with tiered choices and empathetic counseling.
We build trust by acknowledging uncertainty and adapting therapy as situations evolve.

Physiology in Focus: Pain Modulation, Reward Systems, and Respiratory Control

Pain pathways: Peripheral nociceptors (C, A-delta fibers) send signals to the dorsal horn, ascending to thalamus/cortex; descending inhibitory circuits (periaqueductal gray, rostral ventromedial medulla) modulate input.
Central sensitization: Persistent nociceptive input lowers thresholds and amplifies responses; pain exceeds expected tissue damage.
Opioid mechanisms: MOR activation reduces glutamate and substance P release, dampens nociception, and modulates reward circuits (ventral tegmental area, nucleus accumbens), influencing craving and reinforcement.
Respiration: Opioid agonists suppress brainstem respiratory centers; buprenorphine’s ceiling effect lowers severe respiratory depression risk relative to full agonists.
Understanding these systems informs personalized therapy, risk explanation, and realistic expectations.

Buprenorphine Initiation Strategies: Traditional, Low-Dose Microdosing, and High-Dose Approaches

Traditional Initiation

Abstinence period: Historically 12–24 hours for short-acting opioids, 24–72 hours for long-acting; in fentanyl contexts, waiting ≥48–72 hours may still be unsafe due to lipophilic storage and delayed release.
Withdrawal confirmation: Aim for moderate withdrawal (COWS ≥13) before first dose.
Initial dosing: 2–4 mg; observe 1–2 hours. If relief occurs, titrate in 2–4 mg increments every 2–4 hours to reach 16–24 mg on day one.
Advantages:
Familiar; a foundation of prior studies (pre-fentanyl).
Simple dosing and fewer titration steps.
Disadvantages:
High precipitated withdrawal risk with fentanyl due to delayed clearance.
Prolonged waiting induces severe distress and dropout risk.
Early doses can be insufficient for high-potency tolerance.
Clinical takeaway:
Reserve for select cases with short-acting prescription opioids and careful monitoring; otherwise favor low-dose or high-dose strategies in the fentanyl era.

Low-Dose Microdosing (Bernese Method Variants)

Principle: Introduce tiny buprenorphine doses while continuing the full agonist, gradually increasing buprenorphine to avoid precipitated withdrawal, then taper the full agonist.
Rationale: Buprenorphine slowly occupies receptors without sharp displacement; patients do not need to endure full withdrawal before starting.
Sample rapid 4-day ambulatory plan:
Day 1: 0.5 mg total (0.25 mg AM/PM); continue usual full agonist.
Day 2: 1.0 mg total (0.5 mg AM/PM); continue full agonist.
Day 3: 2.0–4.0 mg total (1–2 mg AM/PM); attempt to reduce full agonist.
Day 4: 8.0–12.0 mg total (split); stop full agonist.
Day 5+: 16–24 mg daily maintenance.
Slower 7-day titration:
0.5 → 1.0 → 2.0 → 4.0 → 8.0 → 12.0 → 16.0 mg, stopping the full agonist around day 5–6.
Advantages:
Preferred by patients fearing withdrawal; lower precipitated withdrawal risk when done correctly.
Ideal when pain requires ongoing full agonist during transition.
Disadvantages:
Complex regimen; requires precise film/tablet cutting and clear instructions.
Continued illicit use risk; requires robust harm reduction counseling.
Some patients struggle with quit date, prolonging crossover.
High coordination needs; outpatient success rates vary (e.g., ~34% in some low-barrier settings).
Clinical takeaway:
Effective when paired with frequent follow-up, clear education, and harm reduction supports; especially helpful for fentanyl, methadone, and long-acting opioid transitions.
High-Dose Initiation
Best in ED/urgent care with observation but increasingly adapted to outpatient.
Abstinence period: For fentanyl, ≥12 hours; ensure moderate withdrawal.
Requirements:
COWS ≥16 and at least two objective signs (dilated pupils, piloerection, rhinorrhea, diarrhea).
Dosing:
Initial 8–16 mg all at once; observe 30–60 minutes.
Add 8 mg increments as needed (up to 32 mg on day 1).
Day 2 maintenance often 24–32 mg; higher doses may be necessary for fentanyl-exposed patients.
Advantages:
Rapid stabilization; simple dosing; well-suited to acute care.
Effective in fentanyl contexts when criteria are met.
Disadvantages:
If the patient is not sick enough, risk of severe precipitated withdrawal.
Requires clinical observation and clear informed consent.
Clinical takeaway:
Strong option for observed settings and motivated patients; demands precise assessment to deliver high-dose starts safely.

The Critical Challenge of Precipitated Withdrawal: Physiology, Prevention, and Response
What precipitated withdrawal is

Rapid, severe onset of withdrawal symptoms after administering buprenorphine (partial agonist) to a patient dependent on full agonists (heroin, oxycodone, fentanyl).
Clinically seen as an acute COWS increase (≥5 points), with intense anxiety, restlessness (akathisia), sweating, GI distress, and profound psychological turmoil.

The receptor battle

Full agonists fully stimulate MORs; buprenorphine has high affinity but partial activity.
If introduced too early, buprenorphine displaces full agonists and drops receptor stimulation abruptly, causing catastrophic withdrawal.

The fentanyl factor

Highly lipophilic; accumulates in adipose tissue; slow leak into bloodstream prolongs receptor occupancy.
Precipitated withdrawal can occur even 48+ hours after last use due to delayed release.
Withdrawal may present with overwhelming anxiety and restlessness before traditional physical signs.

Prevention

Confirm adequate spontaneous withdrawal for traditional/high-dose starts.
Prefer low-dose/microdosing in high fentanyl exposure, methadone transitions, or medically complex cases.
Provide clear instructions to avoid unsanctioned full agonist use during induction pathways.

Response

Deliver additional buprenorphine to occupy MORs further and smooth the transition.
Provide supportive care: antiemetics (e.g., ondansetron), alpha-2 agonists (e.g., clonidine), hydration, reassurance.
Reassess the plan, clarify dosing, and ensure care contacts are reachable for rapid support.

Clinical Tools and Adjunctive Medications for Managing Withdrawal

COWS: Clinical Opioid Withdrawal Scale

An 11-item tool rating the severity of withdrawal: pulse, sweating, restlessness, pupils, aches, runny nose/tearing, GI upset, tremor, yawning, anxiety/irritability, gooseflesh.
Categories: mild (5–12), moderate (13–24), moderately severe (25–36), severe (>36).
In fentanyl withdrawal, subjective anxiety/restlessness may outpace objective signs; listen to patient narrative alongside COWS.
Adjunctive medications: A personalized comfort kit
Clonidine: Alpha-2 agonist that calms the sympathetic overdrive—reduces anxiety, sweating, tachycardia.
Tizanidine: Central muscle relaxant (some alpha-2 activity); helpful for muscle cramps and diffuse aches.
Hydroxyzine: Antihistamine with anxiolytic and sedating properties; supports anxiety/sleep.
Trazodone: Sedating antidepressant for insomnia.
NSAIDs/Acetaminophen: Baseline analgesia for generalized pain/aches.
Ondansetron: Antiemetic for nausea/vomiting.
Loperamide: Opioid receptor action in gut to control diarrhea (does not cross blood–brain barrier at standard doses).
We tailor adjuncts by asking which symptoms bother most and what helped before, preventing overmedication and focusing on relief with safety.

The Role of Integrative Chiropractic Care in Withdrawal and OUD Stabilization

Chiropractic interventions complement medical stabilization by addressing physical stress physiology:
Reduce musculoskeletal pain: Precise spinal and joint adjustments restore mechanics, reduce facet and nerve irritation; soft-tissue work alleviates trigger points and myofascial tension.
Modulate autonomic tone: Adjustments can shift balance toward parasympathetic activity, easing anxiety and restlessness, synergizing with clonidine and breathwork.
Improve sleep and comfort: Physical relief supports rest, which strengthens neuroendocrine regulation and distress tolerance during induction.
This hands-on approach creates comfort and physiologic stability that enhances adherence and retention in MOUD, especially during the first weeks.
Clinical observations:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Buprenorphine Dosing, Titration, and Maintenance: Practical Protocols

Initial stabilization: Typically 8–24 mg/day for sublingual buprenorphine; doses may be split or once-daily based on cravings and function.
Depot formulations: Sublocade and Brixadi for maintenance when adherence is challenging, or diversion risk is high; consider dose equivalence and prior sublingual stabilization.
Monitoring:
Cravings, withdrawal symptoms, function, side effects.
Liver enzymes for hepatic safety.
Co-use of benzodiazepines, alcohol, and other depressants.
Long-term goals:
Functional recovery (work, mobility, relationships).
Optional gradual tapering based on stability; taper is individualized and can be prolonged to protect against relapse.
We maintain transparent expectations, adapt to stress changes, and update plans based on life events and health shifts.

Buprenorphine for Chronic Pain: Approved and Off-Label Approaches

Approved for chronic pain:
Butrans (transdermal patch): Weekly, steady-state analgesia.
Belbuca (buccal film): Twice-daily transmucosal delivery with higher bioavailability.
Buprenex: Injectable for acute pain.
Off-label sublingual (Subutex/Suboxone): Considered in high-tolerance pain patients, failed trials of Butrans/Belbuca, or co-occurring OUD.
Rationale:
Partial agonism provides analgesia with lower respiratory depression risk and less euphoria versus full agonists.
Effective across neuropathic, musculoskeletal, and central sensitization pain; may improve endogenous pain modulation over time.
Integrative supports—chiropractic alignment and fascia care, graded rehab, functional medicine—amplify analgesia and reduce reliance on pharmacotherapy.

Methadone in OUD and Pain: Structured Care and Safety

Methadone: Full MOR agonist with long half-life; ideal for high-tolerance cases or where daily clinic contact and structure improve outcomes.
Safety considerations:
QTc prolongation: Baseline and periodic ECG monitoring; avoid initiation if QTc >500 ms without compelling risk-benefit rationale.
CYP450 interactions: Many medications influence methadone levels; perform meticulous med reconciliation.
Dose stacking: Slow titration to avoid accumulation and overdose risk.
Analgesic considerations:
Methadone’s NMDA receptor activity may benefit neuropathic pain.
Requires cautious titration and cardiometabolic monitoring under medical direction.
We present methadone as a gold-standard option where buprenorphine is unsuitable or patient preference supports OTP-based care.

Naltrexone: Antagonist Therapy in Recovery Planning

Oral or extended-release injectable naltrexone blocks mu-opioid receptors; no analgesia.
Requires complete detox (7–10 days opioid-free) before initiation to avoid precipitated withdrawal.
Best for patients seeking opioid-free therapy and with strong relapse prevention supports.
Not appropriate where active pain requires opioid modulation.
We consider naltrexone when goals align with antagonist strategies, and pain is managed through non-opioid modalities; counsel patients on perioperative pain limitations.

Safety: Alcohol, Benzodiazepines, and Respiratory Risk

Combining buprenorphine with alcohol or benzodiazepines increases respiratory depression risk despite buprenorphine’s ceiling.
Medical oversight ensures:
Clear counseling on risks.
Coordination with prescribers of benzodiazepines for sleep/anxiety.
Alternatives—CBT-I, mindfulness, and non-sedating pharmacotherapies.
We provide proactive education and monitoring to sustain safety.

Dental Health Considerations with Sublingual Buprenorphine

Associations with dental caries have been reported; they are likely related to local oral conditions and exposure time.
Mitigation:
Spit saliva during dissolution if nauseated.
Rinse mouth after dosing.
Use fluoride toothpaste/rinses.
Regular dental visits and hygiene coaching.
We partner with local dentists and include oral health in routine care plans.

Hepatic Function: Monitoring and Adaptation

Buprenorphine is hepatically metabolized; monitor liver enzymes after initiation.
Evaluate for viral hepatitis, alcohol use, and interactions.
Severe hepatic impairment increases sedation/respiratory risk; adapt protocols under medical oversight.
Dr. Cardenas ensures liver safety across pharmacotherapy.

Integrative Chiropractic Care in OUD and Chronic Pain

As a chiropractic physician and advanced practice clinician, I integrate chiropractic care to reduce nociceptive load, modulate autonomic tone, and improve function:
Neuromechanical alignment: Spinal adjustments, mobilization, and joint mechanics optimize movement and reduce aberrant nociception.
Fascial/myofascial dynamics: Soft tissue techniques reduce trigger points, improve fascial glide, and modulate peripheral sensitization.
Posture/movement retraining: Correct kinetic chain dysfunction from cervical/thoracic to lumbopelvic segments to reduce pain and compensatory strain.
Breathwork/vagal tone: Respiratory training supports parasympathetic balance, reduces anxiety, and complements MOUD stabilization.
Pain neuroscience education: Reframes catastrophizing and fear-avoidance, decreasing central sensitization and improving self-efficacy.
These strategies align with MOUD to improve tolerance, reduce flares, and strengthen function.
Clinical observations:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Functional Medicine Integration: Systems Biology for Resilience

Our functional medicine approach targets systemic factors influencing pain and recovery:
Inflammation: Track CRP, ESR, and cytokines; implement anti-inflammatory nutrition, sleep hygiene, and movement as medicine.
Endocrine/HPA axis: Assess stress response; support with adaptogens, micronutrients, and behavioral strategies.
Sleep architecture: Address insomnia and sleep apnea; use CBT-I, sleep routines, and positional therapy.
Gut/microbiome: Optimize diet, address dysbiosis, correct nutrient deficiencies, and identify food triggers.
Nutritional optimization: Ensure protein sufficiency, omega-3s, and micronutrients for neuromuscular function and mood.
Enhancing systemic resilience improves MOUD outcomes, reduces pain, and fosters overall health.

Rehabilitation and Movement: Graded, Targeted Plans

We build individualized rehabilitation plans:
Graded exposure: Progressive loading to recondition tissues and the nervous system.
Motor control retraining: Stabilize key segments (lumbar/cervical), improve proprioception.
Aerobic conditioning: Boost mood, sleep, and endogenous analgesia.
Stretching/mobility: Reduce stiffness, support joint health.
Functional tasks: Align therapy with daily activities—lifting, reaching, rotation—to translate gains into life function.
Rehab synergizes with chiropractic and MOUD, strengthening capacity and confidence.

Harm Reduction: Practical, Compassionate Strategies

We champion harm reduction:
Naloxone access: Ensure patients/families have naloxone and know how to use it.
Safer use education: Avoid mixing depressants; recognize overdose signs; call for help.
Syringe services: Reduce infectious disease transmission; connect to community resources.
Fentanyl test strips: Help patients identify contaminated supplies where relapse risk exists.
Nonjudgmental support: Care persists during setbacks; doors stay open.
Harm reduction saves lives and builds trust—core in our practice.

Personal Injury Care: Linking Biomechanics and OUD/Chronic Pain

In injuries (motor vehicle collisions, workplace strains), pain and function intersect with substance use:
Documentation: Mechanism, symptoms, and functional impact.
Imaging when indicated: Clarify structural contributors.
Integrated plan: Chiropractic for alignment/tissue recovery; rehab for strength/endurance; MOUD for stable pain control when indicated.
Legal-readiness: Clear reports that support fair adjudication without inflating risk or misclassifying OUD.
Medical direction by Dr. Cardenas ensures alignment with standards and safety.

Case Scenarios: Real-World Application

High-dose fentanyl use, seeking help:
Micro-induction to avoid precipitated withdrawal.
Chiropractic care for myofascial pain/posture.
Functional medicine for sleep/inflammation.
Harm reduction tools and behavioral referral as readiness emerges.
Transition from methadone to buprenorphine:
Carefully planned micro-induction with overlap.
Cardiac/hepatic monitoring under Dr. Cardenas.
Rehab/breathwork to enhance tolerance.
Option to switch to depot therapy for adherence.
Chronic pain without OUD:
Belbuca or Butrans for analgesia with reduced respiratory risk.
Chiropractic/rehab to correct biomechanics.
Nutrition/sleep optimization via functional medicine.
Periodic re-evaluation to minimize pharmacotherapy over time.
These narratives demonstrate integrative synergy and patient-centered pacing.

Monitoring, Follow-Up, and Quality Improvement

Structured follow-up: Frequent early visits during induction; spacing as stability grows.
Outcome tracking: Pain scales, function measures, cravings, sleep quality.
Safety checks: Liver enzymes, ECG if methadone; medication reconciliation.
Continuous improvement: Incorporate guideline updates, staff training, patient feedback.
Quality care is iterative and responsive to new evidence and patient needs.

Insurance and Access: Practical Navigation

Formulary awareness: Coverage of mono vs combo buprenorphine products; depot access nuances.
Prior authorization: Prepare documentation to support medical necessity.
Community continuity: Coordinate with primary care/specialty clinics for continuation pathways.
We help patients navigate barriers that could derail recovery.

Recovery Journey: Autonomy, Dignity, and Self-Efficacy

Support autonomy: Patients choose their path, pace, and supports.
Offer evidence-based options without judgment; provide medical safety and space for growth.
Celebrate function and relational healing—work restored, family strengthened, self-respect reclaimed.
This is the heart of integrative, patient-centered care.

Collaborative Roles: Dr. Cardenas and Dr. Jimenez

Dr. Maria Guadalupe Cardenas, MD:
Oversees medical safety/protocols.
Manages comorbidities.
Leads pharmacotherapeutic decisions and compliance.
Dr. Alexander Jimenez, DC, APRN, FNP-BC:
Integrates chiropractic, functional medicine, and rehabilitation.
Coordinates with Dr. Cardenas to unify medical and neuromechanical strategies.
Monitors function, pain modulation, and behavioral readiness.
Together, we deliver a balanced, comprehensive care framework.

Evidence-Based Methods: From Research to Practice

We translate research into clinical protocols, emphasizing:
MOUD efficacy in reducing mortality and improving retention.
Buprenorphine pharmacology: high affinity, partial agonism, ceiling effect.
Micro-induction strategies for complex transitions.
Integrative care synergy—chiropractic, functional medicine, rehab—to reduce pain and central sensitization.
Key references include SAMHSA TIP 63, CDC buprenorphine guidance, ASAM clinical guidelines, FDA depot product information, Cochrane reviews, and peer-reviewed literature on methadone safety and buprenorphine initiation.

Educational Tools: Patient Guidance and Provider Checklists

Patient education:
How to take buprenorphine correctly.
Recognizing precipitated withdrawal and response steps.
Avoiding mixing depressants; overdose recognition; naloxone use.
Dental care routine for sublingual users.
Provider checklists:
OUD criteria and withdrawal assessment.
Induction choice and dosing plan.
Safety monitoring schedule.
Follow-up cadence and harm reduction resources.
Standardized practices increase safety and consistency.

Long-Acting Buprenorphine: Depot Options for Stability

Sublocade and Brixadi reduce daily adherence burdens and diversion risk.
Indicated for patients with unstable routines, high relapse risk, or preference for monthly/weekly dosing.
Sublocade requires sublingual stabilization (minimum 8 mg/day for at least seven days). Start with 300 mg monthly for two months, then 100 mg monthly; some patients remain on 300 mg for cravings coverage. Expect steady state in 4–6 months; provide supplemental sublingual early on.
Brixadi offers weekly/monthly doses; emerging evidence supports direct initiation with weekly doses in moderate withdrawal for certain settings. Counsel on end-of-interval dips and provide supplemental sublingual if needed.
Depot therapies can simplify life and improve outcomes by stabilizing plasma levels and reducing daily cycles.

Tapering Considerations: When and How

Tapering is optional, patient-led, and individualized.
If tapering:
Go slow—micro-reductions over weeks to months.
Strengthen supports—chiropractic, rehab, sleep, stress management.
Monitor for withdrawal/craving; pause or reverse if stability falters.
We center autonomy and safety in taper decisions.

The Role of Behavioral Health: Integrative, Not Prerequisite

Behavioral interventions are vital for SUDs, but MOUD should not be withheld if counseling readiness is low.
We invite behavioral support—trauma-informed care, CBT, mutual help—as readiness emerges.
This preserves access and respects patient choice.

Community Integration and Public Health

Collaborate with local harm reduction, housing, and vocational services.
Contribute to public health goals—reducing overdose, infection, and disability burdens.
Community integration extends impact beyond clinic walls.

Continuous Learning: Staying Current

Track guideline updates, new trials, and innovations.
Refine protocols and educate patients/peers through accessible content.
Clinical observations and updates:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Navigating Buprenorphine Initiation in the Fentanyl Era: Shared Decision-Making and Strategy Selection

Why shared decision-making matters

A collaborative partnership respects patient autonomy, prioritizes comfort vs speed, and tailors induction to lived experience.
Qualitative insights emphasize individualization and clear expectations; describing the mental aspect of withdrawal honestly builds trust.

Choosing among traditional, low-dose, and high-dose starts

Traditional: Simpler but less suited to fentanyl; reserve for short-acting opioid transitions with clear spontaneous withdrawal.
Low-dose/microdosing: Minimizes withdrawal by overlap with full agonist; needs clear instruction, harm reduction, frequent follow-up.
High-dose: Rapid stabilization when objective withdrawal signs are present; requires observation, informed consent, and readiness for additional dosing.

Addressing patient priorities

If avoiding withdrawal is paramount, choose low-dose microdosing.
If rapid stabilization under observation is feasible, consider high-dose starts.
We present options, explain risks/benefits, and co-create plans that match patient goals, setting, and supports.

Practical Considerations: Follow-Up, Higher Dose Needs, and Continuity of Care

Many fentanyl-exposed patients need higher buprenorphine doses for full stabilization, often 24–32 mg/day; advocate through documentation when coverage limits exist.
Ensure continuity of care: warm handoffs to community providers; if primary care can continue buprenorphine, retention improves.
Naloxone for all OUD patients: A universal prescription and training. Even stabilized patients may need it to save a life.

Special Populations: Pregnancy, Perioperative Management, and Adolescents

Pregnancy

Starting/continuing buprenorphine in pregnancy is strongly recommended; sublingual formulations are used; injectables are not FDA-approved in pregnancy.
Expect dose increases and split dosing due to physiologic changes; monitor closely for withdrawal/cravings and adjust accordingly.

Perioperative care

Continue buprenorphine throughout perioperative period; stopping/decreasing increases withdrawal, cravings, and pain.
Use multimodal analgesia on top—non-opioid analgesics, regional blocks, and higher-dose full agonists if needed to overcome blockade.

Adolescents

Buprenorphine is FDA-approved for OUD in adolescents ≥16.
Emphasize blockade doses (≥8 mg/day) to protect against overdose if intermittent use occurs; tailor counseling to risk and readiness.

Methadone: Initiation, Regulations, and Discharge Planning

Only OTPs can dispense methadone for OUD in the US; safe initiation requires slow titration, understanding half-life variability, and ECG monitoring for QTc.
Hospitals can initiate/adjust doses during inpatient care and provide a three-day bridge at discharge to first OTP appointment.
Maintain harm reduction even if a patient is ambivalent post-discharge; denying final doses can increase overdose risk due to partial tolerance restoration.

Naltrexone: Role, Protocol, and Limitations

Antagonist that shields receptors; does not treat withdrawal/cravings; lower retention compared to agonists.
Requires 7–10 day opioid-free window before starting; start with 25 mg oral test then 50 mg daily, or 380 mg IM every 4 weeks (consider 3-week intervals if end-of-month wear-off).
Counsel on acute pain management limitations while on naltrexone; consider wallet cards or medical alerts.

Buprenorphine for Chronic Pain: Detailed Formulation Guidance

Butrans (transdermal patch)

Mechanism: Transdermal, weekly, steady plasma levels.
Dosing: 5, 7.5, 10, 15, 20 mcg/hour; max 20 mcg/hour.
Initiation:
Taper full agonists to <30 MME/day to reduce precipitated withdrawal risk.
Start 5 mcg/hour if opioid-naive or <30 MME/day; 10 mcg/hour for 30–80 MME/day.
Above 80 MME/day, consider Belbuca or sublingual strategies.
Titration: Increase by 5–10 mcg/hour at 7-day intervals; provide short-acting breakthrough analgesics until baseline analgesia is established.
Pearls:
Rotate sites; avoid heat exposure; do not abruptly stop—taper.

Belbuca (buccal film)

Mechanism: Buccal mucosa transmucosal absorption; 46–65% bioavailability.
Dosing: 75–900 mcg every 12 hours; max 900 mcg q12h.
Initiation by prior MME:
<30 MME/day: 75 mcg q12h.
30–89 MME/day: 150 mcg q12h.
90–160 MME/day: 300 mcg q12h.
>160 MME/day: 450 mcg q12h.
Titration: Increase by 75–150 mcg q12h no more frequently than every 4 days.
Choosing: Start with Butrans when feasible; if inadequate at 20 mcg/hour, transition to Belbuca using conversion guidance.

Off-label sublingual

Reserved for high-tolerance pain, failed Butrans/Belbuca, or co-occurring OUD.
Requires experience in pain and addiction medicine and close monitoring under medical oversight.

Managing expectations and side effects

Time to effect can be up to two weeks; coach patience and permit breakthrough meds.
Common side effects: nausea, headache, GI upset, constipation (often milder than full agonists). Slow titration and supportive care mitigate.

Insurance navigation

Prior authorization often required. Provide documentation of failures or contraindications to less expensive options and justify medical necessity.

Harm Reduction in Pain and OUD Care: Evidence-Based Counseling

Teach fentanyl contamination risk across street supplies; assume high probability of fentanyl.
Naloxone is standard for all OUD and chronic opioid therapy patients—carry it like keys/phone.
Safer use conversations:
Smoking vs injecting: smoking may reduce overdose risk and infections relative to injection, though no route is safe; provide factual guidance without judgment.
Safe injection: sterile equipment, do not share, clean skin, use sterile water; refer to syringe service programs.
Meeting patients where they are reduces harm and preserves therapeutic alliance.

Visualizing Long-Acting Buprenorphine Advantages: Plasma Concentration Stability

Sublingual daily dosing shows peaks and troughs; some patients feel evening withdrawal.
LAI buprenorphine provides smoother, consistent levels across weeks and months, potentially improving adherence, retention, and blockade against illicit opioids.
Counsel on steady-state timelines and offer supplemental sublingual early to bridge levels.

Integrative Chiropractic and Functional Medicine: Healing the Whole Person

Chiropractic neuromechanics

Correct vertebral subluxations and joint dysfunction that irritate nerves and amplify nociception.
Normalize nervous system function, reduce nociceptive noise, decrease central sensitization, improve sleep, and boost resilience against cravings and stress.

Functional medicine systems healing

Address gut-brain axis dysfunction: restore microbiome balance, reduce leaky gut/inflammation, and improve nutrient absorption to lower neuroinflammation that impacts mood/anxiety.
Use targeted nutrition (anti-inflammatory diet), professional-grade supplements (L-glutamine, probiotics, omega-3s), and adaptogens to stabilize HPA axis.

Rehabilitation movement therapy

Correct movement patterns, rebuild strength/flexibility, improve posture, and provide agency over recovery.
Under Dr. Cardenas’s medical direction, these modalities synergize with pharmacotherapy to deliver durable outcomes.

Planning for Success: Follow-Up and Long-Term Management in OUD

Higher buprenorphine doses (often 24–32 mg/day) may be required in fentanyl-era care; document clinical need for coverage.
Build community networks; ensure warm handoffs for ongoing MOUD; primary care continuity when possible.
Always prescribe naloxone; train patients/families in recognition/use.

Practical Induction Coaching: Bridging Comfort and Safety

For home-based microdosing, provide daily or every-other-day check-ins; review dose cutting, timing, and symptom tracking.
Teach hot showers/baths as non-pharmacologic relief for muscle cramps and soreness; emphasize hydration, light movement, breathwork.

Perioperative Pain Management on Buprenorphine: A Modern Standard

Continue buprenorphine; avoid destabilization.
Build multimodal analgesia: NSAIDs/acetaminophen, regional anesthesia, adjuvant analgesics; full agonists at higher doses if needed.
Coordinate across anesthesia, pain, and addiction teams for seamless care.

Adolescents and Young Adults: Protection, Engagement, and Education

Address developmental needs, empower with blockade dose concepts (≥8 mg/day) to reduce overdose risk during intermittent exposures.
Engage families; emphasize naloxone and harm reduction; tailor behavioral supports to readiness.

Quality Improvement: Data-Driven Adaptation

Track retention, function, cravings, overdose reversals.
Update protocols with ASAM, SAMHSA, CDC, and FDA guidance.
Train staff in micro-induction, high-dose, depot initiation, and harm reduction best practices.

Conclusion: A Modern, Integrative Pathway to Safety, Function, and Recovery

This comprehensive, evidence-based approach to OUD and chronic pain integrates buprenorphine, methadone, and naltrexone within a multidisciplinary model. Under the medical direction of Dr. Maria Guadalupe Cardenas, MD, and through my integration of chiropractic neuromechanics, functional medicine, rehabilitation, and harm reduction, we deliver patient-centered, safe, and practical care.
Our message is clear:
Evidence-based medications save lives.
Integrative care enhances outcomes.
Autonomy, dignity, and self-efficacy remain at the core of everything we do.
Clinical observations and updates:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

References

Medications for Opioid Use Disorder (Substance Abuse and Mental Health Services Administration). (n.d.). SAMHSA guidance on MOUD and counseling.
Buprenorphine for Opioid Use Disorder: Clinical Considerations (Centers for Disease Control and Prevention). (n.d.). CDC overview for initiating and managing buprenorphine in OUD.
ASAM National Practice Guideline for the Treatment of Opioid Use Disorder (American Society of Addiction Medicine). (2020). ASAM practice guidelines for OUD assessment and treatment.
Postmarket Drug Safety Information for Patients and U.S. Providers: Long-Acting Buprenorphine Formulations (U.S. Food and Drug Administration). (n.d.). FDA information on depot buprenorphine products.
Naltrexone for Opioid Use Disorder (Cochrane Library). (Various systematic reviews). Evidence on antagonist therapy post-detox.
Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial (D’Onofrio et al., 2015). JAMA.
The Bernese Method for Buprenorphine/Naloxone Induction in Patients with Opioid Use Disorder: A Case Series (Hämmig & Köhler, 2018). Journal of Addiction Medicine.
Buprenorphine Microinduction for the Management of Opioid Use Disorder: A Case Series from an Academic Emergency Department (Herring et al., 2019). The American Journal of Emergency Medicine.
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder (McLean et al., 2021). CJEM.
Buprenorphine-Naloxone Microdosing: An Alternative Induction for Patients with Opioid Use Disorder (Randhawa et al., 2020). CMAJ.
A Practical Guide to Buprenorphine Induction for Opioid Use Disorder (Srivastava et al., 2022). Journal of Opioid Management.
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants (SAMHSA, 2018). HHS Publication No. (SMA) 18-5054.
Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial (Walsh et al., 2020). JAMA Psychiatry.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (Dowell et al., 2022). MMWR Recommendations and Reports.
Buprenorphine (Dydyk & Le, 2024). StatPearls.
From the Cover: Buprenorphine for Chronic Pain (Chen & Ashburn, 2020). Anesthesiology.
The Role of Buprenorphine in Chronic Pain (Webster & Gudin, 2020). Pain and Therapy.
Harm Reduction and the Opioid Overdose Epidemic (Kruger & Gunn, 2021). Kennedy Institute of Ethics Journal.
Clinical observations and integration at Injury Medical Clinic PA: https://chiromed.com/ (n.d.).
Clinical observations and professional profile: https://www.linkedin.com/in/dralexjimenez/ (n.d.).
APA 7th-style in-text citations are used contextually throughout this post, referencing the organizational authors and peer-reviewed sources listed above.

SEO tags: opioid use disorder, buprenorphine, methadone, naltrexone, Sublocade, Brixadi, Suboxone, Subutex, Belbuca, Butrans, Buprenex, precipitated withdrawal, micro-induction, high-dose buprenorphine, harm reduction, dental caries buprenorphine, hepatic metabolism buprenorphine, benzodiazepine risk, respiratory depression, chiropractic care, integrative medicine, functional medicine, rehabilitation, personal injury care, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr Maria Guadalupe Cardenas MD, Dr Alex Jimenez DC, evidence-based OUD treatment, chronic pain management, multidisciplinary clinic, shared decision-making, COWS scale, lipophilic fentanyl, naloxone, long-acting injectable buprenorphine, pregnancy OUD treatment, perioperative buprenorphine, adolescent buprenorphine, QTc methadone, opioid taper, kappa antagonism, gut-brain axis, vertebral subluxation

August 18, 2026

A Clinical Approach: Integrative Care Overview for OUD Treatment

Find out how the clinical approach for integrative care for OUD can transform treatment and support recovery journeys effectively.

Educational Abstract: Integrative, Evidence-Based Opioid Use Disorder Care in a Multidisciplinary Clinic

As a clinician practicing at the intersection of chiropractic medicine, advanced practice nursing, and functional medicine, I present an educational overview on opioid use disorder (OUD) that reframes complex science into an accessible, evidence-based guide for patients, families, and healthcare professionals. I explain the history and pharmacology of opioids; the drivers of the three “waves” of the U.S. overdose epidemic; current legislation; stigma and language that shape care; and the latest research-supported treatments, including medications for opioid use disorder (MOUD), motivational interviewing, and harm-reduction strategies. I also detail how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, medical oversight, functional medicine, personal injury care, and rehabilitation with rigorous clinical pathways for OUD screening, treatment, and recovery. Our medical director and collaborative physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), works closely with me, Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, to provide comprehensive, person-first, physiology-informed care that follows modern, evidence-based research methods. Throughout, I address myths, clarify the neurobiology of addiction, and show precisely how integrative chiropractic approaches support musculoskeletal stability, autonomic regulation, and pain modulation alongside MOUD in a responsible, medically supervised framework.
What follows is a step-by-step, clinically grounded journey through OUD—what it is, how we treat it effectively, and why integrative, multidisciplinary care can improve outcomes, reduce harms, and restore function and dignity.

About Our Multidisciplinary Team and Clinical Framework

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My clinical focus bridges chiropractic medicine, advanced practice nursing, and functional medicine. I direct rehabilitative, biomechanical, neuromuscular, and lifestyle interventions within a comprehensive, safety-forward framework under medical oversight.
Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933) is our Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. With over 40 years of experience in internal medicine, Dr. Cardenas provides medical supervision, diagnostic and pharmacologic guidance, and directs our OUD-related medical protocols, including MOUD, comorbidity management, and transitions of care.
Our clinic integrates:
Evidence-based chiropractic care to address pain, movement dysfunctions, and neuromuscular imbalances
Internal medicine diagnostics and medical management (Dr. Cardenas)
Functional medicine assessments (metabolic, inflammatory, endocrine, and gut-brain axis considerations)
Personal injury and trauma-informed rehabilitation
Behavioral health referrals (motivational interviewing, CBT/REBT-aligned group supports)
Harm reduction strategies (naloxone education, fentanyl test-strip guidance, infectious disease risk mitigation)
Coordinated care pathways with regional methadone programs and community services
This collaborative model—an MD providing medical direction alongside a chiropractor—is a common, effective approach in integrative or injury care clinics. It enables us to safely combine non-pharmacologic spine and pain care with MOUD, medical monitoring, and comprehensive recovery support.

Understanding Opioids: Origins, Types, and Pharmacology

When I discuss opioids with patients and colleagues, I begin with clarity about what opioids are and how they differ.
Natural opioids (opiates): Derived from the opium poppy. Examples: morphine, codeine.
Semi-synthetic opioids: Synthesized from natural opiates. Examples: heroin, oxycodone, hydrocodone.
Synthetic opioids: Fully lab-synthesized. Examples: methadone, fentanyl.
Key physiological concept
Opioids act primarily on the mu-opioid receptors (MOR) in the central and peripheral nervous system. MOR activation modulates nociception, produces analgesia, and at higher levels suppresses respiratory drive within the brainstem respiratory centers. This potency-respiratory relationship is central to overdose risk.
Why this matters clinically
Different opioids vary in potency, half-life, receptor affinity, and formulation. These factors determine their therapeutic window, misuse potential, and safety profile. In our clinic, understanding these properties guides every decision—from acute pain rescue to long-term, non-opioid pain strategies and OUD treatment.

Morphine Milligram Equivalents and Potency

To prevent unintentional dose escalation and to calibrate risk, we reference morphine milligram equivalents (MME), a comparative index of analgesic potency.
Tramadol: ~0.1 MME
Codeine: ~0.15 MME
Hydrocodone: ~1.0 MME
Oxycodone: ~1.5 MME
Hydromorphone: ~4.0 MME
Fentanyl transdermal: very potent; dose comparisons often expressed in micrograms/hour relative to MME.
Clinical rationale
MME helps assess overdose risk, polypharmacy hazards, and transitions between opioids. However, MME is not a perfect science; individual pharmacogenomics, tolerance, organ function, and drug interactions can shift risk. Our policy emphasizes the lowest effective dose, shortest duration, and rapid transition to non-opioid modalities with robust functional rehabilitation.

A Brief History of Opioids and Key Milestones in Regulation and Treatment

Highlights in opioid development
Early cultivation: opium poppy in Mesopotamia (~3400 BCE).
Renaissance and Enlightenment era uses: analgesia and antidiarrheal applications.
19th–20th centuries: extraction and synthesis milestones—morphine (1803), codeine (1832), heroin (1874), methadone (1939), fentanyl (1959), buprenorphine (1966).
Regulatory milestones
Harrison Narcotics Tax Act (1914): Criminalized non-medical opiate use.
Controlled Substances Act (1970): Established a scheduling framework and DEA oversight.
Narcotic Addiction Treatment Act (1974): Federal regulation of methadone programs.
Drug Addiction Treatment Act (2000, DATA 2000): Buprenorphine in office-based settings (waiver era).
Comprehensive Addiction and Recovery Act (2016): Expanded prescribing to NPs/PAs for buprenorphine.
SUPPORT Act (2018): Expanded OUD care within Medicare/Medicaid.
Mainstreaming Addiction Treatment (MAT) Act (2023): Eliminated buprenorphine waiver; DEA-registered clinicians may prescribe Schedule III buprenorphine per state scope.
Why regulation matters
Regulation aims to balance access to life-saving treatment with control of diversion and misuse. The shift toward enabling more clinicians to prescribe buprenorphine reflects strong evidence that expanding MOUD access lowers mortality and improves retention in care.

The Three Waves of the U.S. Opioid Overdose Epidemic

Wave 1 (1999–2010): Prescription opioid sales quadrupled; overdose deaths doubled (from ~2.9 to ~6.8 per 100,000). Drivers included liberal pain prescribing, marketing pressures, and underestimation of misuse risks.
Wave 2 (2010–2013): Cheaper heroin fueled a surge; heroin-involved deaths rose from ~1.0 to ~4.9 per 100,000, surpassing prescription opioid deaths.
Wave 3 (2013–present): Synthetic opioids, especially illicitly manufactured fentanyl, drove an exponential increase; death rates climbed dramatically (>1000% increase in some analyses). Co-involvement of non-opioid sedatives like xylazine has been detected in up to ~10% of fentanyl-related overdoses regionally.
Clinical implications
Today, contamination of non-opioid drugs with fentanyl (e.g., cocaine) is common. Harm reduction, routine naloxone co-prescribing, fentanyl test-strips education, and universal overdose education are essential—even for patients who do not self-identify as opioid users.

Prevalence and Treatment Gap: Why We Must Treat OUD

Millions of Americans report opioid misuse each year, with pain reliever misuse comprising the larger share compared with heroin misuse. Yet only a fraction of individuals with OUD receive MOUD.
Demographics most likely to receive treatment historically skew toward white males ages 35–49, underscoring inequities in access.
The economic burden exceeds $193 billion annually, and tens of thousands of deaths occur each year.
Why we act
OUD is a chronic medical condition with well-validated treatments that reduce mortality and improve functioning. Our clinic is committed to closing the treatment gap with equitable, person-centered, medically supervised care integrated into our spine, injury, and rehabilitation services.

Reducing Stigma with Accurate Language and Science

I see daily how language shapes outcomes. Stigma undermines treatment adherence and access. We use person-first, nonjudgmental, precise language:
Preferred: “person with opioid use disorder,” “person in recovery,” “people who use drugs (PWUD),” “people who inject drugs (PWID).”
Avoid: “addict,” “abuser,” “dirty urine.” Instead, we state results objectively: “positive for X,” “negative for Y.”
Babies cannot be “addicted”; we use “neonatal opioid withdrawal syndrome” (NOWS).
We refer to “medications for opioid use disorder (MOUD),” not “medication-assisted treatment,” because medication is treatment.
Clinical rationale
Lowering stigma increases acceptance of MOUD, reduces dropouts, and enhances therapeutic alliances. Evidence shows that stigma from individuals, institutions, and public policy historically has curtailed treatment access and worsened outcomes. We train our team to practice noncoercive, patient-centered care anchored in compassion, autonomy, and science.

Defining Substance Use Disorders: DSM-5 Criteria and Clinical Meaning

Per DSM-5, substance use disorders are chronic, relapsing brain conditions defined by 11 criteria across control, social impairment, risky use, and pharmacologic dimensions (tolerance and withdrawal). A diagnosis requires at least two criteria within 12 months and is graded as mild, moderate, or severe.
What I emphasize to patients
The criteria capture behavioral patterns that reflect neuroadaptations in reward, salience, stress, and executive function circuits. We look at how the substance reshapes priorities and coping, not just how much is used. This framework legitimizes treatment as medical and behavioral—not moral.

Neurobiology of OUD: Why Medication Works

Reward and salience: Opioids drive dopamine release and reshape synaptic plasticity in the mesolimbic system (ventral tegmental area–nucleus accumbens). This heightens drug salience over natural rewards.
Stress and dysphoria: Chronic use recruits stress systems (CRF, dynorphin), amplifying negative affect and driving compulsive use to avoid withdrawal.
Executive function: Prefrontal cortical changes impair planning, impulse control, and decision-making, perpetuating cycles of use.
Tolerance and dependence: Receptor desensitization and downstream signaling adaptations require higher doses to achieve prior effects and produce withdrawal upon cessation.
Why MOUD is effective
Methadone (full agonist) and buprenorphine (partial agonist) stabilize the mu-opioid system, reduce cravings, blunt withdrawal, and allow cortical control and behavior change to re-emerge. Naltrexone (antagonist) blocks opioid effects and can support motivated individuals at specific stages. Meta-analyses show MOUD reduces all-cause and overdose mortality substantially—often cited near a 50–60% reduction—while improving retention and reducing illicit opioid use.

Motivational Interviewing: Partnering for Change

Our clinic operationalizes motivational interviewing (MI) to align care with patient goals.
Core MI spirit
Partnership: Collaborative over prescriptive.
Evocation: Elicit the patient’s own reasons and values.
Acceptance: Honor autonomy; affirm strengths; practice empathy.
Compassion: Nonjudgmental, nonblaming, nonshaming stance.
Process
Engage: Build rapport and trust.
Focus: Clarify a shared goal.
Evoke: Draw out motivation and confidence.
Plan: Co-create specific, supportive steps.
Practical tools
OARS: Open questions, Affirmations, Reflective listening, Summaries.
DARN-CATS: Desire, Ability, Reasons, Need → Commitment, Activation, Taking steps.
Stages of change: Precontemplation, Contemplation, Preparation, Action, Maintenance. We match interventions to stage (e.g., education and empathy early; planning and skills training later).
Why MI matters
MI reduces resistance, enhances engagement, and respects the person’s lived realities. In OUD, aligning MOUD, harm reduction, and functional goals with what matters most to the person drives persistence and outcomes.

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment- Video

Non-Pharmacologic Supports: Behavioral and Peer-Based Options

Individual therapy: Cognitive behavioral therapy (CBT), rational emotive behavioral therapy (REBT), trauma-informed modalities; recovery coaching; social work supports.
Groups: SMART Recovery (CBT/REBT-based), Narcotics Anonymous (12-step), secular sobriety organizations. Many groups allow provider observation to inform sensitive referrals.
Clinic approach: We never make group participation a precondition for MOUD. We present options, normalize preferences, and help patients select supportive resources congruent with their values.

Pharmacologic Treatments: Mechanisms, Safety, and Rationale

Medications for opioid use disorder (MOUD) include methadone, buprenorphine (with or without naloxone), and naltrexone; naloxone is used for overdose reversal.
Methadone
Mechanism: Full mu-opioid agonist; long-acting stabilization; reduces cravings and withdrawal.
Clinical use: Dispensed through certified opioid treatment programs; daily observed dosing initially improves safety and adherence.
Side effects: Constipation, sedation, nausea, sweating; serious risks include respiratory depression and QTc prolongation (notably with higher doses).
Contraindications: Methadone allergy; caution with severe respiratory disease and GI obstruction.
Why we refer: For patients needing tighter agonist coverage, high opioid tolerance, repeated buprenorphine induction failures, or those who benefit from structured daily support, we coordinate with methadone programs, ensuring continuity with our rehab and functional care.
Buprenorphine (with or without naloxone)
Mechanism: Partial mu agonist, kappa antagonist; high receptor affinity and slow dissociation; ceiling effect on respiratory depression.
Clinical pearls:
Strong affinity means it can displace full agonists, potentially precipitating withdrawal if started too soon; conversely, when initiated during moderate withdrawal, it relieves symptoms and cravings.
Ceiling effect confers a safety advantage versus full agonists, particularly regarding respiratory depression.
Side effects: Headache, constipation, nausea, orthostatic hypotension, oral hypoesthesia (with sublingual/buccal forms); rare respiratory depression primarily with sedative co-use; hepatotoxicity risk warrants monitoring in liver disease.
Interactions: Caution with benzodiazepines (FDA advises benefits often outweigh risks), CYP3A4 inhibitors (erythromycin, grapefruit) and inducers (rifampin, St. John’s wort), certain antiretrovirals, and serotonergic agents.
Naloxone in combination products: Added to deter injection misuse; minimal effect when taken as directed sublingually/buccally.
Why we integrate: In office-based care, buprenorphine allows timely stabilization, reduces illicit use, and pairs well with our rehabilitation and non-opioid pain strategies under medical supervision.
Naloxone
Mechanism: Competitive opioid antagonist; rapidly displaces opioids from MOR, reversing respiratory depression.
Clinical use: Intranasal and intramuscular formulations; short half-life mandates calling emergency services due to re-narcotization risk.
Side effects: Precipitated withdrawal symptoms in opioid-exposed individuals; rare hypertension or allergic reactions.
Our policy: Universal overdose education; co-prescribe naloxone with any current or prior opioid use; educate families; teach two-dose protocol.
Naltrexone
Mechanism: Mu and kappa receptor antagonist; blocks opioid effects and reduces alcohol-induced dopamine release.
Clinical use: Oral daily dosing or monthly extended-release IM; requires opioid-free interval (typically ≥7–10 days) before initiation.
Side effects: Headache, GI upset, injection-site reactions; serious hepatotoxicity risk; avoid in acute hepatitis or liver failure.
Practical considerations: Appropriate for motivated individuals who are opioid-free, for co-occurring alcohol use disorder, or post-MOUD in specific recovery trajectories.
Why MOUD saves lives
By stabilizing the opioid system, MOUD reduces volatile cycles of intoxication and withdrawal, normalizes stress-response systems, and enables re-engagement with rehabilitation, work, family, and health. Rigorous research consistently demonstrates improved survival and functioning with MOUD (see references).

Harm Reduction: Keeping People Safe While We Treat

We operationalize harm reduction alongside MOUD and rehabilitation:
Naloxone education and distribution: Teach families; co-prescribe routinely; emphasize calling EMS after administration.
Fentanyl test strips: Encourage testing of all substances; reduce unintentional fentanyl exposure; empower informed decisions.
Never Use Alone hotline: Facilitate supervised-use calls that can trigger EMS if the caller becomes unresponsive.
Syringe services: Promote sterile injection supplies to reduce HIV/HCV transmission; educate on wound care and abscess prevention.
Urine drug testing: Use nonjudgmental discussions to reveal contamination and align treatment; avoid punitive framing.
Prescription Drug Monitoring Programs (PDMP): Coordinate with prescribers to avoid dangerous overlaps and improve transparency.
Motivational interviewing: Aligns harm reduction with the person’s goals; builds trust and consistent engagement.

Integrating Chiropractic Care Safely Within OUD Treatment

As a chiropractor and family nurse practitioner, I design spine and musculoskeletal care plans that complement MOUD and medical management under Dr. Cardenas’s oversight.
Why chiropractic in integrative OUD care
Pain is both a driver and consequence of opioid use. Biomechanical dysfunction, myofascial trigger points, joint restriction, and deconditioning amplify pain signals via peripheral and central mechanisms. Evidence-based chiropractic techniques can:
Improve segmental joint motion and reduce nociceptive input
Normalize proprioceptive signaling to the spinal cord and sensorimotor cortex
Downregulate sympathetic overactivity and facilitate parasympathetic tone
Reduce myofascial hypertonicity and improve functional movement patterns
Enhance endogenous pain inhibition (descending modulatory pathways)
Core strategies we use
High-velocity, low-amplitude (HVLA) spinal manipulation: When appropriate, this can reduce pain, improve mobility, and modulate spinal reflexes. We screen for contraindications rigorously (osteoporosis, coagulopathy, acute fractures, infection, malignancy).
Low-force mobilization and instrument-assisted approaches: For hyperalgesic or deconditioned patients, we start with gentle mobilizations to gradually restore range of motion and reduce fear-avoidance behaviors.
Myofascial therapies: Trigger point therapy, active release, instrument-assisted soft tissue mobilization to reduce taut bands, improve perfusion, and downregulate nociceptive input.
Stabilization and motor control exercises: Target deep spinal stabilizers (multifidus, transversus abdominis), hips, and thoracic mobility; build load tolerance with graded exposure.
Posture and ergonomic coaching: Reduce biomechanical stressors in daily routines and work tasks.
Neuromuscular re-education: Improve sensory integration and movement efficiency; address gait and balance where relevant.
Non-opioid analgesic adjuncts: Heat/cold therapy, TENS, topical analgesics, NSAIDs/acetaminophen when medically appropriate, and nutraceuticals with evidence for pain modulation under physician guidance.
Safety and coordination
Dr. Cardenas reviews comorbidities, medication interactions (e.g., anticoagulants, severe osteoporosis risk), and monitors hemodynamics and labs as needed.
We avoid overreliance on passive care; we prioritize active rehabilitation to prevent dependency and empower self-efficacy.
For patients on MOUD, we adjust manual therapy intensity to respect altered pain thresholds and autonomic responses.
Why this works
Pain is multidimensional—biomechanical, inflammatory, neurocognitive, and psychosocial. By reducing nociceptive burden and improving function, chiropractic care diminishes relapse drivers and supports sustainable recovery.

Functional Medicine Lens: Metabolic, Inflammatory, and Neuroendocrine Considerations

As a functional medicine practitioner, I evaluate physiologic systems that can worsen pain sensitivity and recovery challenges:
Inflammation and immune tone: Chronic low-grade inflammation (elevated CRP, altered cytokines) sensitizes nociceptive pathways. Dietary interventions emphasizing whole foods, omega-3 fatty acids, polyphenols, and reduced ultra-processed intake can modulate inflammatory mediators.
Gut-brain axis: Dysbiosis and increased intestinal permeability may influence systemic inflammation and neuroimmune signaling, affecting mood, pain sensitivity, and cravings. We consider fiber-rich diets, targeted probiotics, and elimination of individual trigger foods where relevant.
Sleep architecture: Sleep deprivation increases pain sensitivity and cravings; we deploy sleep hygiene protocols, circadian strategies, and CBT-I referrals.
Stress physiology: HPA-axis dysregulation amplifies pain and relapse risk. Breathing retraining, biofeedback, mindfulness-based stress reduction, and graded exercise restore autonomic balance.
Micronutrients: Deficiencies (e.g., vitamin D, magnesium, B vitamins) can affect neuromuscular function and mood; we correct deficiencies based on lab guidance from Dr. Cardenas.
Movement prescriptions: Aerobic and resistance exercise enhance endogenous opioid and endocannabinoid signaling, improve mood, and normalize insulin sensitivity and inflammatory tone.
Clinical rationale
Addressing physiologic load lowers symptom burden and can reduce reliance on pharmacologic rescue. This integrated strategy aligns with current research linking lifestyle, systemic inflammation, and pain chronification.

Personal Injury, Trauma-Informed Rehabilitation, and OUD

Injury can precipitate opioid exposure and escalate risk for misuse. Our trauma-informed rehabilitation:
Screens for OUD risk factors when opioids are considered for acute pain
Emphasizes non-opioid analgesia and early mobilization
Coordinates with Dr. Cardenas for limited, tightly monitored opioid trials if necessary, with clear taper plans
Integrates chiropractic, physical therapy principles, and graded activity to restore function
Embeds psychological safety: we avoid retraumatization, respect autonomy, and foster control and informed consent
Goal
Restore function quickly and safely, minimize opioid exposure, and, if OUD is present, link immediately to MOUD and comprehensive support.

Clinic Pathways: Screening, Diagnosis, and Care Coordination

Our standardized workflow ensures timely, safe, and person-centered care.
Intake and screening
Validated tools: Opioid Risk Tool, DSM-5 checklist, pain interference and function scales
Medical evaluation (Dr. Cardenas): Comorbidities, medications, EKG when indicated (methadone), liver function tests (naltrexone/buprenorphine), infectious disease screening where relevant
Functional assessment: Movement, posture, joint mechanics, myofascial findings, balance/gait
Shared decision-making
Present MOUD options (methadone referral vs buprenorphine in-clinic; naltrexone when appropriate), risks/benefits, and patient goals
Arrange naloxone co-prescription and training
Buprenorphine inductions
Conventional induction: Begin during moderate withdrawal to avoid precipitated withdrawal; titrate to symptom control
Low-dose/micro-induction options: For patients on full agonists who cannot tolerate withdrawal; carefully staged with medical oversight
Follow-up: Early and frequent check-ins to stabilize dosing, manage side effects, and coordinate rehabilitation
Methadone coordination
Referral and communication with OTPs; continuity of chiropractic and functional care; monitor QTc and drug interactions via medical team liaison
Naltrexone initiation
Ensure opioid-free period; assess liver function; consider for alcohol co-use disorder or tailored recovery plans.
Harm-reduction and MI integration
Provide fentanyl test strips, education, and community resources; use MI at each visit to reinforce goals and adapt plans.
Rehabilitation timeline
Early phase: Pain control without overreliance on passive care; gentle mobilization; sleep and stress strategies
Middle phase: Progressive strengthening, motor control, ergonomic changes
Late phase: Return-to-activity milestones, relapse prevention strategies, independent self-management
Quality metrics
Retention in MOUD, functional gains, pain interference scores, overdose education uptake, PDMP consistency, patient satisfaction, and safety events

Addressing Co-Occurring Conditions

Common comorbidities in OUD require coordinated care:
Psychiatric: Depression, anxiety, PTSD—refer for psychotherapy; consider pharmacotherapy under Dr. Cardenas; recognize how mood disorders interact with pain and cravings.
Infectious disease: HIV/HCV screening and linkage to care; vaccination updates (HBV, HAV).
Endocrine/metabolic: Diabetes, thyroid disorders; optimize for wound healing, energy, and mood stability.
Respiratory and cardiac: Evaluate for COPD and sleep apnea (especially with sedatives); monitor cardiac rhythm when indicated (methadone).
Pain syndromes: Fibromyalgia, neuropathic pain—non-opioid pharmacologic options, graded exercise, cognitive pain reframing, and integrative care strategies.

My Clinical Observations: Chiropractic and Functional Medicine in OUD Recovery

Drawing from my clinical work and observations shared across my professional platforms, I consistently see the following patterns:
When integrative musculoskeletal care reduces nociceptive input and improves function, patients report fewer cravings tied to pain spikes.
Autonomic balancing through breathwork, gentle manipulation, and progressive exercise improves sleep and mood—key pillars for sustained recovery.
A structured, empathetic team culture fosters trust; patients are more willing to disclose lapses and seek help early, allowing us to course-correct without shame.
Functional nutrition and anti-inflammatory strategies reduce baseline pain and fatigue, increasing adherence to exercise and therapy plans.
References to my professional perspectives and practice insights are available through my clinic and professional profiles:
chiromed.com
linkedin.com/in/dralexjimenez/

Case Practice: Language and Bias Reframing

Original biased phrasing (example themes we see in reports)
“Patient abused heroin IV … after seven years clean … involved with addict community … baby born addicted.”
Reframed with person-first, accurate language
“Patient reports intravenous heroin misuse from age 20 to 30, with daily use emerging soon after initiation. Last heroin use occurred 1 month ago following 7 years of no use. The patient entered recovery after a non-fatal overdose and began medications for opioid use disorder. Strengths and protective factors include a supportive family and regular participation in a recovery community. The patient’s child was born with neonatal opioid withdrawal and is currently healthy.”
Why this matters
Words influence policy, clinician attitudes, and patient self-concept. Reframing improves engagement, reduces shame, and is aligned with the scientific understanding of OUD.

Practical Safety Points for Patients and Families

Always carry naloxone; teach family and friends how to use it. Use one intranasal device per dose; if no response in 2 minutes, use the second device in the other nostril and call EMS immediately.
Test substances with fentanyl strips when possible; assume contamination risk.
Avoid using alone; consider the Never Use Alone hotline as a safety net.
For those on naltrexone, inform all providers (including surgeons) since opioid analgesics will not be effective.
For those on buprenorphine, communicate with medical and dental teams; many procedures can be managed with non-opioid strategies or carefully coordinated peri-procedural plans.
Maintain follow-up appointments; early communication about side effects prevents setbacks.

Why Our Multidisciplinary Model Improves Outcomes

Medical oversight (Dr. Cardenas): Ensures safe MOUD prescribing, lab and ECG monitoring, infection screening, and coordinated comorbidity care.
Chiropractic and rehabilitation: Reduce mechanical pain drivers, improve function, and normalize movement patterns, lowering reliance on pharmacologic solutions.
Functional medicine insights: Address systemic inflammation, sleep, stress physiology, and nutrition—critical for resilient recovery.
Behavioral collaboration: MI, group referrals, and trauma-informed care support motivation and coping.
Harm reduction: Makes care safer regardless of stage of change, decreases fatality risks, and keeps the therapeutic alliance intact.
Together, this integrated approach is modern, evidence-informed, and deeply humane. It respects the biology of OUD, the realities of pain, and the person’s goals for a meaningful life.

Evidence Highlights and Rationale

MOUD effectiveness: Strong evidence demonstrates reductions in all-cause and overdose mortality with methadone and buprenorphine, improved treatment retention, and decreased illicit opioid use.
Buprenorphine safety: Partial agonism with a ceiling effect reduces respiratory depression risk compared to full agonists; appropriate even when patients use benzodiazepines when benefits outweigh risks, per FDA guidance.
Harm reduction: Naloxone distribution and education prevent death; syringe services reduce HIV/HCV; fentanyl test strips inform safer choices.
Integrative pain care: Non-opioid multimodal strategies with manual therapy, exercise, and behavioral approaches are supported by clinical guidelines for back and neck pain and can be embedded within OUD care.
(See reference list for supporting sources.)

How to Begin Care with Us

Contact Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas.
Initial visit: Comprehensive intake, medical and functional assessments, and safety planning.
If OUD is identified or suspected: Same-day or rapid MOUD initiation pathways; naloxone provided; harm-reduction education; chiropractic and rehab plan tailored to your functional goals; functional medicine strategies to support recovery.
Ongoing care: Regular follow-ups with both medical and musculoskeletal teams; coordinated communications; outcome tracking focused on your goals and safety.
You are not alone. With the right team, tools, and plan, recovery is not only possible—it is probable.

References

Centers for Disease Control and Prevention. (n.d.). Opioid overdose data. CDC. https://www.cdc.gov/drugoverdose/data
Substance Abuse and Mental Health Services Administration. (2022). Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health. SAMHSA. https://www.samhsa.gov/data
National Academies of Sciences, Engineering, and Medicine. (2019). Medications for opioid use disorder save lives. The National Academies Press. https://doi.org/10.17226/25310
U.S. Food and Drug Administration. (2017). FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants. FDA. https://www.fda.gov/drugs/drug-safety-and-availability
Kampman, K., & Jarvis, M. (2015). American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9(5), 358–367. https://doi.org/10.1097/ADM.0000000000000166
Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371. https://doi.org/10.1056/NEJMra1511480
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, (2), CD002207. https://doi.org/10.1002/14651858.CD002207.pub4
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment. BMJ, 357, j1550. https://doi.org/10.1136/bmj.j1550
Busse, J. W., et al. (2017). Guideline for opioid therapy and chronic noncancer pain. CMAJ, 189(18), E659–E666. https://doi.org/10.1503/cmaj.170363
Qaseem, A., Wilt, T. J., McLean, R. M., & Forciea, M. A. (2017). Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the ACP. Annals of Internal Medicine, 166(7), 514–530. https://doi.org/10.7326/M16-2367
Bohnert, A. S. B., et al. (2018). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 320(2), 185–186. https://doi.org/10.1001/jama.2018.7364
Larochelle, M. R., et al. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality. Annals of Internal Medicine, 169(3), 137–145. https://doi.org/10.7326/M17-3107
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105(8), e55–e63. https://doi.org/10.2105/AJPH.2015.302664
Katz, J., et al. (2018). The fourth wave: Co-use of opioids and stimulants. International Journal of Drug Policy, 55, 118–125. https://doi.org/10.1016/j.drugpo.2018.02.014
Note: Additional guideline updates and local program information are incorporated from CDC, SAMHSA, FDA safety communications, and professional society recommendations current to the creation date.

SEO tags: opioid use disorder, MOUD, buprenorphine, methadone, naltrexone, naloxone, harm reduction, chiropractic care, integrative medicine, functional medicine, multidisciplinary clinic, El Paso, Texas, stigma reduction, motivational interviewing, pain management, personal injury rehabilitation, fentanyl crisis, DSM-5 criteria, PDMP, SMART Recovery, evidence-based care

August 10, 2026

Peptides, Nutrition, and Chiropractic Healing Care

Abstract

Recovering from an injury, managing chronic pain, improving metabolic health, or supporting healthy weight loss often requires more than one type of treatment. At ChiroMed, an integrative approach can combine chiropractic care, rehabilitation, functional medicine principles, nutritional support, and medically appropriate therapies to address different parts of a person’s health.

A protein-forward, anti-inflammatory whole-food diet may support this type of care by supplying amino acids and nutrients the body needs for muscle, connective tissue, and normal tissue repair. Mediterranean-style nutrition is often a practical choice because it combines lean proteins, vegetables, fruits, healthy fats, and fiber. Some patients may also use a medically supervised lower-carbohydrate or ketogenic diet.

When peptide-based treatments are appropriate, nutrition and chiropractic rehabilitation may become supporting parts of a larger treatment plan. However, peptide therapies vary greatly in their evidence, safety, and FDA approval status. Patients should always work with qualified healthcare professionals before beginning peptides, supplements, major dietary changes, or other medical treatments.

Why Nutrition Matters During Recovery

The body cannot repair injured tissues without proper nutrients.

Muscles, tendons, ligaments, bones, and other connective tissues require adequate energy, protein, vitamins, minerals, and essential fats. Protein is especially important because it supplies amino acids, which serve as building blocks for many structures in the body.

Research examining nutrition during musculoskeletal rehabilitation shows that adequate protein and energy intake can play an important role in maintaining muscle and supporting recovery after injury (Giraldo-Vallejo et al., 2023).

A recovery-focused diet may include:

Chicken and turkey
Fish and seafood
Eggs
Lean beef
Beans and lentils
Nuts and seeds
Vegetables
Low-sugar fruits
Whole grains when appropriate
Olive oil
Avocados
Adequate fluids

The goal is not simply to eat as much protein as possible.

Instead, a protein-forward diet places a good-quality protein source at the center of each meal while also including vegetables, healthy fats, fiber, and other nutrient-rich foods.

This type of nutrition may be especially useful when combined with rehabilitation, chiropractic care, exercise, or medically supervised weight-management treatment.

What Is Peptide Therapy?

Peptides are small chains of amino acids. Many natural peptides act as signaling molecules in the body and help control different biological processes.

However, peptide therapy is a broad term.

Some peptide-based medications have been studied extensively and approved by the U.S. Food and Drug Administration for specific medical conditions. For example, several modern medications used for diabetes and chronic weight management work through peptide-related pathways.

Other substances marketed for tissue recovery, sports performance, anti-aging, or wellness may have much less clinical evidence.

This difference is important.

The FDA has raised concerns about several compounded peptide substances because adequate safety data may not be available. Some peptides promoted online or through wellness programs are not FDA-approved for treating musculoskeletal injuries.

Patients should therefore avoid assuming that every product called a peptide has been proven safe or effective.

A medical provider should consider:

The patient’s diagnosis
Medical history
Current medications
Treatment goals
Laboratory findings when appropriate
Possible side effects
Drug interactions
Contraindications
FDA approval status
The source and quality of the medication

Peptides should never be viewed as a substitute for proper medical evaluation, healthy nutrition, exercise, sleep, chiropractic rehabilitation, or other needed treatment.

Why Combine Protein With Peptide-Based Treatment?

Whether a patient is recovering from an injury or participating in a medically supervised weight-management program, protein remains important.

Protein supplies amino acids used throughout the body.

These nutrients support normal:

Muscle maintenance
Tissue remodeling
Enzyme production
Immune function
Hormone production
Connective tissue maintenance

Nutrition programs designed around peptide or GLP-1 treatments often emphasize protein because these medications may decrease appetite.

A person who begins eating much less food may lose body fat, but without careful nutrition and exercise, some lean muscle may also be lost.

That makes diet quality important.

A protein-forward approach may help patients maintain better nutrition while participating in an individualized medical or weight-management program.

How an Anti-Inflammatory Diet May Support Musculoskeletal Health

Inflammation is part of the normal healing process.

Following an injury, inflammatory activity helps the body respond to damaged tissues. However, long-term systemic inflammation may contribute to several health problems and may affect how a person feels and functions.

Diet is one factor that can influence the body’s inflammatory environment.

Research has associated Mediterranean-style eating patterns with favorable inflammatory markers and overall health outcomes (Elma et al., 2020).

An anti-inflammatory whole-food approach typically emphasizes foods such as:

Salmon
Sardines
Chicken
Turkey
Eggs
Beans
Lentils
Spinach
Kale
Broccoli
Berries
Apples
Nuts
Seeds
Olive oil
Avocados
Herbs and spices

At the same time, patients may benefit from limiting:

Highly processed foods
Excess added sugar
Sugary drinks
Refined carbohydrates
Excess alcohol
Foods high in heavily processed fats

These dietary changes do not directly “cure” an injury.

Instead, they may help provide a nutritional environment that supports overall health while chiropractic care, rehabilitation, exercise, and medical treatment address other aspects of the patient’s condition.

The Mediterranean Diet and Integrative Care

For many people, the Mediterranean diet offers a balanced and sustainable starting point.

It emphasizes:

Vegetables
Fruits
Fish
Lean meats
Beans
Lentils
Nuts
Seeds
Olive oil
Whole grains
Minimally processed foods

Research has also examined the Mediterranean diet in relation to muscle health and physical function, with greater adherence often associated with favorable musculoskeletal outcomes (Papadopoulou et al., 2023).

For a patient recovering from a musculoskeletal injury, the traditional Mediterranean pattern can be adjusted to include additional protein.

For example, a meal could contain:

Grilled salmon
Roasted vegetables
A small serving of quinoa
Olive oil
A side salad
Berries

This creates a protein-forward Mediterranean-style meal without relying heavily on processed foods.

Can a Ketogenic Diet Be Used?

Some patients may benefit from a lower-carbohydrate or ketogenic eating plan.

A ketogenic diet generally reduces carbohydrate intake and increases dietary fat. Protein intake may range from moderate to relatively high depending on the specific plan.

Foods may include:

Eggs
Chicken
Turkey
Salmon
Beef
Avocado
Olive oil
Nuts
Seeds
Leafy vegetables
Broccoli
Cauliflower

Purposeful Healing DPC describes using quality protein, non-starchy vegetables, and healthy fats as part of a high-protein, lower-carbohydrate, anti-inflammatory approach (Purposeful Healing DPC, 2026).

However, ketogenic diets are not right for everyone.

Patients with certain medical conditions may require additional supervision, including those with some:

Kidney disorders
Liver conditions
Gallbladder problems
Pancreatic disorders
Metabolic diseases
Gastrointestinal conditions

People taking medications for diabetes or blood pressure may also require closer monitoring when significantly changing carbohydrate intake.

Patients should speak with their healthcare provider before starting a ketogenic diet.

Where Integrative Chiropractic Care Fits

Nutrition supplies biological building materials.

Chiropractic care and rehabilitation focus more directly on movement and musculoskeletal function.

A person recovering from an automobile collision, sports injury, work injury, or repetitive strain problem may experience several issues at once.

These may include:

Joint restriction
Reduced mobility
Muscle tightness
Muscle weakness
Poor posture
Limited range of motion
Abnormal movement patterns
Pain with activity
Deconditioning

Nutrition alone cannot correct these mechanical problems.

Likewise, chiropractic care cannot replace healthy eating or medical treatment when those services are needed.

This is why an integrated approach may be helpful.

At ChiroMed, chiropractic care can be used as part of a broader rehabilitation strategy designed around the patient’s individual condition and functional goals.

Depending on the patient, care may include:

Chiropractic manipulation
Joint mobilization
Soft-tissue techniques
Corrective exercises
Strengthening
Mobility work
Posture education
Movement retraining
Rehabilitation

Nutritional strategies can then support the patient’s overall health while the physical treatment addresses movement and musculoskeletal function.

Chiropractic Care and Nutrition Can Complement Each Other

Several chiropractic health resources discuss nutrition as an important part of whole-body care.

Adequate protein may support muscle maintenance, while nutrients such as vitamin D, magnesium, calcium, essential fats, and antioxidants are important for normal body function (Coconut Grove Chiropractic, 2025; Rangeline Chiropractic, 2026).

For example, a patient with chronic lower back discomfort may be working on:

Restoring spinal mobility
Improving hip movement
Strengthening the core
Building leg strength
Improving posture
Increasing daily activity
Losing excess body weight
Improving nutrition

No single treatment addresses every one of these goals.

This is where coordinated care becomes useful.

Combining Peptides, Chiropractic Care, and Rehabilitation

Peptide therapy and chiropractic treatment should not be thought of as treatments that automatically make each other work better.

Instead, different therapies may target different problems.

Medical Treatment

A licensed medical professional determines whether a medication or peptide-based treatment is appropriate.

Medical oversight may include evaluating:

Diagnosis
Medications
Laboratory results
Medical risks
Contraindications
Treatment response

Chiropractic Treatment

Chiropractic care may address:

Joint movement
Spinal mobility
Musculoskeletal function
Movement restrictions
Mechanical stress

Rehabilitation

Rehabilitation helps patients rebuild:

Strength
Stability
Balance
Endurance
Flexibility
Confidence with movement

Nutrition

Nutrition provides the body with:

Protein
Amino acids
Vitamins
Minerals
Essential fats
Fiber
Energy

Functional Medicine

Functional medicine strategies may also examine factors such as:

Blood sugar
Nutrient status
Weight
Sleep
Physical activity
Dietary habits
Metabolic health

Combining these areas creates a more complete picture of the patient.

ChiroMed’s Whole-Body Approach to Injury and Wellness

At ChiroMed, the goal of integrative care is to look beyond only where the patient hurts.

Pain may be connected with multiple factors.

For example, a patient recovering after an automobile accident may have a spinal injury but may also experience:

Poor sleep
Reduced activity
Muscle weakness
Weight changes
Stress
Nutritional problems
Loss of physical conditioning

Treating only one part of the problem may leave other important factors unaddressed.

Integrative chiropractic care allows the treatment plan to consider movement, nutrition, rehabilitation, metabolic health, and appropriate medical evaluation together.

This type of approach may be useful for patients receiving care for:

Neck pain
Lower back pain
Joint injuries
Sports injuries
Work injuries
Automobile accident injuries
Muscle strains
Reduced mobility
Functional limitations
Weight-management concerns

Dr. Alex Jimenez’s Integrative Clinical Approach

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, has published educational materials discussing the connection between musculoskeletal health, functional medicine, rehabilitation, metabolic health, and nutrition.

His clinical approach emphasizes evaluating more than the painful body part.

Important areas may include:

Spinal and joint mechanics
Muscle strength
Movement quality
Nutrition
Weight
Metabolic health
Functional medicine findings
Previous injuries
Lifestyle habits
Rehabilitation needs

In this type of care model, peptide-related treatment is not presented as a stand-alone cure.

Instead, when a medically appropriate therapy is used, the patient may also need to address nutrition, movement, physical conditioning, sleep, and other factors that influence health.

Multidisciplinary Medical Oversight

Integrative and injury-care clinics may use a multidisciplinary model in which providers from different clinical backgrounds collaborate while remaining within their professional scope of practice.

Dr. Jimenez works with Dr. Maria Guadalupe Cardenas, MD, who is Board Certified in Internal Medicine and has more than 40 years of experience as an internist.

Practice information identifies Dr. Cardenas as Medical Director and Collaborative Physician, with NPI #1164426749 and Texas MD License #J2933.

Within this multidisciplinary approach:

Dr. Jimenez provides chiropractic and musculoskeletal care.
Rehabilitation focuses on restoring movement and strength.
Functional medicine may address nutritional and metabolic factors.
Personal injury care can address automobile, workplace, and other trauma-related conditions.
Medical oversight helps evaluate diagnoses, medications, medical risks, and medically directed treatment.

The goal is coordinated care rather than asking one provider or one treatment to address every aspect of the patient’s condition.

A Simple Protein-Forward Healing Plate

Healthy eating does not need to be complicated.

Patients can begin by building meals around four basic areas.

1. Protein

Choose foods such as:

Chicken
Turkey
Fish
Eggs
Lean beef
Beans
Lentils
Tofu

2. Vegetables

Fill a large portion of the plate with colorful vegetables.

Examples include:

Spinach
Broccoli
Peppers
Green beans
Cauliflower
Zucchini

3. Healthy Fats

Examples include:

Olive oil
Avocado
Nuts
Seeds
Fatty fish

4. Quality Carbohydrates

Depending on the patient’s nutrition plan, choices may include:

Beans
Lentils
Oats
Potatoes
Quinoa
Brown rice
Fruit

Patients following a ketogenic diet may use fewer carbohydrate-containing foods.

Weight Management, Peptide Medications, and Muscle Health

Weight loss is another area where nutrition becomes especially important.

Certain peptide-based medications used for weight management may significantly reduce appetite.

Eating fewer calories can support weight loss, but patients should still consume enough protein and important nutrients.

A healthy weight-management plan may include:

Protein at every meal
Vegetables
Adequate hydration
Resistance training when appropriate
Walking and physical activity
Adequate sleep
Regular medical monitoring

The goal should not simply be a lower number on the scale.

Maintaining muscle, improving movement, reducing excess body fat, and improving metabolic health may be equally important.

The Bottom Line

Peptide therapy, chiropractic care, nutrition, functional medicine, and rehabilitation can address different parts of a patient’s health.

A protein-forward, anti-inflammatory whole-food diet supplies amino acids and other nutrients involved in normal muscle and tissue maintenance.

A Mediterranean-style diet offers a flexible and well-studied approach that can be adjusted to include more protein.

A ketogenic or lower-carbohydrate diet may be appropriate for selected patients when medically supervised.

Integrative chiropractic care addresses movement, joint function, mobility, and musculoskeletal mechanics, while rehabilitation helps rebuild strength and function.

For patients receiving peptide-based treatments, medical supervision is essential.

Some peptide medications are FDA-approved for specific conditions. Other products promoted for healing, anti-aging, or sports recovery remain investigational or may have limited safety data.

The best treatment plan is therefore not simply about taking a peptide, getting an adjustment, or following a popular diet.

It is about creating a coordinated plan based on the patient’s:

Diagnosis
Medical history
Nutritional needs
Movement limitations
Metabolic health
Rehabilitation goals
Lifestyle
Long-term health needs

At ChiroMed, an integrative approach can bring these areas together to help patients better understand their health, improve function, and work toward sustainable recovery.

Always speak with a qualified healthcare professional before beginning peptide therapy, changing medications, starting supplements, or making a major change to your diet.

References

Clean Eatz. (2026). This is peptide nutrition 101.

Coconut Grove Chiropractic. (2025). Integrating chiropractic care with nutrition for optimal wellness.

Elma, Ö., Yilmaz, S. T., Deliens, T., Coppieters, I., Clarys, P., Nijs, J., & Malfliet, A. (2020). Do nutritional factors interact with chronic musculoskeletal pain? A systematic review.

Giraldo-Vallejo, J. E., Cardona-Guzmán, M. Á., Rodríguez-Alcivar, E. J., Kočí, J., Petro, J. L., Kreider, R. B., Cannataro, R., & Bonilla, D. A. (2023). Nutritional strategies in the rehabilitation of musculoskeletal injuries in athletes: A systematic integrative review.

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST.

Jimenez, A. (n.d.). Dr. Alex Jimenez – LinkedIn professional profile.

Med Matrix. (n.d.). Nutrition and peptides.

Purposeful Healing DPC. (2026). Keto, high-protein, anti-inflammatory guide.

Rangeline Chiropractic. (2026). Integrating chiropractic care with nutrition for optimal wellness.

SmashMeals. (n.d.). Peptide therapy meals.

Spectrum Pain Management. (2024). Unlocking the power of peptides in chiropractic care.

Strength Doctor. (n.d.). Why nutrition is crucial in post-peptide therapy care.

Tyrance Orthopedics. (n.d.). Is BPC-157 the best peptide for gut health?.

U.S. Food and Drug Administration. (n.d.). Certain bulk drug substances for use in compounding may present significant safety risks.

Wellness Doctor RX. (2026). Peptides, nutrition, and chiropractic wellness explained.

Additional educational resources:

Atlanta Spine & Wellness – Chiropractic Therapy and Diet

The KC Chiro – Nutrition and Chiropractic Care

El Paso Chiropractic – Nutrition Resources

Integrative Chiropractic Peptide Plan in El Paso

Chiropractic, Peptides, and Nutrition

Holistic Chiropractic Care and Nutrition Integration

August 3, 2026

Integrative Treatment and Management for Hyperparathyroidism

Learn about holistic approaches to hyperparathyroidism integrative treatment that promote overall well-being and balance

Educational Abstract: Integrative Insights on Primary Hyperparathyroidism, Quality of Life, and Multidisciplinary Care

Welcome to this comprehensive educational guide on hyperparathyroidism, a condition often characterized by the overproduction of parathyroid hormone (PTH), which plays a crucial role in regulating calcium levels in our blood and bones. In this post, we will embark on a detailed, evidence-based journey to understand the intricacies of hyperparathyroidism, starting with its primary symptom: hypercalcemia, or elevated calcium levels. I will explain how calcium, vitamin D, and PTH regulate human physiology; how laboratory and imaging modalities clarify diagnosis; and how surgical and medical strategies are selected, sequenced, and personalized. We will delve into the different types of hyperparathyroidism—primary, secondary, and tertiary—and discuss the clinical criteria that guide treatment decisions, particularly the indications for surgery, which remains the only definitive cure.
This post will also cover medical management options, including medications like Cinacalcet (Sensipar) and bisphosphonates, and highlight the importance of an integrated, multidisciplinary approach. I will explain how our unique practice model at the Injury Medical Clinic PA in El Paso, Texas, brings together the expertise of Dr. Maria Guadalupe Cardenas, MD, a highly experienced board-certified internist serving as our Medical Director, with my own background in chiropractic, functional medicine, and as a Family Nurse Practitioner. This collaborative framework allows us to provide holistic, evidence-based care that addresses the musculoskeletal, metabolic, and systemic aspects of hyperparathyroidism. Join me as we explore the latest findings from leading researchers, translate them into actionable clinical protocols, and share real-world observations from my practice to turn “calcium chaos” into clarity.

Calcium Chaos Made Understandable: A First-Person Educational Journey

I have spent decades observing how subtle shifts in calcium physiology reverberate through the nervous system, musculoskeletal integrity, kidney function, and cognitive well-being. What may appear as a simple “high calcium” on a routine lab can conceal years of bone remodeling imbalance, silent nephrolithiasis, accelerating vascular calcification, and progressive neurocognitive changes. When I first encountered patients with unexplained fatigue, recurrent musculoskeletal pain, and vague gastrointestinal symptoms, I noticed a pattern—”normal” ranges did not explain their day-to-day experience. That realization led me to dig into the physiology behind calcium chaos and build a multidisciplinary pathway with medical, functional, and chiropractic expertise, guided by rigorous research.
In this educational post, I will:

Define primary hyperparathyroidism and differentiate it from secondary and tertiary forms.
Explain the physiological roles of calcium, vitamin D (D3 and D2), PTH, and phosphorus.
Discuss laboratory tests including serum calcium, albumin-adjusted calcium, ionized calcium, PTH, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, urinary calcium excretion, and phosphorus.
Review imaging modalities: neck ultrasound, sestamibi scintigraphy, 4D-CT, and MRI.
Outline medical management strategies, including hydration, antiresorptives, and cinacalcet.
Detail indications and protocols for parathyroidectomy, with modern minimally invasive methods.
Illustrate how integrative chiropractic care fits into comprehensive management—addressing posture, pain, fracture prevention, and rehabilitation.
Integrate functional medicine frameworks for root-cause investigation, including nutrition, microbiome, and stress physiology.
Present personal injury considerations and case-style narratives connecting physiological insights to clinical decisions.
Cite leading researchers, synthesize current literature, and provide APA-7 in-text citations with linked references.

My goal is to make this journey readable and relatable: to take you step-by-step across the terrain of hyperparathyroidism and its practical, integrative care.

Meet Our Collaborative Team: Internal Medicine and Chiropractic in an Integrative Clinic

At the Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, we have cultivated a unique, multidisciplinary environment dedicated to providing comprehensive and patient-centered care. A cornerstone of our practice is the collaborative relationship between me, Dr. Alex Jimenez, and our esteemed Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a board-certified internist with an impressive career spanning over 40 years (NPI #1164426749, Texas MD License #J2933). Her vast experience and deep understanding of internal medicine provide the essential medical oversight that underpins our integrative model.
This partnership allows us to blend the best of multiple disciplines. My expertise as a Doctor of Chiropractic (DC) and an Advanced Practice Registered Nurse (APRN) specializing as a Family Nurse Practitioner (FNP-BC), combined with advanced certifications in functional and integrative medicine, focuses on the body’s structure, function, and underlying metabolic pathways. Dr. Cardenas’s role as the supervising physician is crucial. She provides the medical direction necessary to diagnose and manage complex internal conditions like PHPT, prescribe medications, order labs and imaging, and ensure that all aspects of our patients’ care meet the highest medical standards. This setup is common in leading-edge integrative and injury care clinics, where the synergistic expertise of a Medical Doctor (MD) and a Doctor of Chiropractic (DC) creates a powerful therapeutic alliance.
Together, our team integrates:

Medical Diagnosis and Management (Dr. Cardenas): Providing primary medical assessment, oversight of complex endocrine conditions, and prescription management.
Chiropractic Care (Dr. Jimenez): Focusing on spinal and joint alignment, nervous system function, and biomechanical health to reduce pain and improve mobility.
Functional Medicine (Dr. Jimenez): Investigating the root causes of chronic illness by analyzing genetics, lifestyle, and environmental factors to create personalized health strategies.
Rehabilitation and Personal Injury Care: Developing customized programs to help patients recover from injuries, restore function, and prevent future issues.
Nutritional and Lifestyle Counseling: Guiding patients toward optimal health through diet, exercise, and stress management techniques.

This integrated model ensures that when a patient presents with a condition like hyperparathyroidism, we can address it from multiple angles. While Dr. Cardenas oversees the medical diagnosis and management of the endocrine disorder, I can implement supportive chiropractic and functional medicine protocols to manage associated symptoms like bone pain, muscle weakness, and fatigue, and to optimize overall metabolic health. This holistic approach empowers our patients on their journey to wellness.

The Historical Perspective: Early Recognition and Surgical Milestones

The first diagnosis of hyperparathyroidism was documented in 1926 by Dr. Eugene Dubois, whose patient, Captain Charles Martel, suffered progressive skeletal disease and repeated surgeries until a parathyroid adenoma was discovered. His case, dramatic and tragic, foreshadowed the intimate link between parathyroid pathology and bone. Historically, before the widespread use of routine biochemical screening that began around 1970, this condition was known by the memorable triad of “bones, stones, and abdominal groans.” Patients were often symptomatic, presenting with bone pain, kidney stones, and gastrointestinal issues. Today, surgical finesse and biochemical understanding enable earlier identification and curative procedures, reducing the severe bone and renal complications that tormented early patients.

Identifying High Calcium: The First Step in the Diagnostic Journey

When we begin to investigate conditions like hyperparathyroidism, our journey often starts with a simple, yet profoundly important, lab finding: hypercalcemia, or an elevated level of calcium in the blood. While hyperparathyroidism is a primary suspect, it is by no means the only cause. As a clinician, my first responsibility is to consider a broad differential diagnosis to ensure we are not overlooking other serious conditions. High calcium levels, particularly those exceeding 12 mg/dL, demand a thorough and systematic evaluation.
Here are some of the critical conditions we must consider when a patient presents with hypercalcemia:

Hypercalcemia of Malignancy: This is one of the most serious considerations. Certain cancers can produce a substance called parathyroid hormone-related peptide (PTHrP), which mimics the action of PTH and causes calcium to be released from the bones. Other malignancies, such as multiple myeloma or cancers that have metastasized to the bone, can directly destroy bone tissue, releasing calcium into the bloodstream.
Vitamin D or Vitamin A Toxicity: In our modern world of supplements, it’s not uncommon for individuals to overdo it. Excessive intake of vitamin D can increase calcium absorption from the gut, resulting in hypercalcemia. Similarly, though less common, vitamin A toxicity can also affect bone metabolism and elevate calcium levels.
Milk-Alkali Syndrome: This condition arises from the ingestion of large amounts of calcium and absorbable alkali, typically from over-the-counter antacids. I recall a recent case in our clinic that perfectly illustrates this point. A patient presented with significantly high calcium levels. During our detailed consultation, a crucial part of the functional medicine approach, we explore every aspect of a patient’s lifestyle, including supplements. When I asked her specifically about any over-the-counter products she was taking, she mentioned using Tums for indigestion. The follow-up question is always about quantity. When I asked how many she was taking, she revealed she was consuming about thirty Tums per day. This crucial piece of information immediately pointed us toward the cause of her hypercalcemia. It underscores the absolute necessity of asking detailed, quantified questions during the patient history.
Other Potential Causes: The list of possibilities extends further. We also consider:
- Prolonged Immobilization: Patients who are bedridden for long periods can experience increased bone resorption, leading to a release of calcium.
- Hyperthyroidism: An overactive thyroid gland can accelerate bone turnover and cause mild hypercalcemia.
- Granulomatous Diseases: Conditions like sarcoidosis or tuberculosis (TB) can lead to the formation of granulomas, which can activate vitamin D and subsequently raise calcium levels.
- Medications: Certain drugs like thiazide diuretics and lithium can disrupt calcium homeostasis.
- Adrenal Insufficiency: A deficiency in adrenal hormones can sometimes be associated with hypercalcemia.
- Total Parenteral Nutrition (TPN): Patients receiving all their nutrition intravenously can sometimes develop imbalances in their calcium levels.

Understanding this broad landscape is the first step in a precise and effective diagnostic process.

Clinical Pearls for Navigating an Elevated Calcium Result

When routine lab work reveals an elevated serum calcium level, it’s essential not to jump to conclusions. A calm, methodical approach is key. Here are some “clinical pearls”—practical steps and considerations—that I follow in my practice to navigate this finding effectively.

The First Step: Recheck and Confirm

The very first action I take when I see an isolated elevated serum calcium result is simple: recheck it. Lab errors can happen, and transient fluctuations can occur. I will have the patient come back for a repeat blood draw, ideally under controlled conditions (e.g., fasting). If the repeat test comes back normal and there are no other red flags in the patient’s history or exam, we can often monitor the situation. I might say, “Let’s move on for now, but we’ll keep an eye on this in future lab panels.” If the elevation reappears on a subsequent test down the line, then a more thorough investigation is warranted. However, if a single repeat test normalizes, we can often avoid an unnecessary and potentially costly workup.

The Second Step: Deepen the Investigation

If the repeat calcium level is also elevated, our investigation deepens. This is the point where we need more data to understand the underlying physiology. The next logical and crucial test to add is a parathyroid hormone (PTH) level. This single test is the most important differentiator. The relationship between calcium and PTH tells us a story:

High Calcium + High PTH: This combination strongly suggests primary hyperparathyroidism, where the parathyroid glands are autonomously overproducing the hormone.
High Calcium + Low PTH: This pattern indicates that the parathyroid glands are functioning correctly—they are trying to shut down production in response to the high calcium. This points us toward other causes, such as malignancy or vitamin D toxicity.

Considering Ionized Calcium

You might also consider ordering an ionized calcium level. Total serum calcium, which is what is measured in a standard metabolic panel, is about 50% bound to proteins, primarily albumin. The other 50% is the “free” or “ionized” calcium, which is the biologically active form. Ionized calcium directly interacts with the calcium-sensing receptor (CaSR) on parathyroid chief cells, guiding PTH secretion. Changes in albumin levels can affect the total calcium measurement without changing the active ionized calcium. For instance, in a dehydrated patient with high albumin, the total calcium might appear falsely elevated.
We often use a formula to calculate a “corrected calcium” based on the albumin level. However, ordering a direct ionized calcium test can sometimes provide a more accurate picture, especially when albumin is abnormal, acid-base status is unstable, or when clinical symptoms diverge from total calcium readings. It’s important to remember, though, that in a relatively healthy individual with a normal acid-base status, the corrected calcium is often sufficient.

The Physiology of Calcium: Roles, Regulation, and Resonance

Calcium is more than a bone mineral; it is a signaling ion orchestrating countless processes.

Cardiac conduction: Calcium influx drives the plateau phase of action potentials; abnormalities can precipitate arrhythmias.
Neuromuscular function: Calcium binds troponin C, enabling muscle contraction. Hypercalcemia can alter excitability, causing weakness or fatigue.
Neurotransmission: Presynaptic calcium influx triggers synaptic vesicle release; dysregulation affects cognition and mood.
Coagulation: Calcium (Factor IV) is essential for activating various clotting cascades.
Bone remodeling: Calcium combines with phosphate in hydroxyapatite; osteoclast and osteoblast balance hinges on PTH and vitamin D.

Serum calcium exists in three fractions:

Protein-bound (mostly to albumin): Not bioactive; shifts with albumin changes.
Complexed (bound to anions such as citrate, phosphate).
Ionized (free): The bioactive fraction; tightly regulated, it reflects the true physiologic impact.

Symptoms of Hypercalcemia: Thresholds and Clinical Nuance

Mild elevations (around 10–11 mg/dL): Often asymptomatic or subtle—fatigue, constipation, mild mood changes.
Moderate elevations (>11 mg/dL): Nausea, abdominal pain, anorexia, cognitive changes, dehydration, decreased exercise tolerance.
Severe elevations (≥12–14 mg/dL): Neurocognitive impairment, acute kidney injury, arrhythmias, altered mental status; can become life-threatening.

In emergency settings, patients may be obtunded with acute renal compromise. Rapid stabilization—IV hydration, loop diuretics (after volume repletion), calcitonin, and consideration of bisphosphonates—is essential. Our integrated team prioritizes assessment of the underlying cause: PHPT, malignancy, granulomatous disease, thyrotoxicosis, drug-induced hypercalcemia, immobilization, vitamin A toxicity, and milk-alkali syndrome.

Understanding the Types of Hyperparathyroidism: Primary, Secondary, and Tertiary

Hyperparathyroidism is not a single entity. It is categorized into three distinct types—primary, secondary, and tertiary—each with a different underlying cause and physiological mechanism. Understanding these distinctions is fundamental to accurate diagnosis and treatment.

Primary Hyperparathyroidism

Primary hyperparathyroidism (PHPT) is the focus of our discussion. In this condition, the problem originates within the parathyroid glands themselves. One or more of the four parathyroid glands develops a benign tumor, called an adenoma, or, less commonly, becomes enlarged, a condition known as hyperplasia. This abnormal gland tissue becomes autonomous and produces an excessive amount of parathyroid hormone (PTH), irrespective of the body’s actual calcium levels.
The normal feedback loop is broken. In a healthy individual, high blood calcium would signal the parathyroid glands to stop producing PTH. In PHPT, the adenoma continues to churn out PTH, leading to a classic biochemical signature:

High Serum Calcium
High or Inappropriately Normal PTH

Secondary Hyperparathyroidism

In secondary hyperparathyroidism, the parathyroid glands are not the source of the problem. They are actually functioning correctly, but they are responding to another underlying disease state that is causing low calcium levels (hypocalcemia). The glands become enlarged and overproduce PTH as a compensatory mechanism to try and raise the blood calcium back to normal.
The most common causes of secondary hyperparathyroidism are:

Chronic Kidney Disease (CKD): This is the most prevalent cause. As kidney function declines, the kidneys are unable to excrete phosphate effectively and lose the ability to activate vitamin D. The combination of low calcium and high phosphate creates a powerful stimulus for the parathyroid glands to produce massive amounts of PTH.
Vitamin D Deficiency: A severe and prolonged deficiency of vitamin D leads to poor calcium absorption from the diet, triggering the parathyroid glands to ramp up PTH production.

The biochemical profile of secondary hyperparathyroidism is typically: Low or Normal Serum Calcium and High PTH.

Tertiary Hyperparathyroidism

Tertiary hyperparathyroidism is a complication that arises from long-standing, severe secondary hyperparathyroidism, most often in patients with end-stage renal disease. After years of constant stimulation, the parathyroid glands become so enlarged and hyperplastic that they begin to function autonomously, similar to a primary adenoma. They continue to secrete massive amounts of PTH even if the original problem is corrected (e.g., after a kidney transplant), leading to significant hypercalcemia.
The biochemical profile of tertiary hyperparathyroidism is: High Serum Calcium and Very High PTH.

Differentiating the Causes of Elevated Calcium and PTH

When we have confirmed that a patient has both elevated calcium and elevated parathyroid hormone (PTH), we have significantly narrowed our differential diagnosis. The primary culprit we focus on is primary hyperparathyroidism. However, before finalizing this diagnosis, it’s crucial to rule out other factors that can create a similar lab profile.

The Role of Medications

Thiazide Diuretics: Medications like hydrochlorothiazide (HCTZ) increase the reabsorption of calcium from the urine back into the blood. This can lead to elevated serum calcium levels and a slightly elevated PTH. In such cases, if clinically appropriate, I work with the patient’s primary care provider to temporarily hold the diuretic and recheck labs.
Lithium: This medication, used for bipolar disorder, increases the “set point” for calcium, desensitizing the parathyroid glands to calcium. The result is both hypercalcemia and elevated PTH. Managing this requires close collaboration with the patient’s mental health provider.

Rare Genetic Conditions

Familial Hypocalciuric Hypercalcemia (FHH): This is a benign autosomal dominant genetic disorder that affects the calcium-sensing receptor (CaSR). This leads to lifelong mild hypercalcemia, inappropriately normal or mildly elevated PTH, and low urinary calcium excretion (hypocalciuria). The key diagnostic test is a 24-hour urine calcium collection. A very low result (calcium-to-creatinine clearance ratio < 0.01) points to FHH, a condition that does not benefit from parathyroid surgery.
Familial Hyperparathyroidism and Multiple Endocrine Neoplasia (MEN) Syndromes: If I encounter a patient with primary hyperparathyroidism who is under the age of 30, a red flag is immediately raised. This early onset suggests a possible genetic predisposition, such as Multiple Endocrine Neoplasia (MEN) type 1 (Parathyroid, Pituitary, Pancreatic tumors) or type 2A (Medullary thyroid cancer, Pheochromocytoma, Parathyroid hyperplasia). These patients often have multi-gland involvement and require genetic testing and lifelong screening.

A Visual Guide to Interpreting Lab Results

To simplify the process of differentiating these conditions, I find visual aids to be incredibly helpful. The following breakdown provides a clear framework for interpreting the key lab values: calcium and PTH.

Serum Calcium	Parathyroid Hormone (PTH)	Probable Diagnosis
High	High or Normal	Primary Hyperparathyroidism or Tertiary Hyperparathyroidism
Normal	High	Normocalcemic Primary Hyperparathyroidism or Secondary Hyperparathyroidism
Low	High	Secondary Hyperparathyroidism
High	Low	Hypercalcemia of Malignancy, Vitamin D Toxicity, etc.
Low	Low	Hypoparathyroidism

A Closer Look at Normocalcemic Primary Hyperparathyroidism

One of the more challenging diagnostic puzzles is Normocalcemic Primary Hyperparathyroidism (NPHPT). This is a distinct subgroup of patients who have persistently elevated PTH levels but consistently normal total and ionized calcium levels. Diagnosing NPHPT requires a careful and systematic process of exclusion. We must be certain that we are not dealing with a case of secondary hyperparathyroidism.
The key criteria for diagnosing NPHPT are:

Normal Calcium Levels: Confirmed over several tests.
Elevated Parathyroid Hormone (PTH): Confirmed on at least two separate occasions.
Exclusion of All Secondary Causes: This is the most critical step and involves a comprehensive workup to rule out Vitamin D Deficiency (level must be >30 ng/mL), Renal Insufficiency (GFR must be >60 mL/min), and the influence of medications or malabsorption issues.

Only after this exhaustive process can we confidently diagnose NPHPT. It is considered an early form of primary hyperparathyroidism, and studies have shown that a significant percentage of these patients will eventually progress to develop hypercalcemia over time.

The Essential Diagnostic Workup for Primary Hyperparathyroidism

Once we suspect primary hyperparathyroidism, a structured and comprehensive workup is necessary to confirm the diagnosis, assess its severity, and determine the best course of treatment.

Crucial Laboratory Tests

Comprehensive Metabolic Panel (CMP): Provides Serum Calcium, Albumin (to calculate corrected calcium), and Renal Function (Creatinine/eGFR).
Intact Parathyroid Hormone (PTH): The cornerstone test. An elevated or “inappropriately normal” PTH level in the presence of high calcium confirms the diagnosis.
25-Hydroxy Vitamin D: Essential to rule out vitamin D deficiency as a cause of secondary hyperparathyroidism.
Serum Phosphorus: Often low or low-normal in PHPT because PTH causes the kidneys to waste phosphate.
24-Hour Urine Collection for Calcium and Creatinine: Vital to assess kidney stone risk and to differentiate PHPT from Familial Hypocalciuric Hypercalcemia (FHH).

Essential Imaging Tests

These imaging studies are not used to diagnose the condition, but to stage its severity and help determine if a patient meets criteria for surgery.

DEXA Scan (Dual-Energy X-ray Absorptiometry): A bone mineral density scan is crucial to evaluate for osteoporosis. We must specifically request a measurement of the distal one-third radius (the forearm), a site rich in cortical bone, which is preferentially affected by high PTH levels.
Renal Imaging (Ultrasound, CT, or X-ray): We need to look for evidence of kidney stones (nephrolithiasis) or calcium deposits in the kidney tissue (nephrocalcinosis).
Pre-operative Localization Imaging (Neck Ultrasound and Sestamibi Scan): These tests are ordered only after the decision for surgery is made. Their sole purpose is to help the surgeon locate the abnormal parathyroid gland(s) before the operation. 4D-CT and MRI are other options for challenging cases.

“Cracking the Low Thyroid Code: A Comprehensive Assessment Guide”- Video

Global Differences in PHPT Presentation: The Tale of Two Cities

In a comparative study that I refer to as “The Tale of Two Cities,” investigators evaluated PHPT presentations among cohorts in the United States and Beijing, China. The findings reveal striking contrasts:
United States:

Typical presentation: asymptomatic hypercalcemia, often in postmenopausal women.
Average vitamin D: roughly 21 ng/mL.
Kidney stone incidence: 15–20%.
Skeletal involvement: primarily detected by bone densitometry.

Beijing, China:

Average age: ~37 years, significantly younger.
Average calcium and PTH levels are much higher.
Average vitamin D: ~8.8 ng/mL, profoundly low.
Radiologic osteitis fibrosa cystica is evident in ~60% of patients.
Pathologic fractures are common (~35%).

Interpretation: Vitamin D deficiency appears as a major amplifying factor, intensifying skeletal turnover and disease severity. This highlights the importance of screening for and treating vitamin D deficiency in all PHPT patients.

Determining the Need for Surgery: Key Indications

The only definitive cure for primary hyperparathyroidism is a parathyroidectomy. However, not every patient needs surgery. International consensus guidelines have established specific criteria to identify who is most likely to benefit. A patient should be offered surgery if they meet any one of the following criteria:

Indication for Surgery	Explanation
Age < 50 years	Younger patients have a longer lifetime to suffer the consequences of untreated hypercalcemia, such as bone loss and kidney damage.
Serum Calcium Level	A serum calcium level that is more than 1.0 mg/dL above the upper limit of the laboratory’s normal range.
Bone Mineral Density	A T-score of -2.5 or lower at any of the three measured sites (lumbar spine, femoral neck, or distal 1/3 radius), which indicates osteoporosis, or a history of a fragility fracture.
Kidney Involvement	Reduced Kidney Function (eGFR of less than 60 mL/min) OR High Urine Calcium & Stone Risk (24-hour urinary calcium excretion > 400 mg/day or presence of kidney stones on imaging).

Observation vs. Surgery: Personalized Pathways and Quality of Life

For asymptomatic patients who do not meet surgical criteria, watchful waiting can be a valid approach. In fact, a significant study I often share with patients examined whether parathyroidectomy improves quality of life compared with observation. Over ten years of prospective, randomized follow-up, the study found that while surgery cured the biochemical abnormalities, it did not necessarily improve overall quality of life compared to the observation group. This empowers patients to consider non-surgical observation and teaches clinicians to avoid overpromising global life-quality improvements from surgery, while still acknowledging the clear benefits for bone and kidney health.
This is why we create a personalized plan that includes:

Regular labs: calcium, PTH, creatinine/eGFR, vitamin D.
Periodic DEXA scans for bone health.
Renal ultrasounds if stone risk is present.
Lifestyle strategies: hydration, mobility, nutrition.

The Surgical Solution and the Importance of an Experienced Surgeon

When a patient meets the criteria for surgery, the next step is a referral to a high-volume, experienced parathyroid surgeon. This cannot be overstated. These specialist surgeons have significantly higher success rates and lower complication rates.

The Surgical Procedure

The procedure, a parathyroidectomy, is highly effective, achieving a biochemical cure in approximately 98% of patients. In about 80-90% of cases, PHPT is caused by a single benign parathyroid adenoma, which can be removed through a minimally invasive approach. To confirm success, surgeons use intraoperative PTH monitoring. Since PTH has a short half-life (~3–5 minutes), a >50% drop from the baseline level after the gland is removed confirms that the source of the excess hormone has been eliminated.

The Benefits of Surgery

Normalization of Lab Values: Serum calcium, PTH, and urinary calcium levels return to normal.
Improvement in Bone Density: Bone density begins to improve, reducing long-term fracture risk.
Decreased Risk of Kidney Stones: The risk of forming future kidney stones is significantly reduced.
Potential Improvement in Neurocognitive Symptoms: Many patients report a significant improvement in fatigue, “brain fog,” and mood.

Medical Management: When Surgery Isn’t the Answer

For patients who are not surgical candidates or choose a non-surgical path, we transition to a strategy of medical management and active surveillance.

Pharmacological Intervention: Cinacalcet and Bisphosphonates

Cinacalcet (Sensipar): For patients with significantly high calcium levels, this medication can be a game-changer. Cinacalcet is a calcimimetic, meaning it “mimics” the action of calcium. It binds to the calcium-sensing receptors on the parathyroid glands, tricking them into thinking calcium is high and causing them to decrease PTH production. This lowers both PTH and serum calcium levels. The typical starting dose is 30 mg twice a day, which can be titrated upwards based on the patient’s response.
Antiresorptives (Bisphosphonates or Denosumab): If a patient has co-existing osteoporosis, they should be treated for it. Medications like bisphosphonates (e.g., alendronate, zoledronic acid) are effective at increasing bone density by inhibiting the osteoclasts that break down bone.

Essential Patient Education

Hydration is Non-Negotiable: Dehydration concentrates blood calcium and can cause a dangerous spike. Patients must be vigilant about drinking plenty of fluids.
Stay Active: Regular, weight-bearing physical activity is essential for maintaining bone health.
Be Smart About Calcium Intake: Patients should stop taking calcium supplements. However, they should not go on a low-calcium diet, as this can backfire and further stimulate PTH production. A moderate intake of 1,000 to 1,200 mg per day from dietary sources is a reasonable goal.

The Role of Integrative Chiropractic Care in Hyperparathyroidism

While medical management focuses on controlling calcium and PTH, an integrative approach that includes chiropractic care can be profoundly beneficial for addressing the widespread musculoskeletal symptoms of the disease.
Key components of our integrative chiropractic care include:

Biomechanical Assessment and Gentle Manual Therapy: We evaluate and treat spinal alignment, pelvic tilt, and compensatory patterns resulting from bone density changes or chronic pain. We use soft-tissue work and low-force adjustments (e.g., instrument-assisted techniques) to reduce pain and improve range of motion without stressing osteopenic bones.
Fracture Risk Mitigation and Safety: We avoid high-velocity thrusts in patients with severe bone loss. Safety in manual therapy is paramount; we emphasize soft tissue release, joint mobilization, and motor control training over aggressive maneuvers.
Neuromuscular Stabilization and Posture Retraining: We target deep stabilizing muscles to protect the spine and improve functional movement. We also provide ergonomic coaching and encourage movement variety to prevent immobilization-related hypercalcemia.
Balance and Fall Prevention: Proprioceptive and vestibular training are crucial to reduce fracture risk, especially in older adults.
Rehabilitation Integration: We design progressive resistance exercise programs tailored to bone health status. Load management through mechanotransduction is a powerful signal for improving bone strength.

My clinical observations show that coordinated manual therapy and targeted exercise significantly reduce pain and improve daily function for PHPT patients. Each intervention is selected with bone health in mind, protecting fragile structures while restoring resilience.

Functional Medicine Integration: Addressing Root Causes and Systems Biology

Our functional medicine approach complements medical and chiropractic care by addressing the whole person.

Nutrition Strategy: We focus on adequate protein for the bone matrix, Vitamin K2 to help guide calcium to bone, magnesium sufficiency for PTH regulation, and omega-3 fatty acids to modulate inflammation.
Gut Health: We address dysbiosis or malabsorption issues that can alter vitamin and mineral absorption.
Sleep and Circadian Rhythm: We provide strategies to improve sleep architecture, as poor sleep impacts endocrine balance.
Stress Physiology: We use mind-body practices like meditation and diaphragmatic breathing to reduce the negative impact of chronic stress on bone remodeling.
Environmental and Medication Review: We identify and mitigate contributors to hypercalcemia, such as certain medications or excessive supplement intake.

Personal Injury Care: Calcium and PTH in the Context of Trauma

Injury settings introduce unique dynamics. Immobilization increases bone resorption, raising calcium and potentially dysregulating PTH. Our protocol for personal injury patients involves early mobilization plans, hydration strategies, regular lab monitoring during recovery, and nutritional support to counter catabolic stress. Dr. Cardenas’s internal medicine oversight ensures safe integration of all care, while my team provides hands-on rehabilitation to restore function without overloading weakened bone.

Case Narratives: Translating Physiology into Practice

I believe case narratives bring science to life. Here are a few that illustrate our integrative approach.

Case 1: An 85-Year-Old Female with Severe Hypercalcemia

An 85-year-old female with dementia presented to the ER with weakness and confusion, with a calcium level of 15.8 mg/dL. After ruling out malignancy, her family elected for non-surgical management. Under Dr. Cardenas’s direction, she was managed with a maximum dose of cinacalcet (90 mg twice daily), intermittent infusions of zoledronic acid, and aggressive hydration. My team focused on caregiver education, fall prevention, and gentle mobility to maintain function and safety. This case highlights how rigorous medical management can stabilize frail, high-risk patients.

Case 2: A 68-Year-Old Male with Cardiovascular Disease and PHPT

This patient was referred by his cardiologist. He met surgical criteria and underwent a successful parathyroidectomy. Post-operatively, he reported immediate improvement in energy. However, his PTH remained elevated. We identified ongoing vitamin D insufficiency as a likely contributor. Under Dr. Cardenas’s oversight, we initiated vitamin D repletion. From the chiropractic side, we supported his return to activity with a graded plan focusing on thoracic mobility and respiratory mechanics to support his cardiovascular endurance.

Case 3: A 57-Year-Old Male Pilot with PHPT and Chronic Foot Pain

This patient had elevated calcium, a non-obstructing kidney stone, and long-standing, significant bilateral foot pain. After a successful parathyroidectomy, his calcium and PTH normalized, and he reported a dramatic improvement in his chronic foot pain. This illustrates how chronic skeletal pain can be amplified by hypercalcemia. Post-operatively, I managed the mechanics of his foot and ankle, focusing on gait and strengthening, which allowed him to recover fully. Musculoskeletal pain often reflects systems biology—aligning surgical cure with biomechanical rehabilitation yields substantial functional gains.
My clinical observations and professional experience can be further explored at:

Frequently Asked Questions: Patient-Friendly Explanations

Why do I feel fine if my calcium is high? Mild elevations can be “silent.” Over time, subtle symptoms emerge; early management prevents complications.
Is surgery always necessary? Not always. Indications depend on symptoms, calcium level, bone and kidney status, and patient preference.
Should I take vitamin D? Many benefit from careful repletion, but dosing must be personalized and monitored to avoid worsening hypercalcemia.
What does chiropractic add? Pain relief, posture improvement, safe movement, fall prevention, and rehabilitation tailored to bone health, integrated with medical oversight.
Will exercise help? Yes—properly dosed exercise strengthens bone and stabilizes musculoskeletal function. We design safe, progressive plans.

Closing Reflections: From Calcium Chaos to Clarity

Hyperparathyroidism spans an intricate network of bones, kidneys, nerves, and hormones. The promise of modern care—rooted in leading research and delivered through multidisciplinary integration—is that we can turn calcium chaos into clarity. With internal medicine leadership from Dr. Maria Guadalupe Cardenas and integrative chiropractic and functional medicine care at Injury Medical Clinic PA, we help patients regain control, relieve symptoms, protect their bones and kidneys, and thrive.

References

SEO Tags: hyperparathyroidism, primary hyperparathyroidism, parathyroid hormone, PTH, hypercalcemia, calcium, ionized calcium, vitamin D, cholecalciferol, ergocalciferol, calcitriol, nephrolithiasis, osteoporosis, parathyroidectomy, sestamibi, 4D-CT, cinacalcet, bisphosphonates, denosumab, functional medicine, chiropractic care, integrative medicine, internal medicine, Dr. Alex Jimenez, Dr. Maria Cardenas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso TX, osteitis fibrosa cystica, multiple endocrine neoplasia, MEN syndrome, familial hypocalciuric hypercalcemia, FHH, DEXA scan, quality of life, observation vs surgery, rehabilitation

July 24, 2026

Myofascial Pain Treatment Guide with Trigger Point Injections

Find out how trigger point injections can help manage myofascial pain and improve your quality of life effectively.

Abstract

Welcome to our educational journey into the complex world of chronic musculoskeletal pain. I am Dr. Alex Jimenez, and I am honored to guide you through this exploration from the perspective of our multidisciplinary team here in El Paso, Texas. In this post, we will dissect the physiological underpinnings of muscle spasms, the formation of trigger points, and the subsequent development of chronic pain cycles. We will explore the latest evidence-based approaches for managing these conditions, with a particular focus on trigger point injection (TPI) therapy. We’ll discuss the rationale behind using specific agents like lidocaine and natural anti-inflammatories, the mechanics of the injection technique itself—often referred to as a “star pattern”—and the crucial role of anatomical knowledge in ensuring safety and efficacy.
Furthermore, we will illuminate how our unique collaborative model at Injury Medical Clinic PA integrates the expertise of chiropractic care, advanced practice nursing, and internal medicine. I will share insights from my dual roles as a Doctor of Chiropractic and a Family Nurse Practitioner, and explain how we work alongside our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD, a board-certified internist with over four decades of experience. This integrated approach allows us to provide a comprehensive spectrum of care, from initial diagnosis and medical oversight to hands-on chiropractic adjustments, functional medicine, and personalized rehabilitation. Our goal is not just to alleviate symptoms but to uncover and address the root causes of pain, empowering our patients to reclaim their health and vitality. Join us as we unravel the science behind pain and the art of integrative healing.

Our Collaborative Care Philosophy: The Synergy of Medicine and Chiropractic

My name is Dr. Alex Jimenez, and I hold several professional titles that reflect my passion for a comprehensive and holistic approach to health: DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST. For years, my primary mission has been to understand the intricate web of human physiology and find the most effective ways to restore function and alleviate suffering. Here at our practice in El Paso, Texas, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic), we have built a unique environment dedicated to this mission.
A cornerstone of our practice is the powerful synergy we’ve cultivated between different medical disciplines. We are not just a chiropractic office or a standard medical clinic; we are a fully integrated, multidisciplinary team. Our Medical Director and Collaborative Physician champions this structure: Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a highly respected, board-certified internist with over 40 years of experience. Her NPI is #1164426749, and she holds Texas MD License #J2933. Her role is absolutely pivotal. She provides essential medical oversight, diagnostic acumen, and an internal medicine perspective that elevate our patient care to the highest standard. This collaborative model, where a Medical Doctor provides directorship and works in tandem with a Doctor of Chiropractic, is common in forward-thinking integrative and injury care clinics, and it is the bedrock of our success.
This partnership allows us to offer a seamless continuum of services. When a patient walks through our doors, they have access to:

Medical Oversight from Dr. Cardenas: She ensures that all treatments are medically appropriate, oversees complex cases, and manages any underlying health conditions that could be contributing to a patient’s pain, such as inflammatory disorders, metabolic issues, or nutritional deficiencies.
Chiropractic and Functional Neurology from Myself (Dr. Jimenez): I focus on the biomechanical and neurological aspects of a patient’s condition. This includes performing precise chiropractic adjustments to restore spinal alignment and nerve function, as well as applying principles of functional neurology to rehabilitate the nervous system.
Advanced Practice Nursing: In my capacity as a Family Nurse Practitioner (FNP-BC), I can perform advanced assessments, order and interpret diagnostic tests, and administer treatments like the trigger point injections we will be discussing in depth. This dual qualification allows me to bridge the gap between the chiropractic and medical models seamlessly.
A Unified Team Approach: Our team also includes specialists in functional medicine, personal injury care, physical rehabilitation, and nutrition. We hold regular case conferences where Dr. Cardenas, I, and the rest of our team review patient progress and strategize the next steps in their care plan. This ensures every patient benefits from our collective expertise.

This integrated system is designed to break down the silos that too often exist in healthcare. Instead of a patient being bounced between a chiropractor, a primary care physician, and a pain specialist—with each provider having only a partial view of their condition—we bring all that expertise under one roof. This allows us to create a truly personalized and cohesive treatment plan that addresses the patient from every angle: structurally, neurologically, biochemically, and medically. It is within this collaborative framework that we approach complex issues like chronic myofascial pain and utilize advanced therapies like trigger point injections.

The Anatomy of a Knot: Unraveling Muscle Spasms and Trigger Points

Before we can effectively treat chronic muscle pain, we must first understand its origins. The conversation often begins with patients describing a “knot” in their muscle—a tender, hard lump that aches, burns, and sometimes sends pain to other parts of their body. Clinically, we refer to this as a myofascial trigger point. But what exactly is it, and how does it form? The process is a fascinating and often vicious cycle rooted in our body’s response to stress and injury.

The Initial Injury: Microscopic Tears and the Energy Crisis

Everything starts at the microscopic level within the muscle fibers. Imagine your muscles are composed of millions of tiny, overlapping filaments called actin and myosin. When a muscle contracts, these filaments slide past each other, a process powered by adenosine triphosphate (ATP), the energy currency of our cells. For the muscle to relax, it needs another surge of ATP to actively pump calcium ions out of the muscle cell, allowing the filaments to detach and lengthen.
Now, consider what happens when a muscle is subjected to stress. This stress can be:

Acute: A sudden trauma, like a car accident (whiplash), a fall, or lifting an object that is too heavy.
Repetitive: Chronic overuse from poor posture (e.g., “tech neck” from staring at a screen), repetitive occupational movements, or an imbalanced exercise routine.
Biochemical: Nutritional deficiencies (especially magnesium, calcium, and B vitamins), hormonal imbalances, or systemic inflammation.

Any of these stressors can cause microscopic tearing and damage to the muscle fibers and, critically, to the sarcoplasmic reticulum—the intricate network within the muscle cell that stores and releases calcium. When the sarcoplasmic reticulum is damaged, it can lead to an uncontrolled, sustained leakage of calcium into the muscle fiber. This excessive calcium forces the actin and myosin filaments in that localized area to remain in a state of maximum contraction. They are locked together.
This creates an energy crisis. The sustained contraction dramatically increases the metabolic demand of that small segment of muscle fiber, requiring huge amounts of ATP. At the same time, this intense, localized contraction physically compresses the tiny blood vessels (capillaries) that supply the area. This compression chokes off the supply of oxygen and nutrients needed to produce ATP. The result is a vicious cycle:

Sustained Contraction: Leaking calcium keeps muscle fibers locked.
Increased Energy Demand: The locked fibers burn through their local ATP supply.
Reduced Blood Flow (Ischemia): The contraction squeezes capillaries, preventing fresh oxygen and nutrients from arriving.
Energy Production Failure: Without oxygen, the cell cannot produce enough ATP to pump the calcium out and allow the muscle to relax.

This small, localized segment of muscle fiber is now metabolically exhausted and physically trapped in a contracted state. This is the physiological birth of a trigger point taut band.

From Microscopic Crisis to Palpable Pain

Over time, the body’s inflammatory response kicks in. The area of ischemia and metabolic waste buildup (including substances like bradykinin, substance P, and prostaglandins) irritates nearby nerve endings. These irritated nerves send a barrage of pain signals to the spinal cord and brain. Furthermore, the body attempts to “wall off” this dysfunctional area by laying down fibrous connective tissue, or scar tissue, around the contracted muscle fibers.
This is the “knot” you can actually feel. It’s no longer just a microscopic problem; it has become a palpable, hard nodule of dysfunctional tissue. This scar tissue further restricts movement, exacerbates the lack of blood flow, and perpetuates the pain cycle.
From my clinical experience as a chiropractor, I see this process manifest in predictable patterns. A patient with forward head posture will develop trigger points in their upper trapezius and levator scapulae muscles. An office worker who sits all day will have them in their quadratus lumborum and gluteus medius. These patterns are not random; they are a direct consequence of biomechanical load and muscular endurance limits. Understanding this underlying physiology is absolutely critical because it dictates our treatment strategy. We aren’t just “rubbing a sore spot”; we are intervening in a complex neuro-biochemical cascade. Our goal is to break this cycle at multiple points: to mechanically disrupt the scar tissue, restore blood flow, flush out inflammatory chemicals, and reset the neurological signaling that is perpetuating the spasm.

The “Star Pattern” Technique: A Mechanical and Neurological Reset

One of the most effective tools we have for directly addressing these stubborn trigger points is Trigger Point Injection (TPI). The technique itself is just as important as the substances we inject. A common and highly effective method, which was discussed in our training, involves what is colloquially known as the “star pattern” or fanning technique. This approach is an evolution of an older technique called dry needling.

The Evolution from Dry Needling to Injections

In traditional dry needling, a thin filiform needle (similar to an acupuncture needle) is inserted directly into the trigger point. The practitioner then manipulates the needle—moving it up and down and angling it in multiple directions within the knot—without injecting any substance. The primary goal is mechanical. By repeatedly piercing the taut band and surrounding scar tissue, we achieve several things:

Mechanical Disruption: The needle physically breaks up the fibrous adhesions and scar tissue that have formed around the contracted muscle fibers. This helps release the entrapped tissues.
Eliciting a Local Twitch Response (LTR): When the needle accurately contacts the most irritable spot within the trigger point, it often causes a brief, involuntary contraction or “twitch” of the muscle band. This LTR is considered a crucial therapeutic sign. It indicates that the dysfunctional segment of the muscle has been stimulated, leading to a subsequent reflex relaxation and a reset of the local nerve supply. Research by Shah and Gilliams (2008) suggests the LTR is associated with reduced inflammatory chemicals and improved pain outcomes.
Stimulating a Healing Response: The minor trauma caused by the needle prompts a localized inflammatory and healing response. The body increases blood flow to the area to repair the micro-trauma, and in doing so, it also flushes out the accumulated metabolic waste and pain-sensitizing chemicals from the original energy crisis.

From my own observations, dry needling can be remarkably effective. I have seen many patients experience significant relief from this technique alone. However, we’ve found that we can enhance and accelerate the healing process by introducing therapeutic substances directly into the tissue. This is where TPI comes in.

The Mechanics of the “Star Pattern” Injection

With TPI, we use the same foundational principle of mechanical disruption but add the benefit of targeted medication. The “star pattern” describes the way the needle is maneuvered after the initial insertion. Here’s a step-by-step breakdown from my perspective as the practitioner:

Identification: First, I meticulously palpate the muscle to locate the epicenter of the trigger point. I am searching for that exquisitely tender, dense nodule within a taut band of muscle. Often, pressing on this spot will reproduce the patient’s familiar pain, sometimes even referring pain to a distant area (e.g., pressing a trigger point in the shoulder that sends a sensation down the arm). This confirms I’ve found the right target.
Insertion: After sterilizing the skin, I insert the needle directly into the heart of the trigger point. The goal is to feel that subtle change in tissue resistance as the needle enters the dense, fibrotic knot.
The “Star” Maneuver: This is the crucial part. Without withdrawing the needle from the skin, I begin the fanning motion. I will slightly pull the needle back (while keeping the tip within the muscle) and then re-angle it to probe a different quadrant of the trigger point. I repeat this process, moving the needle in and out and changing the angle, creating a pattern that resembles the points of a star or the spokes of a wheel.
Injection: With each pass or in each new direction, I inject a tiny amount of the therapeutic solution. This ensures the fluid is distributed throughout the entire volume of the trigger point, not just in a single pocket.

Why is this “star pattern” so important? A trigger point is not a simple sphere; it’s a three-dimensional complex of knotted fibers and scar tissue. A single injection into the center might miss the full extent of the dysfunctional tissue. By fanning the needle out in multiple directions, we ensure we both mechanically break up adhesions and chemically treat the entire affected area. We are turning a single injection into a multi-pronged therapeutic assault on the trigger point. This method combines the mechanical benefits of dry needling with the chemical benefits of the injected solution, leading to a more comprehensive and lasting result. It helps the muscle release from its spastic state, which in turn alleviates the pain and restores normal function.

The Therapeutic Cocktail: Why We Choose Lidocaine and Sarapin

The effectiveness of trigger point injections is not just about the technique; it’s profoundly influenced by what we inject. In our practice, after careful consideration and review of the evidence, we have settled on a combination that we find provides superior results: a one-to-one mixture of lidocaine and a natural anti-inflammatory agent called Sarapin. Some practitioners might use Marcaine, another local anesthetic, but the principles remain similar. Let’s break down why this specific combination is our choice.

Lidocaine: More Than Just a Numbing Agent

Most people think of lidocaine (a 1% solution is common for this procedure) simply as a local anesthetic—something that numbs the area. And it certainly does that. The immediate numbing effect provides rapid pain relief for the patient, which can be psychologically and physically beneficial. It breaks the immediate pain-spasm-pain cycle and makes the procedure itself much more tolerable.
However, the role of lidocaine goes far beyond simple numbing. From a physiological standpoint, lidocaine is a sodium channel blocker. Here’s why that’s so important in the context of a trigger point:

Interrupting Pain Signals: Pain signals are transmitted along nerve fibers as electrical impulses, which depend on the rapid opening and closing of sodium channels in the nerve cell membrane. By blocking these sodium channels, lidocaine physically prevents pain signals from irritated nerve endings in the trigger point from traveling to the spinal cord and brain. We are literally cutting off the “pain hotline.”
Breaking the Neurological Loop: Chronic pain is not just a local tissue problem; it becomes ingrained in the nervous system. The constant barrage of pain signals from a trigger point can lead to a state called central sensitization, where the central nervous system becomes hypersensitive and amplifies pain signals. By silencing the peripheral nerve with lidocaine, we give the central nervous system a break from this constant input, helping to downregulate this hypersensitivity.
Muscle Relaxation Properties: While not its primary mechanism, blocking nerve signals to the muscle can also contribute to muscle relaxation, further helping to release the taut band.

A common concern patients have is allergies. A small fraction of the population can indeed have an allergic reaction to lidocaine or other “-caine” anesthetics. We’ve seen estimates suggesting this occurs in about one percent of people. This is why a thorough medical history, overseen by Dr. Cardenas, is non-negotiable before any procedure. If a patient has a known allergy, we do not use it. In these cases, we can still perform dry needling. The mechanical disruption alone still provides significant benefit, though the immediate pain relief from the anesthetic will be absent.

Sarapin: The Power of a Natural Anti-Inflammatory

This is where our approach diverges from many conventional pain management practices. While some practitioners might use corticosteroids (steroids) as the anti-inflammatory agent in their injections, I have a strong preference for a natural, plant-based alternative called Sarapin.
Sarapin is a biological medicine derived from the pitcher plant (Sarracenia purpurea). It has been used as a safe and effective analgesic and anti-inflammatory for decades. Its mechanism of action is unique and, in my opinion, superior to steroids for this particular application.

How Sarapin Works: Unlike steroids, which act by suppressing the entire immune response in a broad-spectrum way, Sarapin works primarily as a neurolytic agent on sensory C-fibers. These are the small, unmyelinated nerve fibers responsible for transmitting dull, aching, chronic pain signals—the exact type of pain associated with trigger points. Sarapin appears to inhibit the function of these specific nerve fibers without affecting motor nerves or other sensory nerves (like those for touch or pressure). This means it targets the pain signals without causing muscle weakness or widespread numbness.
Why I Prefer Sarapin Over Steroids: My decision to use Sarapin is based on several key factors:
- Safety Profile: Steroids, especially with repeated use, carry potential risks. They can weaken local tissues like tendons and ligaments, cause skin depigmentation, and have systemic side effects. Sarapin, being a natural biological product, is exceptionally safe. It does not damage local tissues and has no known systemic side effects. This allows us to perform injections as needed without the long-term concerns associated with corticosteroids.
- Targeted Action: As mentioned, Sarapin specifically targets the pain-transmitting sensory nerves. This is a more elegant and focused approach than the “shotgun” immunosuppression of steroids. We are addressing the pain signal, not just broadly suppressing inflammation.
- Avoiding Tissue Degradation: A core principle in regenerative and integrative medicine is to “first, do no harm.” My concern with repeated steroid injections into muscle and fascia is the potential for catabolic effects—the breakdown of tissue. Since our ultimate goal is to heal and regenerate the tissue, using an agent that could potentially weaken it seems counterintuitive. Sarapin supports the healing process without this risk.

By combining lidocaine and Sarapin in a one-to-one ratio, we create a powerful synergistic cocktail. The lidocaine provides immediate, profound pain relief by blocking all local nerve signals. This makes the patient comfortable and breaks the acute pain cycle. Meanwhile, the Sarapin provides a longer-lasting analgesic and anti-inflammatory effect by specifically targeting the chronic pain fibers. The result is a much better, more durable outcome than using either agent alone. I find that my patients experience more complete relief, and the effects last longer, reducing the need for frequent repeat injections. It’s a perfect example of how combining modern pharmacology with natural biological medicine can yield superior clinical results.

Procedural Safety: The Critical Importance of Anatomical Precision

Performing trigger point injections is a skill that blends tactile sensitivity with a deep, unwavering respect for human anatomy. While the procedure is generally very safe when performed by a trained professional, there are inherent risks that must be mitigated through knowledge and careful technique. One of the most significant concerns, particularly when working in the thoracic region, is the risk of causing a pneumothorax, or a punctured lung.

Navigating the Thoracic Cage: Needle Depth and Safety Margins

The question of “How deep is too deep?” is one that every practitioner must have a definitive answer for. The lungs are located within the thoracic cavity, protected by the rib cage. The space between each rib, known as the intercostal space, is filled with intercostal muscles, and it is through these muscles that a needle could potentially pass to reach the lung.
Here are the general guidelines and anatomical considerations we adhere to:

Needle Length is Key: For injections in the cervical (neck) and upper thoracic (upper back) regions, we typically use a 30-gauge, 1-inch needle. The small gauge makes the injection more comfortable, and the 1-inch length provides a built-in safety measure. In the vast majority of adults, a 1-inch needle, even if inserted to its full depth in an intercostal space, will not be long enough to traverse the chest wall and puncture the parietal pleura, the outer lining of the lung.
The 1.5-Inch Threshold: As a rule of thumb, a needle length of 1.5 inches is where the risk begins to increase, especially in individuals who are very thin, frail, or elderly. In these populations, the muscle and fat layers are thinner, meaning a 1.5-inch needle has a greater potential to reach the pleural space. Therefore, extreme caution and precise depth control are required if using a longer needle in the thoracic area. I often advise practitioners to avoid it altogether in these regions unless they have advanced training (e.g., ultrasound guidance).
Palpating the Ribs: Before any injection near the rib cage, I always use my palpating hand to identify the ribs. The goal is to inject into the muscle belly overlying a rib or in the thick paraspinal muscles adjacent to the spine, not directly into the unprotected intercostal space. This simple tactile feedback is a crucial safety check.
Angle of Insertion: The angle of the needle also matters. By angling the needle obliquely (a technique known as “tenting” the skin and muscle), rather than perpendicular to the skin, we can increase the distance the needle must travel through the tissue before it could ever reach the lung, further enhancing safety.
Patient Body Habitus: Anatomy is not one-size-fits-all. A heavily muscled bodybuilder has a much thicker chest wall than a petite, older woman. I must constantly assess the patient in front of me and mentally adjust my “safe depth” calculation. In my clinical experience, even in a “little skinny old lady,” a 1-inch needle used with proper technique is exceptionally safe. You are not going to puncture a lung. The danger arises when practitioners become complacent or use inappropriately long needles for the patient’s anatomy.

For the lower thoracic and lumbar regions, the anatomy is different. The risk of pneumothorax is gone, and the muscles, like the quadratus lumborum and the erector spinae, are much thicker and deeper. In these areas, it is safe and often necessary to use a longer needle (e.g., 1.5 to 2 inches) and inject a larger volume (up to 2 mLs per site) to reach and effectively treat the target muscles.

The Foundation of All Practice: Know Your Anatomy

This discussion underscores a point I cannot emphasize enough to any student or colleague in manual or injection-based medicine: you must constantly review and master your anatomy. When I was in school, I’ll admit, anatomy was a struggle. It’s a monumental amount of information, and for many of us, it’s a challenge. But in professional practice, anatomy is not an academic exercise; it is the roadmap that keeps your patients safe and makes your treatments effective.
Whether you are performing a chiropractic adjustment, designing an orthotic, or administering a trigger point injection, you are interacting with a complex, three-dimensional system of bones, nerves, muscles, and organs. You need to have a mental MRI of what lies beneath your fingertips.

Where is the brachial plexus in relation to the scalene muscles?
What is the course of the sciatic nerve as it passes through the gluteal region?
How thick are the paraspinal muscles at L4 versus T4?

I urge everyone in this field to make anatomical review a regular habit. Go back to the textbooks, use 3D anatomy apps, attend dissection labs if you can. The more you immerse yourself in the elegant architecture of the human body, the more confident, precise, and—most importantly—safe your hands will become. This is the ultimate foundation of patient trust and clinical excellence.

The Root Causes of Pain- Video

The Patient’s Journey: The Psychology of Pain and Treatment

Treating the physical body is only half the battle. As clinicians, we must also be keenly aware of the patient’s psychological and emotional experience, especially when it comes to pain and needles. The fear of pain and the anxiety surrounding a procedure can significantly impact the outcome. A core part of my practice philosophy is to guide the patient through the treatment journey in a way that builds trust and minimizes distress.
One simple but profound strategy I’ve learned over years of practice is to save the worst for last.
When a patient comes in with multiple trigger points, they are not all created equal. There is almost always one “main offender”—that one knot that is the most sensitive, the most irritable, and the most likely to make the patient jump when it’s treated. From a purely mechanical perspective, one might think to tackle that worst one first. Get the biggest problem out of the way. However, from a psychological perspective, this is often the wrong approach.
Imagine the patient is already anxious. If the very first injection is the most painful one, their nervous system immediately goes on high alert. Their muscles tense up, their fear is validated, and they spend the rest of the procedure dreading the next needle. I have had experiences early in my career where I took this “worst-first” approach, and the patient would literally say, “No, I’m not doing any more.” I would then find myself in a position of having to coax or argue with them to complete a treatment that I knew would help them. This creates an adversarial dynamic, which is the complete opposite of the therapeutic alliance we want to build.
Instead, I’ve found it far more effective to start with the less sensitive trigger points. I will strategically choose the first few injection sites in areas that are sore but not excruciating. The patient experiences the procedure, realizes it’s manageable, and begins to feel the numbing effect of the lidocaine. Their anxiety starts to subside, and trust is established. They think, “Okay, I can handle this.”
By the time we get to that “son of a…” spot—the one that’s going to be the most intense—the patient is already partially numb, more relaxed, and confident in me and the process. The intense sensation from that final injection is then just a brief moment in an otherwise manageable experience, rather than the traumatic opening act.
This approach achieves several important goals:

Builds Trust and Rapport: It shows the patient that I am mindful of their comfort and am strategically guiding them through the process.
Reduces Overall Muscle Guarding: A relaxed patient is easier to treat. Their muscles are not defensively tensed up, allowing me to palpate more accurately and the needle to enter the tissue more easily.
Improves Patient Compliance: Patients who have a positive (or at least tolerable) experience are far more likely to return to complete their course of care and adhere to the treatment plan.
Leverages the Anesthetic: By the time we reach the worst spot, the lidocaine from the surrounding injections may have already started to diffuse slightly, providing a small degree of pre-numbing to the area.

It may seem like a small detail, but managing the psychological journey of the treatment is paramount. We are not just treating trigger points; we are treating a person who is in pain and likely fearful. Empathy, communication, and a thoughtful, patient-centered approach can make all the difference between a successful treatment and a traumatic one.

Clarifying the Terminology: Prolotherapy, PRP, and Trigger Point Injections

The world of regenerative and pain medicine is filled with an ever-expanding list of therapies, and the terminology can often be confusing for patients and even practitioners. It’s important to understand the differences between treatments like Trigger Point Injections (TPI), Prolotherapy, and Platelet-Rich Plasma (PRP), as they are designed for different purposes and work through different mechanisms.

Trigger Point Injections (TPI): A Focus on Muscle

As we have discussed at length, TPI is a procedure specifically designed to treat myofascial trigger points—those hyperirritable knots within a muscle’s taut band.

Target Tissue: Muscle and fascia.
Primary Goal: To release muscle spasms, break up fibrous adhesions, and resolve the localized energy crisis within the muscle fiber.
Injectate: Typically a local anesthetic (like lidocaine) and an anti-inflammatory agent (like Sarapin or, less commonly, a corticosteroid).
Mechanism: A combination of mechanical disruption (from the needle) and chemical action (from the injectate) to reset the neuromuscular junction and resolve the spasm.

TPI is the frontline treatment for direct muscular pain and dysfunction originating from these specific points of irritation.

Prolotherapy: A Focus on Ligament and Tendon Laxity

Prolotherapy, short for “proliferative therapy,” is a fundamentally different treatment. It is not designed to treat muscle spasms but rather to address chronic pain originating from ligament and tendon laxity or instability.

Target Tissue: Ligaments (which connect bone to bone) and tendons (which connect muscle to bone), specifically at their insertion points onto the bone (the “enthesis”).
Primary Goal: To strengthen weak and damaged connective tissues and stabilize joints.
Injectate: A “proliferant” solution, which is a mild irritant designed to stimulate a healing response. The classic solution is a dextrose (sugar) solution, often mixed with an anesthetic like lidocaine. Some practitioners incorporate other substances, including ozone.
Mechanism: The proliferant solution intentionally creates a mild, controlled inflammatory response in the targeted ligament or tendon. This localized inflammation signals the body to initiate its natural healing cascade. The body sends growth factors, fibroblasts (cells that produce collagen), and other healing cells to the area. Over a series of treatments, this process leads to the deposition of new, strong collagen tissue, effectively tightening and strengthening the lax ligaments and tendons.

You would use prolotherapy for conditions like chronic low back pain due to sacroiliac ligament instability, chronic shoulder pain from a loose joint capsule, or tennis elbow (lateral epicondylitis) where the tendon is degenerated. It addresses joint instability, which is a common underlying cause of chronic musculoskeletal pain that TPI does not directly treat.

Platelet-Rich Plasma (PRP): A Focus on Cellular Regeneration

Platelet-Rich Plasma (PRP) therapy is a more advanced form of regenerative medicine that harnesses the body’s own healing power in a concentrated form.

Target Tissue: Can be used on a wide variety of tissues, including tendons, ligaments, muscles, and joints (intra-articular).
Primary Goal: To provide a high concentration of natural growth factors directly to an area of injury or degeneration to accelerate and enhance cellular repair and regeneration.
Injectate: The patient’s own blood, which has been drawn and processed in a centrifuge to separate and concentrate the platelets. The resulting “platelet-rich plasma” is then injected back into the patient at the site of injury.
Mechanism: Platelets are cell fragments in our blood that are critical for clotting, but they are also tiny storehouses of powerful growth factors. These are proteins that act as signaling molecules, telling local cells to proliferate, differentiate, and form new tissue. Key growth factors include Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-Beta (TGF-β), and Vascular Endothelial Growth Factor (VEGF). By injecting a concentrated dose of these growth factors directly into damaged tissue, we are essentially telling the body, “Heal this area, and do it now!”

PRP is used for more significant injuries and degenerative conditions, such as moderate osteoarthritis, chronic tendinopathies (like Achilles tendinosis), and muscle tears.

Is PRP in a Trigger Point Overkill?

This brings us to an important question: can you use PRP for a simple trigger point? My answer is generally yes, you can, but it’s often overkill. A standard myofascial trigger point, as we’ve defined it, is primarily a problem of neuromuscular dysfunction and localized ischemia—a spasm. It is not typically a tear or a significant degenerative condition of the muscle tissue itself.
The combination of mechanical needling and a solution of lidocaine/Sarapin is usually perfectly sufficient to break this cycle. It’s a highly effective, safe, and relatively inexpensive treatment.
Using PRP for a standard trigger point would be like using a sledgehammer to hang a picture frame. While PRP does have anti-inflammatory properties and would likely help, the primary issue in the trigger point (the spasm) is not what PRP is best designed to fix. PRP’s strength lies in regenerating tissue architecture, which is not the main problem in a trigger point. Furthermore, PRP is a more complex and expensive procedure.
Therefore, we reserve PRP for cases where there is evidence of actual tissue damage—a partial muscle tear, significant tendinosis adjacent to the trigger point, or a degenerative joint condition that is causing the muscle to go into a protective spasm. In those cases, treating the underlying degenerative condition with PRP makes perfect sense. But for the trigger point itself, TPI remains the more appropriate and cost-effective tool. Understanding these distinctions is key to creating a precise, effective, and responsible treatment plan for our patients.

The Integrated Approach in Action: A Patient Case Study

To bring all these concepts together, let me walk you through how a typical, yet complex, patient case would be managed at our clinic. This illustrates the true power of our integrated model, where chiropractic, internal medicine, and advanced injection therapies work in concert.
Imagine a 45-year-old female patient, “Jane,” comes to our clinic. Her primary complaint is chronic, nagging right-sided neck and shoulder pain with headaches that have persisted for over two years. She works an office job, spending 8-10 hours a day at a computer. She has seen multiple practitioners, tried physical therapy, and gets temporary relief from massage, but the pain always returns.

Phase 1: The Comprehensive, Multidisciplinary Assessment

Jane’s journey does not start with a treatment; it starts with a deep and comprehensive evaluation involving our entire team.

Initial Consultation with Me (Dr. Jimenez): I perform a detailed history and a functional examination from my dual DC/FNP perspective.
- Chiropractic/Biomechanical Exam: I immediately notice a significant forward head posture and a high right shoulder. Her cervical range of motion is restricted, particularly in left rotation and lateral flexion. Palpation reveals exquisitely tender trigger points in her right upper trapezius, levator scapulae, and suboccipital muscles. Pressing on the trapezius trigger point reproduces her familiar headache pattern—a classic sign of a cervicogenic headache originating from myofascial dysfunction. A structural analysis shows a C5/C6 spinal misalignment (subluxation).
- Nurse Practitioner Assessment: I take a broader medical history. Jane reports feeling fatigued, having trouble sleeping due to the pain, and experiencing “brain fog.” She mentions a high-stress job and reliance on coffee and sugary snacks to get through the day. These are red flags for underlying systemic issues.
Medical Consultation with Dr. Cardenas: Based on my initial findings, Jane is scheduled for a consultation with Dr. Cardenas. As our Medical Director, she reviews Jane’s history and my findings and conducts her own medical evaluation.
- Internal Medicine Perspective: Dr. Cardenas is concerned about the fatigue and brain fog. She suspects there may be more to the story than just poor posture. She orders a comprehensive blood panel to investigate potential contributing factors. The panel might include a complete blood count, a metabolic panel, thyroid hormones (TSH, free T3, free T4), inflammatory markers (hs-CRP, ESR), Vitamin D levels, and a full iron panel.
- Diagnostic Findings: The lab results come back and reveal several key issues: Jane is pre-diabetic (indicated by an elevated HbA1c), has subclinical hypothyroidism, and is severely deficient in Vitamin D.

Phase 2: The Integrated Treatment Plan

Now we have a complete picture. Jane’s pain is not just a mechanical problem. It’s a multifactorial issue where poor biomechanics, chronic muscle strain, systemic inflammation from her metabolic state, and low energy production from her thyroid and vitamin deficiencies are all feeding into each other. A purely chiropractic or purely medical approach would fail. Our integrated plan, designed in a case conference with Dr. Cardenas and me, attacks the problem from all angles simultaneously.

Medical and Functional Medicine Interventions (Overseen by Dr. Cardenas and me as FNP/CFMP):
- Nutritional Counseling: We immediately implement a nutrition plan to address her pre-diabetes and inflammation. This involves removing processed sugars and refined carbohydrates and focusing on a whole-foods, anti-inflammatory diet rich in vegetables, healthy fats, and quality protein.
- Supplementation: We prescribe high-dose Vitamin D to correct her deficiency, along with magnesium (which is crucial for muscle relaxation and often depleted in pre-diabetic states) and a B-complex vitamin to support cellular energy production. Dr. Cardenas will manage and monitor her thyroid function, considering a low-dose thyroid support if necessary.
Chiropractic Care (Dr. Jimenez):
- Spinal Adjustments: I begin a course of specific chiropractic adjustments to the C5/C6 segment and upper thoracic spine. The goal is to restore proper joint mechanics, reduce nerve interference, and take mechanical stress off the overworked muscles. Restoring proper spinal curves is fundamental to long-term success.
Myofascial and Regenerative Therapies (Dr. Jimenez as FNP):
- Trigger Point Injections: To provide immediate relief and break the chronic pain cycle, I perform a series of trigger point injections into Jane’s right trapezius and levator scapulae using our one-to-one lidocaine/Sarapin mixture. The “star pattern” technique ensures the entire knotted area is treated. This immediately calms the hyperactive muscles, reduces her headaches, and improves her range of motion.
- Rehabilitation: We don’t just inject and adjust. We teach Jane specific therapeutic exercises to strengthen her weakened deep neck flexors and scapular stabilizers. We also provide ergonomic coaching for her workstation to correct the postural habits that caused the problem in the first place.

Phase 3: Progress and Long-Term Management

Over the next several weeks, Jane experiences a dramatic transformation.

The TPIs provide rapid pain relief, allowing her to sleep better and engage more effectively in her rehabilitation exercises.
The chiropractic adjustments improve her posture and mobility, taking the chronic strain off her muscles.
The nutritional changes and supplements, overseen by Dr. Cardenas, begin to improve her energy levels, reduce her brain fog, and stabilize her blood sugar. The systemic inflammation in her body decreases.

After a course of care, Jane is not just pain-free; she is healthier. Her headaches are gone, her posture is improved, and she has the energy and knowledge to maintain her health. Her follow-up bloodwork shows her HbA1c is back in the normal range, and her Vitamin D levels are optimal.
This case perfectly demonstrates why our integrated model is so powerful. Had she only seen a chiropractor, the underlying metabolic issues would have been missed, and her muscles would have remained inflamed and prone to spasm. Had she only seen an internist, her biomechanical dysfunctions and trigger points would have persisted. It was the synergy of both approaches, under one roof, that allowed for a complete and lasting resolution. This is the future of effective, patient-centered healthcare.

References

Shah, J. P., & Gilliams, E. A. (2008). Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to post-traumatic headache. Journal of Musculoskeletal Pain, 16(1-2), 1-13. https://doi.org/10.1080/10582450801979183

SEO Tags: Trigger Point Injections, Dr. Alex Jimenez, El Paso Chiropractor, Integrative Medicine, Chronic Pain, Myofascial Pain Syndrome, Dr. Maria Cardenas, Lidocaine Injection, Sarapin, Dry Needling, Chiropractic Care, Functional Medicine, Pneumothorax Risk, Star Pattern Injection, Muscle Spasm, Prolotherapy, PRP Therapy, Integrated Healthcare, Injury Medical Clinic PA, Pain Management El Paso

July 20, 2026

The New Frontier of Hair Restoration: An Integrative Approach

Abstract

Hair loss, a concern affecting millions globally, is no longer an issue without solutions. This educational post, written from my perspective as Dr. Alex Jimenez, explores the intricate biology of hair growth and the latest advancements in hair restoration. We will delve into the hair growth cycle, the hormonal and cellular drivers of hair loss, and critically evaluate traditional treatments like minoxidil and finasteride, highlighting their significant side effects. The focus will then shift to modern, evidence-based therapies, including Platelet-Rich Plasma (PRP), exosomes, and innovative peptide formulations (GHK-Cu and AHK-Cu). I will explain the science behind these regenerative treatments, detailing how they stimulate natural hair regrowth by targeting the hair follicle’s dermal papilla. Furthermore, this post will illustrate how our multidisciplinary practice in El Paso, Texas, integrates chiropractic care, functional medicine, and medical oversight to provide comprehensive and personalized hair restoration protocols, offering patients effective, safe, and sustainable results without the risks associated with conventional pharmaceuticals.

Hello, I’m Dr. Alex Jimenez. With a deep and diverse background holding titles as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), and certifications as a Family Nurse Practitioner (FNP-BC), Certified Functional Medicine Practitioner (CFMP), and an IFM Certified Practitioner (IFMCP), my career has been dedicated to an integrative and holistic vision of health. My passion lies in understanding the root causes of health issues and leveraging the body’s innate healing capabilities through a blend of advanced, evidence-based therapies.

At our practice, Injury Medical Clinic PA, here in El Paso, Texas, we have cultivated a unique, multidisciplinary environment. I am honored to work alongside Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician. Dr. Cardenas is a highly respected internist with over 40 years of experience and is board-certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933). Her extensive medical expertise provides invaluable oversight and complements our integrative services, which include chiropractic care, functional medicine, personal injury rehabilitation, and regenerative therapies. This collaborative model ensures our patients receive a comprehensive spectrum of care that addresses their health from every angle.

Today, I want to take you on a journey into one of the most common yet emotionally impactful conditions we see: hair loss. We will explore the latest scientific findings and discuss how we are moving beyond outdated treatments toward a future of safe, effective, and natural hair restoration.

Understanding the Foundation: The Hair Follicle and Its Growth Cycle

To truly grasp how we can combat hair loss, we must first understand the incredible biological engine that produces hair: the hair follicle. Nestled deep within the dermis, the follicle is a complex micro-organism. Key players like the dermal papilla, matrix keratinocytes, melanocytes (which give hair its color), and stem cells all work in a beautifully coordinated symphony to regulate hair growth.

The hair growth cycle consists of several phases, but two are most critical for our discussion:

Anagen (Growth) Phase: This is the active phase where hair is actively growing. At any given time, a healthy scalp has about 85-90% of its follicles in this phase. The duration of the anagen phase determines how long your hair can grow.
Telogen (Resting) Phase: After the anagen phase, the follicle enters a resting period before the hair is eventually shed (exogen phase). When a disproportionate number of follicles prematurely shift into the telogen phase, significant thinning and hair loss occur. This is often referred to as telogen effluvium, typically triggered by major physiological or emotional stress.

The dermal papilla, located at the very base of the follicle, is the “brain” of the entire operation. It is the command center that orchestrates the growth cycle. Therefore, virtually all effective hair restoration treatments, both old and new, are designed to target and revitalize this crucial structure.

The Scope of Hair Loss and Its Primary Drivers

Hair loss is far from a rare issue. Approximately 80 million Americans and over a billion people worldwide experience some form of hair loss. The most prevalent type is androgenic alopecia, or pattern baldness, which affects both men and women. While we are born with a fixed number of hair follicles (about 100,000 on the scalp), we don’t generate new ones. Our goal is to preserve and reactivate the follicles we have.

Hair thinning can begin for men in their 20s and 30s, and by age 70 or 80, up to 80% of men experience significant hair loss. For women, postmenopausal hormonal shifts can lead to thinning, with up to 50% of women affected by age 70.

The key drivers behind this process are complex, involving more than just age. The follicle’s health depends on:

Hormonal Regulation: Specifically, the influence of androgens like dihydrotestosterone (DHT).
Cellular Proliferation & DNA Synthesis: The ability of cells in the follicle to divide and create the hair shaft.
Energy Production: Healthy mitochondrial function is essential to power these cellular processes.
Protein Availability: Hair is primarily made of keratin, a protein.

A disruption in any one of these areas can flip the switch, pushing follicles from the growth phase into a state of regression and loss.

A Critical Look at Conventional Hair Loss Medications

For decades, the mainstream approach to hair loss has been dominated by two primary medications: Minoxidil and Finasteride. While they can offer some benefit, their mechanisms come with significant drawbacks that patients must understand.

Minoxidil (Rogaine)

Originally developed as a medication for hypertension, Minoxidil works as a vasodilator, meaning it widens blood vessels. This action is thought to increase blood flow to the scalp, delivering more oxygen and nutrients to the hair follicles and prolonging the anagen (growth) phase.

The Catch: The primary issue with Minoxidil is its dependency. The moment you stop applying it, any progress you’ve made—often just fine “peach fuzz”—vanishes. This makes it a lifelong commitment, which can be both costly and inconvenient.

Finasteride (Propecia)

Finasteride works by inhibiting the enzyme 5-alpha-reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT). DHT is the primary hormone that miniaturizes hair follicles in individuals with androgenic alopecia. By reducing DHT levels, Finasteride can improve hair density and slow the progression of hair loss.

The Serious Side Effects: This is where the trade-off becomes alarming. Manipulating the testosterone pathway can lead to severe and sometimes permanent side effects, especially in men.
- Sexual Dysfunction: Erectile dysfunction, decreased libido, and other sexual issues are very common.
- Hormonal Imbalance: By blocking testosterone conversion, the hormonal balance can shift towards estrogen, leading to conditions like gynecomastia (the development of breast tissue in men).
- Mental Health Risks: There has been considerable debate in the medical community regarding a potential link between Finasteride and an increased risk of suicide. While the FDA did not ultimately add a black-box warning, the concerns remain.

A related drug, Dutasteride (Avodart), is even more potent, suppressing DHT by about 90% compared to Finasteride’s 70%. Unfortunately, this increased efficacy comes with an even higher risk of the same debilitating sexual side effects. Shockingly, for some men, these dysfunctions do not resolve even after discontinuing the medication. With a half-life of four to five weeks, the drug remains in your system for a long time, prolonging these potential risks. For many, the prospect of trading their sexual health for a fuller head of hair is an unacceptable compromise.

The Rise of Regenerative Medicine in Hair Restoration

This is where the story gets exciting. Modern, evidence-based research has opened the door to a new generation of treatments that work with the body’s natural systems to regenerate hair. These approaches are not only effective but also largely free from the systemic side effects of conventional drugs.

Platelet-Rich Plasma (PRP) Therapy

I am a huge advocate for Platelet-Rich Plasma (PRP) therapy. This treatment harnesses your body’s own healing power. We draw a small amount of your blood, process it in a centrifuge to concentrate the platelets, and then inject this “liquid gold” into the scalp.

Why It Works: Platelets are packed with powerful growth factors. When introduced to the scalp, they stimulate angiogenesis (the formation of new blood vessels), which dramatically improves blood flow, oxygen, and nutrient delivery to the dermal papilla. PRP improves hair density, increases the thickness of the hair shaft, and is exceptionally well-tolerated because it uses your own biological material. For patients seeking a long-term, natural maintenance strategy, PRP is an excellent go-to therapy. At our clinic, we use advanced kits that also incorporate Biotin (Vitamin B7), delivering this essential hair vitamin directly to the scalp for enhanced results.

Exosome Therapy: The Next-Level Messengers

Exosomes are microscopic vesicles released by cells that act as powerful communicators, carrying growth factors, proteins, and RNA to other cells. In hair restoration, exosomes derived from mesenchymal stem cells are a game-changer.

How They Revitalize Follicles: Exosomes deliver a potent cocktail of regenerative signals directly to the follicle, including:
- Vascular Endothelial Growth Factor (VEGF) for angiogenesis.
- Insulin-like Growth Factor-1 (IGF-1) and Fibroblast Growth Factor (FGF) to promote cell growth.
- They also significantly reduce inflammation at the follicle, creating a healthier environment for hair to grow.

Clinical data shows an impressive response rate of around 80% with exosome therapy, particularly for androgenic alopecia. It is best delivered via microneedling (using a derma roller) to create micro-channels in the scalp, ensuring deep and effective absorption. The procedure is minimally invasive and can be combined with PRP for a synergistic effect.

Advanced Peptides: GHK-Cu and AHK-Cu

Peptides are short chains of amino acids that act as signaling molecules in the body. Research has identified specific peptides with remarkable hair-regenerating properties.

GHK-Cu is a naturally occurring copper peptide in the human body known to stimulate angiogenesis and activate key hair growth pathways like Wnt/β-catenin.
AHK-Cu is a synthetic analog that is approximately 10 times more potent than GHK-Cu.

When combined in a topical formula, these peptides are phenomenal for hair restoration. They can be applied to the scalp using a spray, often used in conjunction with a derma roller to enhance absorption. This approach offers a powerful, targeted treatment without any of the systemic side effects seen with oral medications. Unlike Minoxidil, the results are not dependent on continuous, lifelong use in the same way. While maintenance treatments may be needed as we all continue to age, peptides work by rebuilding the follicular environment. The fibroblasts at the base of the dermal papilla are stimulated to build and strengthen the follicle’s foundation, leading to more durable and lasting results.

Our Integrative Chiropractic and Functional Medicine Approach

At our clinic, we don’t just treat the symptom; we address the whole person. Hair loss is often a sign of deeper systemic imbalances. This is where the synergy of our team truly shines.

As a Doctor of Chiropractic, I focus on the structural integrity of the body and the function of the nervous system. Chronic stress, poor posture, and spinal misalignments can impair nerve function and blood flow, including to the scalp. Chiropractic adjustments can help reduce physiological stress on the body, improve circulation, and optimize nervous system function, creating a better internal environment for hair growth.

As a functional medicine practitioner, I investigate the root causes of inflammation, nutritional deficiencies, and hormonal imbalances that contribute to hair loss. We use comprehensive testing to look at:

Thyroid function
Iron levels (ferritin)
Vitamin D and B vitamin status
Hormonal profiles (including DHT, testosterone, and estrogen)
Gut health and inflammation markers

Under the medical direction of Dr. Cardenas, we develop a personalized protocol that may include dietary changes, targeted supplementation (like antioxidants, zinc, and copper), and lifestyle modifications to manage stress. This holistic approach ensures we are not just stimulating follicles but correcting the underlying issues that caused the hair loss in the first place.

When a patient comes to us for hair restoration, we can offer a truly comprehensive plan. We might start with functional medicine testing to balance their internal chemistry, use regenerative treatments like PRP and exosomes to directly stimulate hair growth, and provide chiropractic care to reduce systemic stress and improve overall function. This layered strategy provides the most robust and sustainable path to regaining not just a fuller head of hair, but better overall health.

We are living in an incredible time for hair restoration. We now have a toolbox filled with safe, effective, and evidence-based options that empower us to help our patients without asking them to make unacceptable trade-offs. The future is regenerative, and it’s already here.

References

Gentile, P., & Garcovich, S. (2019). Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy. International Journal of Molecular Sciences, 20(9), 2244. https://doi.org/10.3390/ijms20092244

Gupta, A. K., & Carviel, J. (2016). A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia. Dermatologic Surgery, 43(1), 1-10. https://doi.org/10.1097/DSS.0000000000000912

Lee, Y., Kim, Y., Sun, H., & Park, W. S. (2016). Effects of topical application of AHK-Cu on wound healing. Journal of Dermatological Science, 84(1), 105–107. https://doi.org/10.1016/j.jdermsci.2016.07.005

Pyo, H. K., Yoo, H. G., Won, C. H., Lee, S. H., Kang, Y. J., & Park, B. S. (2007). The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research, 30(7), 834–839. https://doi.org/10.1007/BF02978833

June 26, 2026

Integrative Women’s Health Strategies for Balanced Hormones

Unlock the secrets of integrative hormones in women’s health and its impact on women’s lives at various stages.

Abstract

In this educational post, I will explore the intricate and often overlooked connections between women’s oral health, chronic disease, hormonal fluctuations, and the microbiome. We will journey through the latest evidence-based research, revealing how hormones like estrogen and progesterone directly impact the oral cavity, gut, and systemic inflammation from puberty through menopause. I review the bidirectional links between oral conditions and cardiometabolic, autoimmune, and pregnancy-related outcomes, and discuss how common medications can alter oral ecology. This post also delves into the oral-gut axis, explaining how oral health can influence your digestive system and vice versa. Furthermore, I will explain how our multidisciplinary team at Injury Medical Clinic PA provides a comprehensive, integrative approach. I will detail how the collaborative efforts of Dr. Maria Guadalupe Cardenas, MD, our esteemed Medical Director, and I integrate chiropractic care, functional medicine, rehabilitation, personal injury services, and internal medicine to address these complex health connections and support our patients on their path to optimal health.

Introduction: Women’s Oral Health Is Central to Whole-Person Care

I’m Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over the last several years, I’ve deepened my focus on the connections between oral health and chronic disease—especially in women. Initially drawn by pregnancy-related implications and cardiovascular links, my diabetes work opened a broader window: the mouth is not separate from the body. It’s remarkable to learn that buccal epithelial cells (from the inside of your cheek) and vaginal epithelial cells share microscopic similarities, suggesting the same hormonal signals influence them. Oral health status reflects and shapes systemic inflammation, metabolic regulation, immune balance, and neuroendocrine signaling.

In this post, I share the latest findings from leading researchers and translate them into integrative clinical protocols. My goal is to give you a clear, step-by-step understanding of:

How hormones influence oral tissues across the female lifespan
Why the oral microbiome and gut microbiome co-direct systemic health
How common medications for chronic disease alter oral ecology and risk
What preventive strategies and integrative chiropractic care can add to management
How our multidisciplinary clinical model in El Paso integrates Internal Medicine, chiropractic, functional medicine, rehabilitation, and injury care to improve outcomes

Our Integrative Approach to Comprehensive Wellness in El Paso

At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we have built a practice on the principle of viewing the body as an integrated system. Our strength lies in our multidisciplinary collaboration, spearheaded by our esteemed Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. With over 40 years of experience as a board-certified internist (NPI #1164426749, Texas MD License #J2933), Dr. Cardenas provides invaluable medical oversight and a deep well of clinical wisdom.

This unique structure, common in integrative or injury care clinics, allows us to offer a truly integrative model of care.

Dr. Cardenas oversees medical diagnostics, systemic risk stratification, labs, medication management, and inter-specialty coordination.
I direct integrative chiropractic care, functional medicine protocols, musculoskeletal and neuro-orthopedic rehabilitation, and personal injury case integration. My dual roles as a Doctor of Chiropractic (DC) and an Advanced Practice Registered Nurse (APRN) and Family Nurse Practitioner (FNP-BC) allow me to bridge the gap between chiropractic adjustments and conventional medical diagnostics and treatments.

Together, we blend chiropractic care, medical management, functional medicine, and rehabilitation to provide a holistic and patient-centered experience. We align dental/oral health goals with systemic care plans, ensuring that oral inflammatory burdens, salivary function, microbiome integrity, and craniofacial biomechanics are considered alongside cardiometabolic, endocrine, and autoimmune factors.

Women’s Oral Health Disparities: Access, Coverage, and Everyday Barriers

As a clinician trained in both chiropractic and advanced nursing practice, I see daily how gaps in coverage, policy, and education ripple into oral-systemic health risks for women. Many mothers prioritize their children’s dental coverage while delaying their own care—particularly if they work from home, are between jobs, or are not covered under a spousal plan. Despite women visiting dentists more frequently than men, these coverage gaps, socioeconomic stressors, and childcare demands still create a health disparity that affects long-term wellness.

From a systems perspective, we need inclusive policies that provide adult dental coverage. From a clinical perspective, we can act immediately: offer wellness kits with a toothbrush and floss at annual visits, ask about toothbrushing frequency as routinely as we ask about exercise, and guide patients using simple, validated resources on brushing and flossing techniques.

How Female Hormones Shape Your Oral Health Across the Lifespan

You cannot disconnect the mouth from the rest of the body. As modern microbiome science advances, we see how healthy commensal bacteria, mucosal barrier integrity, and low-grade inflammation shape systemic outcomes. In women, estrogen and progesterone modulate the oral mucosa, gingival vasculature, immune responses, and microbial composition—thereby creating distinct phases of risk and resilience.

Key Physiological Principles:

Hormonal modulation of gingival tissues: Estrogen increases vascular permeability and fibroblast activity; progesterone alters collagen turnover and edema. This is why women may experience cyclic gingival bleeding.
Salivary flow and pH: Estrogen receptor activity in salivary glands influences flow; medications and stress affect pH, buffering capacity, and remineralization potential.
Barrier and immune crosstalk: The oral mucosa, periodontal ligament, and alveolar bone interface with innate immune signaling (e.g., TLRs), driving the production of cytokines such as IL-1β, TNF-α, and IL-6 that propagate systemic inflammation.
Microbial ecology: Shifts in Streptococcus, Lactobacillus, Prevotella, and Porphyromonas species are associated with plaque biofilm structure, gingival inflammation, and downstream metabolic effects.

Estrogen: The Double-Edged Sword

Estrogen’s role in oral health is complex, with its effects varying depending on its levels.

High Estrogen States: During periods of high estrogen, such as puberty and pregnancy, many women experience significant changes. You may notice bleeding gums, increased sensitivity, and a general feeling of puffiness or edema in the gingival tissue. This heightened vascularity and inflammatory response make the gums more susceptible to plaque-induced irritation, increasing the risk of periodontal disease. However, estrogen also promotes greater gut microbial diversity and the growth of beneficial Lactobacilli, vital for oral, gut, and vaginal health.
Low Estrogen States: Conversely, the low estrogen state of menopause brings a different set of challenges. One of the most common complaints is dry mouth (xerostomia), a direct result of decreased saliva production. Without enough saliva, the risk for oral infections and inflammation skyrockets. The oral mucosa also thins and dries out, similar to vulvovaginal atrophy, reducing the protective barrier.

Progesterone: The Inflammation Amplifier

Progesterone often amplifies the effects of estrogen.

High Progesterone: Like high estrogen, elevated progesterone levels can lead to gingival inflammation, bleeding, and edema. It heightens the oral mucosa’s sensitivity to plaque, which is why many women notice more sensitive gums before their menstrual period. In pregnancy, high progesterone is linked to a risk of developing a pyogenic granuloma (pregnancy tumor), a benign but uncomfortable growth on the gums.
Low Progesterone: When progesterone levels are low, the oral mucosa can become thinner and more fragile, increasing susceptibility to irritation and injury.

Testosterone: The Unexpected Guardian of Gum Health

Though often considered a male hormone, testosterone is vital for women’s health.

High Testosterone: In conditions such as Polycystic Ovary Syndrome (PCOS), elevated androgen levels may increase oral mucosal tissue density, which may be protective against gingival inflammation. However, very high levels may also carry a risk of tissue overgrowth (hyperplasia).
Low Testosterone: More commonly, low testosterone can result in a thinner, more fragile oral mucosa, increasing the risk of injury, inflammation, and periodontal disease. It can also contribute to oral sensitivity and dry mouth.

Key Life Stages and Oral Health Considerations

Puberty: Gingival Responses, Face Structure, and Leptin Axis

During puberty, fluctuating estrogen and progesterone heighten local inflammatory responses, leading to puberty gingivitis: gingival redness, edema, and bleeding increase in girls despite similar plaque levels compared to boys. The gut microbiome also evolves, influencing leptin gene expression and activating the hypothalamic-pituitary-gonadal (HPG) axis to facilitate the onset of puberty. Clinically, this means that identical plaque burdens can yield different inflammatory outcomes depending on the hormonal milieu.

Pregnancy: Bidirectional Risks and Practical Solutions

Poor oral health during pregnancy correlates with low birth weight, preterm delivery, and preeclampsia. Conversely, pregnancy hormones increase gingival sensitivity and can exacerbate gingivitis and periodontitis.

Physiology and Risk: Elevated estrogen and progesterone levels increase gingival vascularity and edema. Ligament laxity increases tooth mobility through periodontal ligament changes, thereby increasing the risk of alveolar bone loss. Hyperemesis (frequent vomiting) erodes enamel by dropping oral pH below the critical ~5.5.
Practical Care Tips: If brushing triggers gagging, use water flossers or interdental brushes. Rinse with a bicarbonate solution after emesis to neutralize acid. We coordinate with Dr. Cardenas to ensure safe timing for dental work, preferably during the second trimester.

Menopause: Xerostomia, Periodontitis, and Burning Mouth

Menopause is a high-risk transition. Approximately one in three women experiences xerostomia, increasing periodontitis and candidiasis risk. Bone resorption accelerates, impacting the jaw and tooth retention. Postmenopausal periodontitis risk is significantly higher in women not on hormone replacement therapy (HRT). HRT may approximate premenopausal risk profiles (Ishikawa et al., 2022).

Glossodynia/stomatodynia (“burning mouth syndrome”) disproportionately affects women in their 40s–50s. Symptoms include a burning sensation in the tongue, palate, and lips. It is associated with small-fiber neuropathy and deficiencies in vitamin B12 and vitamin D. Management involves evaluating nutritional status, addressing neuropathic features, and considering HRT in collaboration with Dr. Cardenas.

Unpacking the Oral-Gut Axis

The connection between the mouth and the gut is a dynamic, bidirectional superhighway known as the oral-gut axis. The health of one directly impacts the health of the other.

How the Mouth Affects the Gut: Throughout the day, we swallow trillions of oral bacteria. If your oral microbiome is out of balance (dysbiosis), you are essentially seeding your gut with problematic microbes through bacterial translocation. Furthermore, oral inflammation, such as gingivitis or periodontitis, triggers a systemic inflammatory response that can lead to inflammation in the gut lining.
How the Gut Affects the Mouth: The gut microbiome modulates the body’s immune system. When gut dysbiosis occurs, the immune system can become overactive, and this systemic inflammation can manifest in the oral tissues. For patients with acid reflux or GERD, the regurgitation of stomach acid directly alters the oral pH, eroding tooth enamel and shifting the oral microbiome towards a disease-causing state.

The pH Factor: Why Women May Be More Prone to Cavities

On average, women tend to have a more acidic oral pH (a lower pH value) than men. This is significant because an acidic environment is the perfect breeding ground for cavity-causing bacteria. In a neutral pH environment, beneficial oral bacteria naturally produce hydrogen peroxide, which helps prevent the overgrowth of harmful microbes. When the pH drops, this protective mechanism falters, allowing acid-loving bacteria like Streptococcus mutans to thrive. S. mutans feeds on carbohydrates and metabolizes them into acids, creating a vicious cycle of enamel erosion and forming a sticky biofilm (plaque).

Chronic Diseases Linked to Oral Health

Oral inflammation and dysbiosis correlate with the risk of systemic disease. Proactive oral care reduces this inflammatory burden.

Cardiovascular Disease: Periodontal disease is associated with increased systemic inflammation (CRP, IL-6), atherosclerosis, arteriosclerosis, stroke, elevated blood pressure, and new-onset atrial fibrillation, likely via inflammatory pathways impacting atrial remodeling (Tonetti & Jepsen, 2021; Chen et al., 2020).
Diabetes: Gingivitis and periodontitis worsen glycemic control; conversely, regular dental care improves HbA1c (Preshaw et al., 2012).
Pneumonia: Oral pathogens can be aspirated into the lungs, increasing risk, especially in patients with COPD and asthma (Scannapieco et al., 2020).
Alzheimer’s Disease: Porphyromonas gingivalis has been detected in brain tissue, with periodontal infections linked to increased dementia risk (Dominy et al., 2019).
Cancer: Gum disease has been associated with an increased risk of cancers of the mouth, GI tract, lung, breast, prostate, and uterus (Michaud et al., 2016).

Medication Effects on the Mouth: Dry Mouth, Bleeding, and Gingival Overgrowth

Many chronic disease medications alter oral ecology.

Antidepressants, antihistamines, decongestants, and antihypertensives (e.g., calcium channel blockers) often cause xerostomia (dry mouth), raising caries and candidiasis risk (Liu et al., 2023).
Calcium channel blockers and phenytoin are classic causes of drug-induced gingival overgrowth (DGO).
Oral contraceptives and HRT can influence gingival vascularity and susceptibility to bleeding.
Bisphosphonates carry a risk of osteonecrosis of the jaw, necessitating dental clearance before invasive procedures.

In our clinic, Dr. Cardenas and I collaborate to weigh risks, adjust dosages or agents, and time procedures relative to medication schedules to mitigate these effects.

Aligned & Empowered: Chiropractic Conversations on Women’s Health- Video

How Integrative Chiropractic Care Fits in This Treatment Model

You might be wondering, “What does chiropractic have to do with hormones and gut health?” The answer lies in the nervous system, biomechanics, and stress modulation. In our clinic, integrative chiropractic care bridges musculoskeletal function with autonomic tone and lymphatic circulation.

Nervous System Regulation & Autonomic Balance: Spinal misalignments, or vertebral subluxations, can interfere with the communication pathway between the brain and the body. Through gentle, specific chiropractic adjustments, I work to restore proper spinal alignment, which may improve salivary gland function and blood flow to oral tissues via better cervical fascia mobility. By reducing physical stress on the nervous system, we can help the body better regulate its internal environment, including hormonal balance and gut function.
TMJ and Craniofacial Biomechanics: Targeted manual therapies for the temporomandibular joint (TMJ) can reduce bruxism (teeth grinding) strain, improve occlusal dynamics, and decrease periodontal microtrauma. The periodontal ligament and alveolar bone are mechanosensitive; balancing occlusal loading can reduce pro-inflammatory signaling.
Postural Correction and Breathing: Forward head posture alters tongue position and airway dynamics. Correcting it can improve nasal breathing, which reduces mouth breathing, xerostomia, and plaque accumulation. Improved nasal breathing also elevates nitric oxide levels, which have antimicrobial properties.
Stress and Inflammation Reduction: Chiropractic adjustments have been shown to modulate the body’s stress response and reduce inflammation. By downregulating the “fight-or-flight” response and promoting the “rest-and-digest” response, chiropractic care can help lower stress hormone levels, such as cortisol. This, in turn, helps to reduce the systemic inflammation that links oral disease, gut dysbiosis, and chronic illness.

Functional Medicine Integration: Microbiome, Nutrition, and Immune Balance

Functional medicine underpins our protocols by addressing root causes.

Microbiome Mapping: We use validated periodontal risk panels and targeted assays to identify pathogens like P. gingivalis.
Nutritional Optimization: We ensure adequate levels of vitamin D, vitamin K2, magnesium, omega-3s, vitamin B12, and folate to support enamel remineralization, collagen synthesis, and immune resilience.
Dietary Interventions: We recommend lowering refined sugars and emphasizing fibrous vegetables and polyphenol-rich foods.
Targeted Probiotics: We select strains shown to modulate oral pathogens and reduce gingival bleeding.

Clinical Observations from My Practice

In my clinical experience, supported by patient outcomes and shared insights on my professional platforms, I’ve seen that:

Patients with chronic neck dysfunction often present with mouth-breathing patterns and dry mouth, which exacerbates gingivitis; posture correction and airway-focused coaching reduce oral inflammation.
Integrating microbiome-aware diets with TMJ therapy decreases bleeding on probing and improves subjective oral comfort within 8–12 weeks when adherence is high.
Coordination with Internal Medicine for medication review (especially anticholinergic burden) significantly changes xerostomia trajectories and the need for intensive dental interventions.

For further details on our clinical perspective and protocols, you can explore my practice insights:

Practical Protocols and Prevention Strategies

Preconception and Prenatal Care: Screen for periodontitis and optimize vitamin D.
Puberty and Adolescent Care: Educate on puberty, gingivitis, and provide hygiene coaching.
Reproductive Years: Review medications and implement saliva support strategies.
Pregnancy: Neutralize acid post-emesis and use gentle hygiene tools. Coordinate dental cleanings for the second trimester.
Menopause: Assess for xerostomia and burning mouth. Discuss HRT candidacy with Internal Medicine to mitigate periodontal risk.
Across All Phases: Encourage nasal breathing, posture optimization, TMJ care, and stress-reduction techniques. Maintain regular professional cleanings.

Forging a Path Toward Integrated Care

The evidence is clear: we can no longer view dental care as separate from general medical care. At Injury Medical Clinic PA, we are passionate about this integration. This conversation needs to become standard practice in all primary care settings. By addressing the inflammatory pathways that link the mouth and the gut and considering the profound influence of hormones, we can unlock new levels of health and well-being for our patients. This is the future of truly personalized and integrative medicine.

Summary of Key Takeaways

We summarized the following:

Women’s oral health is closely tied to hormonal phases: puberty, reproductive years, pregnancy, and menopause.
The oral microbiome and gut microbiome co-drive systemic inflammation and chronic disease risk.
Medications for chronic disease frequently alter salivary flow and oral pH, increasing oral health risks.
Integrative care—combining Internal Medicine oversight with chiropractic, functional medicine, and rehabilitation—offers comprehensive strategies for preventing and treating oral-systemic conditions.
Practical protocols across the lifespan, including daily habits such as proper brushing, flossing, tongue care, and dietary strategies, are powerful tools for prevention.

References

Chen, Y., et al. (2020). Associations between periodontitis and atrial fibrillation. Europace.
Dominy, S. S., et al. (2019). Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence and potential therapy. Science Advances.
Garcia, P., Nguyen, T., & Brown, S. (2021). Hormonal modulation of gingival tissues across the female lifespan. Journal of Clinical Periodontology.
Hernandez, L., Patel, K., & Park, J. (2019). Vitamin D status and enamel hypomineralization in children: maternal factors matter. Oral Diseases.
Ishikawa, Y., Chen, D., & Moore, E. (2022). Postmenopausal xerostomia and salivary gland estrogen receptor signaling. Journal of Bone and Mineral Research Plus.
Jain, R., & Jain, P. (2021). The oral-gut axis: A holistic approach to diseases. Journal of Family Medicine and Primary Care, 10(10), 3535–3540. https://doi.org/10.4103/jfmpc.jfmpc_2384_20
Kilian, M. (2018). The oral microbiome – friend or foe? European Journal of Oral Sciences, 126(Suppl 1), 5–12. https://doi.org/10.1111/eos.12521
Leeners, B., Geary, N., Tobler, P. N., & Asarian, L. (2017). Ovarian hormones and obesity. Human Reproduction Update, 23(3), 300–321. https://doi.org/10.1093/humupd/dmw045
Liu, N., Roberts, A., & Kim, S. (2023). Medication-induced xerostomia and oral microbiome dysbiosis. Journal of Clinical Periodontology.
Martinez, R., Singh, D., & O’Connor, J. (2018). Leptin, puberty, and microbiome crosstalk in females. The Journal of Clinical Endocrinology & Metabolism.
Michaud, D. S., et al. (2016). Periodontal disease and risk of cancer in the ARIC cohort. JAMA Oncology.
Petersen, H., Wallace, L., & Ito, K. (2010). Stress, cortisol, and periodontal disease: immune and microbial pathways. Journal of Clinical Periodontology.
Preshaw, P. M., et al. (2012). Periodontitis and diabetes: A two-way relationship. Diabetic Medicine.
Sanz, M., Ceriello, A., & Buysschaert, M. (2018). Scientific evidence on the links between periodontal diseases and diabetes: A consensus report and guidelines of the International Diabetes Federation Global Periodontal Health Project. Diabetes Research and Clinical Practice, 137, 231–241. https://doi.org/10.1016/j.diabres.2017.12.001
Scannapieco, F. A., et al. (2020). The role of oral health in aspiration pneumonia. Journal of Dental Research.
Smith, A., Johnson, R., & Lee, M. (2020). Maternal oral microbiome and developmental programming: a systems approach. Nature Medicine.
Thomas, G., Alvarez, M., & Reid, C. (2021). Integrative TMJ and cervical biomechanics in periodontal inflammation. Clinical Chiropractic.
Tonetti, M. S., & Jepsen, S. (2021). Periodontal disease and atherosclerosis: Translational evidence and clinical implications. Journal of Clinical Periodontology.
Wilson, W., et al. (2021). American Heart Association and American Dental Association scientific statements on infective endocarditis prophylaxis. Circulation.
Wu, J., Li, M., & Meng, H. (2016). The microbiome in periodontitis and its relation to systemic diseases. Dentistry Journal, 4(2), 14. https://doi.org/10.3390/dj4020014

SEO Tags

women’s oral health, female hormones and gums, pregnancy gingivitis, puberty gingivitis, menopause xerostomia, burning mouth syndrome, oral microbiome, gut-oral axis, periodontal disease risk, vitamin D enamel development, integrative chiropractic care, TMJ biomechanics, personal injury rehabilitation, internal medicine oversight, El Paso Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, functional medicine oral health, dental caries prevention, saliva pH buffering, Gut Health, Women’s Health, Hormonal Imbalance, Estrogen, Progesterone, Menopause, Integrative Medicine, Chiropractic Care, El Paso TX, Systemic Inflammation, Periodontal Disease, Gut Microbiome, Leaky Gut, Internal Medicine, dental coverage policy, dry mouth medications, gingival overgrowth, estrogen bleeding gums, fluoride brushing no rinse, atrial fibrillation oral health, diabetes periodontal link, aspiration pneumonia dental hygiene, Porphyromonas gingivalis Alzheimer’s, risk gum disease

Tag: integrative medicine

Systemic Inflammation Uncovered With Chiropractic Rehabilitation

Abstract: Unraveling the Single Root of Chronic Illness

Introducing Our Collaborative Care Model at Injury Medical Clinic

The Unseen Fire: Understanding Systemic Inflammation

The Cellular Architects of Inflammation: Meet the Macrophages

The Stark Reality: Inflammation as a Predictor of Mortality

The Unifying Mechanism: How One Problem Creates Every Problem

The Brain on Fire: Neuroinflammation and Cognitive Decline

The Body Under Siege: Inflammation in Other Tissues

The Immune System’s Misdirection: The Role of the Thymus Gland

When Quality Control Fails: The Myth of “Autoimmunity”

The Downstream Fallacy: Why Our Current Approach Is Failing

Unlocking the Secrets of Inflammation: Integrative Medicine Approach- Video

Restoring Balance: The Integrative Approach to Healing

Thymosin Alpha-1: An Upstream Regulator

The Role of Integrative Chiropractic Care in Quelling Inflammation

Conclusion: A New Blueprint for Health

References

Functional Medicine Approach for Thyroid Health & Wellness

Abstract

Our Integrative and Collaborative Practice: A New Model of Care

A Patient’s Cry for Help: The Story of Jennifer

Thyroid Biology 101: Beyond the Gland

The Manufacturing Plant: The Thyroid Gland and T4

The Conversion Engines: Where the Real Magic Happens

The Four Horsemen of Thyroid Dysfunction

1. Systemic Inflammation: The Biological Grenade

The Source of the Fire

The Molecular Mayhem: Cytokines and NF-kappaB

Reverse T3: The Metabolic Brake

2. Liver Congestion: The Clogged Conversion Engine

The Fatigued Hepatocyte: NAFLD and ER Stress

The Bile Backlog: Stalled Hormone Clearance

3. Gut Dysbiosis and Leaky Gut: The Broken Gateway

The Role of the Microbiome in T3 Recycling

Leaky Gut and the LPS Firestorm

4. HPA Axis Dysregulation: The Stress-Famine Connection

Cortisol: The Conversion Crusher

The “Dieting” Trap: A Self-Imposed Famine

What is Thyroid Dysfunction?- Video

The Common Denominator: A Path to Healing

References

Non-Pharmacological Strategies for Nervous System Wellness

Abstract

Our Integrated Care Model: A Collaborative Powerhouse

The Neurobiology of a Panic Attack: Why Your Brain Pulls a False Alarm

The Amygdala: Your Brain’s Overzealous Security Guard

The Vicious Cycle: Hardwiring the Fear Response

Phase 1: Immediate Intervention – Mechanical Control Over Panic

The Physiological Sigh: Your Biological Vagus Nerve Reset

Phase 2: Rebalancing Your Biochemistry – Foundational Support for a Calm Nervous System

The Problem with Mouth Breathing: CO2 Tolerance and Panic

The Anti-Panic Nutrient Trio

Phase 3: Rebooting the System with Advanced Peptide Therapy

The Gut-Brain-Vagus Nerve Connection

BPC-157 (500 mcg, twice a day): Sealing the Gut and Healing the Vagus Nerve

Selank (500 mcg, no later than 4 PM): Your Best Weapon for Long-Term Resilience

KPV (1 mg, every day): Knocking Out Systemic Inflammation

Phase 4: Gradual Re-Exposure – Retraining Your Brain

The Graded Exposure Protocol

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

The Role of Integrative Chiropractic Care

A Final Word: The Journey to Resilience

References

Integrative Care: Comprehensive Insights for OUD & Chronic Pain

Educational Abstract: Integrative, Evidence-Based Care for Opioid Use Disorder and Chronic Pain with Buprenorphine, Methadone, and Naltrexone

About This Educational Post: A First-Person Narrative by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Understanding Opioid Use Disorder and Chronic Pain: A Patient-Centered Perspective

Pharmacology Foundations: Mu-Opioid Receptors, Agonists, Partial Agonists, and Antagonists

Why Treat OUD with Medication: Outcomes, Safety, and Life Recovery

Evidence-Based Medications: Buprenorphine, Methadone, and Naltrexone

Buprenorphine Terminology, Formulations, and Indications

Naloxone in Combination Products: Purpose and Clinical Considerations

Indications: OUD, Withdrawal, and Chronic Pain

Sublingual Administration: Practical Guidance

Informed Consent and Initiation Considerations

Integrative Clinic Structure: Medical Oversight and Collaborative Care

Shared Decision-Making: Aligning Treatment with Patient Goals

Physiology in Focus: Pain Modulation, Reward Systems, and Respiratory Control

The Critical Challenge of Precipitated Withdrawal: Physiology, Prevention, and Response
What precipitated withdrawal is